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Abstract 
The airway epithelium forms a continuous barrier from the nose to the alveoli and 
serves a variety of functions. Multiple functionally distinct cell types are involved in 
these processes. The innate defence functions require a patent airway epithelium, with 
infections often associated with epithelial defects and phenotypic alterations that are 
themselves associated with multiple lung diseases. Non-typeable Haemophilus 
influenzae (NTHi) and respiratory syncytial virus (RSV) are frequently identified in the 
airways in a range of respiratory diseases These pathogens often trigger exacerbations 
and worsening symptoms that often result in hospitalisation. This is particularly true in 
paediatric populations. Although mortality for NTHi and RSV infections alone are 
themselves low it remains unclear what role these infections play in mortality rates in 
complex chronic respiratory infections. These studies aimed to establish NTHi and RSV 
infections within airway epithelium models, and use them as tools to study pulmonary 
innate defence mechanisms in order to understand the role of these infections in 
respiratory disease.  
 
In vitro airway models were established using lung derived cell lines, undifferentiated 
primary human bronchial epithelial (uHBE) cells and air-liquid interface (ALI) 
differentiated uHBE cell cultures. Following establishment of differentiation we 
validated ALI cultures using a number of markers, including for the putative innate 
defence PLUNC family proteins, gel-forming mucins and tubulin. These markers are 
representative of different epithelial cell types within the cultures. Cultures were 
infected with NTHi or RSV for periods of time ranging from 1 hour to 7 days with a 
view to establishing chronic infections and allowing biofilm formation. Monolayer 
cultures showed an enhanced susceptibility to both infections. Cytokine array profiling 
showed enhanced pro-inflammatory cytokine profiles in response to NTHi and RSV 
infections in ALI cells resulting in an ability to manage infections compared to 
monolayer cultures. Expression analysis indicated that both infections altered the 
transcription of a number of pro-inflammatory genes. Neutrophil products and trypsin 
were shown to degrade PLUNC proteins in ALI cell secretions. NTHi also appeared to 
cause degradation of PLUNC proteins suggesting that infection may impair the innate 
defence shield of the airway epithelium. Our data showed that differential ALI cultures 
of human airway cells are a useful model for the study of respiratory pathogens. 
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 1. Introduction 
 
1.1. The Human Airway Epithelium 
The human airway epithelium forms a continuous lining of the entire respiratory tract 
from the cartilaginous trachea to the gas exchanging alveoli. From the trachea, through 
the  bronchi,  the respiratory bronchioles and finally the alveolar ducts, the airways 
gradually decreasing in diameter (Empey 1978). The cellular structure of the airway at 
these differing regions changes according to the function of the particular section. The 
airway epithelium is an integral part of the airway system, with defence mechanisms to 
protect the respiratory surface from invading pathogens or foreign particles, which we 
inhale constantly. Patients with a ‘diseased’ airway are often more susceptible to 
infections from these inhaled pathogens than ‘normal’ airways due to the effect of 
alterations of cellular structure on the innate defence mechanisms. 
 
 Structure of the Airway Epithelium 1.1.1.
Predominantly the airway epithelium is a ciliated, pseudostratified, columnar epithelium 
broadly consisting of ciliated, basal and secretory cell types in the proximal conducting 
epithelium (Spina 1998). The epithelium is deemed pseudostratified as the multi-level 
arrangement of the cells’ nuclei makes it appear stratified despite all cells being in 
contact with the basement membrane. As the airway narrows so does the thickness of 
this epithelium until it is a single layer of roughly cuboidal cells in the distal gas 
exchanging epithelium (Empey 1978) (See Figure 1.1).  
 
 Basal Cells 1.1.1.1.
Basal cells are characteristically the smallest cells of the airway epithelium, with a large 
nucleus to cytoplasmic ratio and a densely staining nucleus. There are few cytoplasmic 
organelles, secretory granules or cilia; there are, however bundles of low molecular 
weight cytokeratin (Hicks, Hall et al. 1997) which function in cell adhesion to the basal 
lamina and other cells. Basal cell morphology differs depending on the height of the 
epithelium. In a tall epithelium, the basal cells have higher levels of keratin filaments 
than shorter epithelium. The primary role of basal cells is to interact with the basal 
lamina and columnar epithelium to adhere the cells of the airway epithelium together.  
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This interaction occurs via hemidesmosomal attachments that use anchoring filaments 
and fibrils to form bonds with keratin in the basement membrane (Green and Jones 
1996), acting as a tether, a feature only found on basal cells in the airway epithelium 
(Evans, Cox et al. 1990). These attachments are strong, as the basal cells are the only 
cell type that firmly attaches to the basal lamina. They are also responsible for the 
binding of all other cell types; however these do not bind to the basal lamina so the 
basal cell is an important mediator. Tracheal columnar cells bind to the basal cells as 
well as neighbouring cells using desmosomal attachments; a trans-membrane complex 
belonging to the cadherin family consisting of cell adhesion and linking proteins that 
tether intracellular keratin to the cell surface adhesion proteins allowing cells to bind to 
each other (Green and Jones 1996). Desmosomal attachment structure numbers may be 
Figure 1.1: The cell types of the airway epithelium 
The variety of cell types present in the airway decreases with size. The larger 
bronchus contains basal, goblet and ciliated cells and is also the location of most 
sub-mucosal glands. The smaller bronchiolus consists mainly of ciliated and 
Clara cells, eventually becoming a single layer of cuboidal cells in the very small 
airways (respiratory bronchioles). Finally, the respiratory surface of the alveolus 
consists of Type I and Type II alveolar cells. 
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related to the level of physical stress on the epithelium as well as its adhesiveness; as it 
appears that there are the same amounts of hemidesmosomal attachment structures per 
cell (Evans, Cox et al. 1990). Therefore basal cells are important to the integrity of the 
airway epithelium as they differentiate with respect to the height of the epithelium, as 
well as the number of desmosomal attachments and the density of the keratin filaments. 
Basal cells are also thought to secrete various cytokines, 15-lipoxygenase and neutral 
endopeptidase as well as being the primary cell type from which goblet and ciliated 
cells originate (Boers, Ambergen et al. 1998; Knight and Holgate 2003). 
 
 Secretory Cells 1.1.1.2.
The secretory epithelial cell types consist of mucous (goblet) cells, serous cells and 
Clara (Club) cells. The main characteristic of the goblet cell is membrane-bound, 
electron-lucent, acidic, mucin (Muc) granules that are secreted throughout the airway. 
Goblet cells are the predominant source of mucin secretion in the non-cartilaginous 
airways alongside Clara cells, which have been shown to produce mucins in low levels 
in mice (Evans, Williams et al. 2004; Zhu, Ehre et al. 2008). Sub-mucosal glands found 
in the cartilaginous airways also secrete mucus (Empey 1978). Mucins are the major 
component of mucus, which is necessary for the trapping of invading pathogens and 
foreign particles for removal before they can cause damage to the airway epithelium and 
preventing tissues from drying out. Goblet cells are involved in regulating the amount 
of mucins secreted as well as the acidity and viscosity of the mucus, all important 
mediators in generating functional mucus. Normal human airways have approximately 
6800 mucus secreting cells per mm
2
 of epithelial surface (Knight and Holgate 2003), 
which change in shape and size depending on the proliferation of other epithelial cells 
(Rogers 2003). In some circumstances goblet cells are thought to be progenitors for 
ciliated cells (Patel, Brody et al. 2011) and can self-renew. 
 
Another type of cell classed as secretory, is the serous cell. These have a similar 
morphology to goblet cells but their granules are electron-dense rather than electron-
lucent (Rogers 2003). Serous secretions act as a lubricant to reduce friction generated by 
muscle movement in the lungs. 
 
The final major type of secretory cell type is the Clara cell. Clara cells are the 
predominant secretory cell type in the bronchioles (Thompson, Robbins et al. 1995). 
They contain electron-dense granules of approximately 500-600nm and are thought to 
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secrete mostly bronchiolar surfactant and Clara Cell Secretory Protein (CCSP) rather 
than mucins (Rogers 2003; Evans, Williams et al. 2004).  
 
 Ciliated Cells 1.1.1.3.
The most predominant cell type throughout the airway epithelium is the ciliated 
columnar epithelial cell, which arises from basal cells. Each cell has up to 300 cilia 
(Knight and Holgate 2003), which beat in a synchronized way at more than 100 beats 
per minute (Empey 1978), to sweep mucus away from the peripheral airways and 
towards the trachea as part of the mucociliary clearance process. It has been suggested 
in various studies that ciliated and goblet cells share a common lineage and will trans-
differentiate between the cell types, thus remodelling the airway epithelium. A recent 
study conducted by Turner et al (2011) showed trans-differentiation of ciliated cells to 
goblet cells by fluorescent tagging of the forkhead box protein J1 (FoxJ1) gene, a 
ciliated cell specific protein required for motile cilia (Yu, Ng et al. 2008). Using 
lentiviral constructs, they inserted a Cre recombinase under the control of the FoxJ1 
promoter and floxed the stop sequence to prevent expression of the inserted green 
fluorescent protein (GFP) under the control of a cytomegalovirus (CMV) promoter. 
FoxJ1 is expressed in ciliated cells, so upon differentiation and expression of FoxJ1, Cre 
was also expressed, which irreversibly removed the stop sequence to allow expression 
of the GFP tag, therefore labelling the ciliated cell lineage green (Patel, Brody et al. 
2011; Turner, Roger et al. 2011). It had previously been shown that cells cultured in the 
presence of interleukin (IL)-13 developed more goblet cells (Tyner, Kim et al. 2006), so 
after this period of differentiation, cells were exposed to IL-13 to change the proportions 
of cell types during a further differentiation period. Turner et al (2011) found expression 
of green fluorescence in goblet cells that also stained positively for MUC5AC, showing 
trans-differentiation of FoxJ1 expressing ciliated cells to goblet cells. 
 
 Function of the Airway Epithelium 1.1.2.
The major function associated with the airway epithelium is that of protection, it is the 
first line of defence against foreign invading particles. The junctional mechanisms 
holding the various cell types together mean that the airway epithelium also forms a 
protective barrier. Junctional mechanisms comprise 3 aspects; zonula adherens which 
are involved in adhesion and recognition through use of cellular adhesion molecules 
(CAM), desmosomes which as previously mentioned are involved in conserving the 
integrity of the epithelium and finally tight junctions which provide an effective 
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physical barrier against invading pathogens (Thompson, Robbins et al. 1995). The 
mucociliary phenotype of the airway epithelium protects the lower/smaller airways from 
infection by trapping foreign particles (including bacteria and viruses) in mucus 
secreted by the goblet cells and sub-mucosal glands. The mucus, complete with trapped 
particles, is then transported up towards the trachea, and the oropharynx by the beating 
of the cilia, where it is either swallowed or expectorated. The epithelium also secretes 
various antimicrobials (including lactoferrin (LF), defensins and cathelecidin), anti-
proteases (including secretory leukoprotease inhibitor, elafin and alpha-1-antitrypsin) 
and antioxidants as additional protective mechanism that aid in the trapping and 
clearance of foreign particles (Thompson, Robbins et al. 1995).  
 
 Airway Lining Fluid 1.1.2.1.
The airway lining fluid (mucus) is crucial for maintaining hydration and protection of 
the airway epithelium. It broadly consists of mucins, immunoglobulins, anti-microbial 
enzymes and a variety of other proteins and inorganic salts and water.   
 
The major contributor to mucus composition are mucins, with gel-forming mucins 
MUC5AC and MUC5B being the most highly expressed. Mucins are high molecular 
mass, highly glycosylated proteins that function as components of mucosal secretions 
where they are involved as lubricants and also function as part of the host defensive 
shield. Other mucins detected in low amounts include MUC2, MUC7 and MUC16. 
MUC7 is expressed in the serous cells of the sub-mucosal glands (Sharma, Dudus et al. 
1998). MUC2 is expressed by goblet and serous cells of the sub-mucosal gland and the 
epithelium. MUC16 is expressed on the surface of serous and goblet cells, both on the 
surface of the airway epithelium and the sub-mucosal gland, and becomes trapped 
within the ciliary layer as part of the periciliary fluid (Davies, Kirkham et al. 2007). 
There are many more mucins than are mentioned here; some are membrane-tethered and 
some are secreted and these are reviewed in Linden, Sutton et al. (2008) and Kreda, 
Davis et al. (2012). As outlined above the gel forming mucins, MUC5AC and MUC5B 
are the major airway mucins and are described in more detail below. 
 
1.1.2.1.1. MUC5AC 
Initial identification of MUC5 identified 3 proteins, MUC5A, MUC5B and MUC5C, 
however MUC5A and MUC5C were shown to be encoded by the same gene, designated 
Muc5AC which is localised to chromosome 11p15 (Nguyen, Aubert et al. 1990). 
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Characterisation of this gene identified a 24bp tandem repeat domain and a consensus 
cysteine rich domain consisting of 10 cysteine residues repeated multiple times in the 
protein (Guyonnet Duperat, Audie et al. 1995).The gene contains at least 49 exons and 
encodes a peptide approximately 5700 amino acids in length (Guo, Zheng et al. 2014). 
The protein is highly glycosylated and this makes the protein form a huge complex that 
is measured in the mega Dalton range. MUC5AC is secreted in high quantities from 
goblet cells (Hovenberg, Davies et al. 1996) in the respiratory and digestive tracts. In 
the airways of asthmatics, levels if MUC5AC are significantly increase in comparison 
to normal airways (Ordonez, Khashayar et al. 2001; Takeyama, Fahy et al. 2001; Rose 
and Voynow 2006; Woodruff, Modrek et al. 2009; Fahy and Dickey 2010). 
 
1.1.2.1.2. MUC5B 
The gene encoding MUC5B is also localised to chromosome 11p15, but is separated 
from the Muc5AC gene by CpG islands (Nguyen, Aubert et al. 1990; Guyonnet 
Duperat, Audie et al. 1995). The Muc5B gene has a similar sequence to that of Muc5AC, 
and encodes a peptide that is approximately 5662 amino acids long (Desseyn, Buisine et 
al. 1998). Like MUC5AC, MUC5B is also very highly glycosylated. MUC5B is 
expressed predominantly in the mucous cells of the sub-mucosal gland (Sharma, Dudus 
et al. 1998). A recent paper identified MUC5B as the dominant gel-forming mucin in 
the normal distal airway epithelium which consists of basal and mucous cells, and 
expression of both MUC5B and MUC5AC are increased in idiopathic pulmonary 
fibrosis/ usual interstitial pneumonia, associating them with respiratory disease 
(Seibold, Smith et al. 2013). 
 
As both MUC5 proteins are secreted predominantly by goblet cells and from 
submucosal glands, it is perhaps not unsurprising to find that both proteins are 
significantly elevated in a number of chronic lung diseases. Excessive production of 
MUC5B and MUC5AC in chronic inflammatory lung diseases is a direct result of 
goblet cell hyperplasia and metaplasia. This increase in cell number directly correlates 
with increased MUC5B and MUC5AC levels (Hauber, Foley et al. 2006). It is also clear 
that the proteins can have alterations in their glycosylation associated with lung disease 
(Schulz, Sloane et al. 2005). 
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1.1.2.1.3. PLUNCs 
A key family of proteins secreted into the mucus are the ‘bactericidal permeability 
increasing (BPI) fold containing’ (BPIF) family (also known as the Palate, Lung and 
Nasal Epithelium Clone (PLUNC) family), which are localised to the goblet cells and 
sub-mucosal glands of the upper respiratory tract, though not all are mucus of 
respiratory associated. The genes for the PLUNC family members are located within a 
300kb region on human chromosome 20q11 (Bingle and Craven 2002). Family 
members have very little sequence homology, initially making them difficult to identify. 
They are termed ‘short’ or ‘long’ depending on the number of BPI-like domains they 
contain and currently short PLUNCs contain a single domain whereas the LPLUNCs 
have two domains. In humans, there are four short proteins (including one pseudogene) 
and seven long proteins (including two pseudogenes) (Bingle, Bingle et al. 2011).  
 
The best characterised family member, SPLUNC1 (BPIFA1) is encoded by the plunc 
gene is a leucine-rich protein of 256 amino acids (Bingle and Bingle 2000). SPLUNC1 
is found in some non-ciliated upper airway epithelial cells, but is predominantly found 
in the airway sub-mucosal glands (Bingle, Cross et al. 2005). SPLUNC1 has been 
identified in a range of cancers in the lung and airways (Acton, Dahlberg et al. 1996; 
He, Xie et al. 2000; Iwao, Watanabe et al. 2001; Bingle, Cross et al. 2005), salivary 
gland (Vargas, Speight et al. 2008) and the stomach (Sentani, Oue et al. 2008), and an 
increase in SPLUNC1 expression has been associated with cystic fibrosis (CF) and 
chronic obstructive pulmonary disease (COPD) (Bingle, Barnes et al. 2007).  
 
LPLUNC1 (BPIFB1), another well characterised family member, is a 484 amino acid 
protein that is post-translationally modified to form two differentially glycosylated 
isoforms. It is expressed in goblet cells of the upper airways and in the sub-mucosal 
glands (Bingle, Wilson et al. 2010). These proteins are rarely co-localised. The true 
functions of these proteins are unknown but based on structural comparisons it is 
thought that they may play a role in innate defence (Bingle and Craven 2004). There is 
increasing evidence that these proteins play a role in host defence against a range of 
respiratory and oral pathogens.  
 
Studies have shown that SPLUNC1 functions in the maintenance of homeostasis in the 
upper airway (McGillivary and Bakaletz 2010), and has shown anti-biofilm activity as a 
surfactant (Gakhar, Bartlett et al. 2010) and anti-microbial functions against a number 
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of pathogens, including Pseudomonas aeruginosa (Lukinskiene, Liu et al. 2011) and 
Mycoplasma pneumoniae (Chu, Thaikoottathil et al. 2007). Ghafouri, Kihlstrom et al. 
(2004) has shown PLUNC in human nasal lavage fluid exhibits its anti-microbial effects 
by binding to lipopolysaccharide (LPS). More relevant to this thesis, SPLUNC1 has 
also been shown to be involved in NTHi infection. Jiang, Wenzel et al. (2013) showed 
that SPLUNC1 was degraded by human neutrophil elastase, increasing the airways 
susceptibility to NTHi infections, that is a known cause of acute exacerbations in 
COPD, Data on functions of LPLUNC1 in the lungs is more limited but it has been 
shown the protein is also differentially expressed in CF (Bingle, Wilson et al. 2012) and 
IPF lung tissues. 
 
1.1.2.1.4. Anti-microbial agents 
As well as secreting high volumes of mucus, the sub-mucosal glands are responsible for 
secreting some anti-microbial agents; three major agents are lysozyme (LYS), LF and 
secretory leukoprotease inhibitor (SLPI). Lysozyme is a hydrolysing enzyme that 
cleaves the β14 glycosidic bond between N-acetylglucosamine and N-aceytlmuramic 
acid residues in peptidoglycan of the bacterial cell wall. It can easily target the 
peptidoglycan of Gram-positive bacteria; however it isn’t as effective against Gram-
negative bacteria resulting in the need for a co-factor such as LF to aid its access to the 
peptidoglycan layer. LF binds to LPS, with the oxidised iron parts of LF forming 
peroxides to destabilise membrane permeability and break down bacterial cell walls for 
lysozyme to access peptidoglycan (Ellison, Giehl et al. 1988; Ellison and Giehl 1991; 
Farnaud and Evans 2003). LF is an 80kDa non-haem iron-binding glycoprotein 
belonging to the transferrin family that plays a major role in the maintenance of cellular 
iron levels as well as possessing anti-microbial activity. It is thought to exhibit its anti-
microbial activity by two mechanisms; one of which is direct interaction with the agent 
causing infection, the other is the sequestering of iron in infection sites therefore 
depriving the infecting micro-organism of nutrients (Gonzalez-Chavez, Arevalo-
Gallegos et al. 2009). SLPI is an endogenous serine protease inhibitor secreted by the 
serous cells of the sub-mucosal gland as well as Clara and goblet cells in the epithelium. 
It provides protection from serine proteases released by the neutrophil during 
inflammation. The N-terminal domain has been shown to exhibit some antibacterial 
activity (Hiemstra, Maassen et al. 1996). SLPI has also been shown to exhibit antiviral 
activity, particularly against HIV (McNeely, Dealy et al. 1995). Other key anti-
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microbial agents that interact with the airway mucus and common pathogens include β-
defensins and LL-37 (Zuyderduyn, Ninaber et al. 2011). 
 
 Airway Cilia Beating 1.1.2.2.
Structurally the axoneme of the respiratory cilia consists of nine outer microtubule 
doublets surrounding two single central tubules. Microtubules are made up of α- and β-
tubulin heterodimers and provide a useful marker of ciliated cells. The wave motion 
exhibited by cilia is driven by inner and outer dynein arms, nexin links and radial spoke 
apparatus (Figure 1.2). The axoneme terminates at a cytoplasmic basal body in the 
epithelial cell (You, Huang et al. 2004). FoxJ1, the specific ciliated cell marker 
expressed in the later stages of ciliogenesis, traffics the cytoplasmic basal bodies to 
positions directly below the cells apical surface to complete axoneme development 
(You, Huang et al. 2004). 
 
The periciliary layer/brush is required for fluid movement of cilia. This layer is 
approximately 7µm in depth (cilia are approximately 6µm in length) and is composed of 
macromolecules forming a mesh that act as a tether for mucins in the mucus layer. The 
periciliary brush acts as an intermediate between the periciliary space and the mucus 
layer to prevent penetration of mucus into the much more fluid periciliary layer (Button, 
Cai et al. 2012). Any particles that survive this process and reach the epithelial cells, 
whether due to abnormalities in cilia function, inadequate mucus or increased pathogen 
survival, may produce airway infections triggering the immune system to generate an 
inflammatory response. 
 10 
 
 
 
 
 Diseases of the Human Airway Epithelium 1.1.3.
Given the importance of the respiratory epithelium in providing the respiratory tract 
with much of its function, it is not surprising that many lung diseases are associated 
with epithelial abnormalities.  The airways of patients suffering from diseases such as 
asthma, CF and COPD undergo cellular remodelling producing differing phenotypes in 
comparison to in the “normal” airways. In airway diseases such as asthma, CF and 
COPD the airways tend to have increased numbers of goblet cells and fewer ciliated 
cells; they also tend to have an increased susceptibility to structural damage (Parker, 
Sarlang et al. 2010). Many of the morphological change seen in these different diseases 
are actually quite similar and lend support to the view that multiple drivers underpin the 
remodelling process. The following section gives a brief overview of some of the 
changes that are seen in the airway epithelium during the development of a number of 
chronic respiratory diseases. 
Figure 1.2: The structure of cilia 
The cilial axoneme consists of two single central tubules surrounded by nine 
microtubule doublets (that consist of α- and β-tubules.  The wave motion exhibited 
by cilia is driven by inner and outer dynein arms, nexin links and radial spoke 
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 Asthma 1.1.3.1.
Asthma is an inflammatory disease that is characterised by variable airflow obstruction, 
airway inflammation and airway hyper-responsiveness (predominantly caused by 
eosinophils) (Sont, Willems et al. 1999). Symptoms include broncho-constriction, 
hypersensitive airways, breathlessness and wheezing. Relief from symptoms is achieved 
through the regular use of corticosteroids and β-2-agonists to relax the smooth muscle 
surrounding the narrowed airway. According to the World Health Organisation (WHO) 
asthma is the most common chronic respiratory disease with prevalence on the increase. 
Exacerbations of symptoms may be caused by a variety of environmental factors such 
as allergen exposure (Djukanovic, Feather et al. 1996), pollution (Taggart, Custovic et 
al. 1996; van der Zee, Hoek et al. 1999) and cigarette smoke (Chilmonczyk, Salmun et 
al. 1993), as well as upper respiratory pathogens. The most frequent cause of 
exacerbations is viral infection, such as rhinovirus (RV) which is the major viral cause, 
and respiratory syncytial virus (RSV) (Nicholson, Kent et al. 1993; Johnston, Pattemore 
et al. 1995). The airway cells of asthmatics are deficient in interferon (IFN)-β which 
leads to an inadequate immune response, facilitating viral replication and further 
infection of cells (Wark, Johnston et al. 2005). RSV capitalises on a deficiency of IFN-α 
exhibited by asthmatics (Gehlhar, Bilitewski et al. 2006) which up regulates IL-10 
expression to suppress eosinophil influx (Grissell, Powell et al. 2005).  
 
Bacterial pathogens have also been shown to be involved in exacerbations of asthma 
(Cunningham, Johnston et al. 1998; Lieberman, Lieberman et al. 2003). A recent study 
of the microbiota of asthmatic airways shows that pathogenic Proteobacteria, especially 
Haemophilus species, were identified much more frequently in the airways of 
asthmatics and exhibited a disturbed microbiota when compared to non-asthmatic 
controls (Hilty, Burke et al. 2010).  
 
Most asthma patients have increased levels of the pro-inflammatory Th2 cytokines IL-4 
and IL-13 in the airway (Grunig, Warnock et al. 1998; Wills-Karp, Luyimbazi et al. 
1998). Th2 cytokines appear to be activated non-specifically as a result of defective 
epithelium. It is thought that the epithelial-mesenchymal trophic unit responsible for 
maintaining the tissue micro-environment of the epithelium becomes dysregulated, 
leaving the epithelium susceptible to damage (Holgate, Roberts et al. 2009). A murine 
model of mucous cell metaplasia showed no change in the number of cells after 
epithelial injury, despite a 75% decrease in Clara cells (as a result of Clara cell 
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metaplasia) and a 25% decrease in ciliated cells, leading to an approximate mucous cell 
population of 70% of total cells (Reader, Tepper et al. 2003). This makes mucous cells 
the predominant cell type whereas in normal airways ciliated cells are the predominant 
cell type accounting for approximately 50% of total cells (Spina 1998). The increase in 
mucous cell numbers leads to hyper-secretion of mucus, resulting in ineffective 
clearance of pathogens by the cilia and obstruction of airflow. Epithelial cells identify 
the pathogens left behind following the ineffective clearance through pattern recognition 
receptors (PRRs) and pathogen-associated molecular patterns (PAMPs) leading to 
activation of the inflammatory response and a prolonged exacerbation. 
 
 Cystic Fibrosis (CF) 1.1.3.2.
Cystic fibrosis (CF) is an autosomal recessive genetic disorder causing mutations in the 
chloride ion channel cystic fibrosis trans-membrane conductance regulator (CFTR), 
giving rise to abnormal transport of chloride and sodium across the epithelium 
(Trapnell, Chu et al. 1991). As a result of this impaired function the surface is 
dehydrated causing the mucus layer to compress the periciliary brush and cilia to slow 
down and eventually halt mucociliary clearance (mucus stasis) (Button, Cai et al. 2012). 
As is the case in asthma, the chronic and unresolved pro-inflammatory environment that 
exists in the lungs of patients with CF is associated with a proliferation of airway goblet 
cells. This directly leads to the over secretion of mucus and the resulting increased 
thickness of mucus prevents the effective host defence action of secreted and the 
cellular immune response as movement of these products are inhibited. Mucus stasis 
allows invading pathogens trapped in the immobile mucus layer to overcome/evade the 
immune system and initiate chronic bacterial infection of the airways, particularly 
anaerobic pathogens. The airways of CF patients can be colonised with multiple 
pathogens, some existing in biofilms which leads to increased frequency of 
exacerbations and infections from multiple bacterial species at the same time.  
 
 Chronic Obstructive Pulmonary Disease (COPD) 1.1.3.3.
Chronic obstructive pulmonary disease (COPD) is a life threatening lung disease 
characterised by irreversible lung damage and airway obstruction causing limitations in 
airflow. It is predominantly caused by smoking and develops over a number of years. 
The WHO estimated that in 2004 there were 64 million people worldwide suffering 
from COPD, with 3 million deaths. They predict that by 2030 it will be the third leading 
cause of death worldwide. Symptoms include a persistent cough with increased sputum 
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production, increasing breathlessness, wheezing and frequent chest infections. Sufferers 
endure frequent exacerbations of symptoms, eliciting an inflammatory response, which 
is inherently linked to the progression of the disease.  
 
The key aspect of COPD progression is tissue damage and the inflammation that 
directly results from this. Inflammation causes the recruitment of cells to the airways, 
causing the lumen to become filled with mucus exudates and inflammatory cells. 
Investigations into the nature of the cellular inflammatory response, through analysis of 
bronchoalveolar lavage (BAL) fluid, in the peripheral airways have identified CD8+ T-
cells as the major contributor, as well as identifying neutrophils, macrophages and 
CD4+ T-cells (Saetta, Di Stefano et al. 1998; Hogg, Chu et al. 2004) all with their own 
range of cytotoxic agents to contribute to destruction of the airway epithelium.  The 
immune response is also associated with thickening of the airway epithelium, resulting 
in airflow limitation. This remodelling process is more strongly associated with disease 
progression than the extent and severity of the inflammatory response (Hogg, Chu et al. 
2004). This thickening of the airway wall, combined with a malfunction of the 
mucociliary process, the expansion of goblet cells within the airway epithelium and 
increase in mucosal tissue thickness, results in the accumulation of mucus in the lumen 
of the airway. Unlike asthma and CF, COPD also affects the lower airways, with 
destruction of the alveoli and development of emphysema resulting in reduction in 
oxygen levels and increased shortness of breath. 
 
It is thought that persistence of micro-organisms in the airway is a cause for disease 
progression. A bacterial profiling study conducted using bronchoscopy in the distal 
airways of COPD patients showed colonisation with a range of bacterial species, some 
with the potential to be pathogenic (Cabello, Torres et al. 1997). The most abundantly 
identified organisms were non-pathogenic microorganisms, but of the potentially 
pathogenic the most abundant was Haemophilus influenzae (Cabello, Torres et al. 
1997). The presence potentially pathogenic microorganisms is significantly associated 
with higher numbers of neutrophils and a higher concentration of tissue necrosis factor 
(TNF)-α in BAL fluid suggesting that these pathogens are responsible for enhancing 
airway inflammation, linking them to disease progression (Soler, Ewig et al. 1999).  
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1.2.  Infection of the Respiratory Tract 
 Bacterial Infection  1.2.1.
It is now accepted that the human airway is not sterile but is host to a variety of 
commensal bacterial species that remain in the airways without causing any harm to the 
host. However, when the microbiota is altered, potentially by an imbalance of a 
particular species or defence measure or infection with a new bacterium, infection 
occurs with some infections resulting in colonisation of the epithelium in the form of a 
biofilm. The airways are also home to a wide variety of bacterial species that make up 
the commensal microbiota. A study published by Hilty et al (2010) examined the 
microbial communities of the airways of asthmatic and COPD patients alongside 
healthy controls and found the airway microbiota was disturbed is asthmatic airways. 
They identified the seven most frequent genera as Croynebacterium, Prevotella, 
Staphylococcus, Streptococcus, Veilonella, Haemophilus and Neisseria.  
 
 Biofilms 1.2.1.1.
A bacterial biofilm is a complex of aggregated cells, enclosed in extracellular 
polysaccharide (EPS) matrix complete with water channels for the transport of organic 
compounds and nutrients to the bacteria deep within the biofilm structure (Woodworth, 
Tamashiro et al. 2008). Studies performed on Pseudomonas aeruginosa biofilms have 
indicated a developmental sequence for single species biofilm development consisting 
of five stages; attachment, irreversible binding, two maturation steps and a cell 
dispersion step (Sauer, Camper et al. 2002). The attachment step is probably triggered 
within seconds of the activation of an environmental signal. This may be changes in 
levels of nutrients, pH, temperature, iron levels or oxygen concentration. Attachment is 
reversible, however rough surfaces are more susceptible. It has also been found in 
laboratory situations that bacteria attach more readily to hydrophobic surfaces than 
other surfaces. The second step, occurring minutes after the attachment step, is 
irreversible attachment/binding. Chemical signals emitted by the bacteria are used to 
‘inter-communicate’ and once the signals have reached a certain threshold, genetic 
mechanisms of EPS production are activated in order to ‘trap’ planktonic bacteria in 
order to form cell aggregates as well as nutrients to feed the bacteria. Steps three and 
four are maturation steps. Step three maturation is complete when the cell aggregates 
have reached a thickness of 10µm, which causes a significant reduction in bacterial 
motility. Step four is complete when the cell aggregates have reached 100µm. The final 
step is the cell dispersion step. Several days after the completion of step four, some 
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bacteria develop a planktonic phenotype; they are released from the biofilm into the 
airway in order to potentially infect another area and form another biofilm (Sauer, 
Camper et al. 2002; Aparna and Yadav 2008). Studies into the structure of the P. 
aeruginosa biofilm, a common biofilm forming infecting bacterium in the CF airway, 
shows that the biofilm structure enables the bacteria to resist the effects of antibiotics, 
>1000 fold, and to evade host defence factors much more efficiently (Woodworth, 
Tamashiro et al. 2008). Bacteria in the centre of the biofilm are thought to enter a 
‘dormant’ state, requiring fewer nutrients and slowing down growth in order to increase 
chances of survival. 
 
The development, structural integrity and viability of biofilms relies on signals 
transcribed in response to stress and other signalling through quorum sensing. Quorum 
sensing is a system that detects signals and responds in order to control the density of 
the bacterial population. This ‘communication’ between bacteria is widespread within 
non-pathogenic and pathogenic bacteria species (Aparna and Yadav 2008). Both Gram 
positive and negative bacteria share the same principles but the signal molecules and 
molecular mechanisms for activating this signalling differ. Quorum sensing plays an 
important role in diseases that were caused by opportunistic pathogens (Bjarnsholt and 
Givskov 2007). Targeted blocking of the small molecules involved in quorum sensing 
could be used as a method to control infections. 
 
 Viral Infection  1.2.2.
The respiratory tract is also a target of viral infections, rhinovirus (RV), influenza and 
respiratory syncytial virus (RSV) being the most common. These pathogens frequently 
affect ‘normal’ airways, as seen by the seasonal increases in the frequency of ‘colds’. 
However, the implications are more serious for patients with a diseased airway 
phenotype, as infections often trigger exacerbations of established diseases, including 
COPD, CF and asthma. The key viral pathogen used in this thesis is RSV. 
 
 Impact and Treatment of Respiratory Tract Infections 1.2.3.
NTHi is a major cause of mucosal infection, including sinusitis, conjunctivitis otitis 
media and also triggers COPD exacerbations. This predominantly affects children under 
the age of 2 years old, the elderly and the immuno-compromised. The incidence of 
NTHi infections has increased steadily over the last 20 years or so. Symptoms may 
persist for several weeks without treatment. Treatment usually compromises of 
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antibiotics, including ampicillin, cefcapene, clarithromycin, azithromycin and 
fluoroquinolones such as levofloxacin (Sekiya, Eguchi et al. 2008) for several days. 
Any treatment with antibiotics increases the risk of bacterial resistance, especially in 
patients with chronic respiratory disease that have experienced repeated infections with 
multiple pathogens due to treatment with multiple antibiotics. This success of this 
treatment can be limited, resulting in colonisation of the airway with multiple pathogens 
and biofilm formation. 
 
Similarly RSV predominantly affects children, the elderly and the 
immunocompromised, with most children having an RSV infection by the time they are 
3 years old. Usually RSV is not treated and left to ‘go away’ on its own. Treatment to 
manage symptoms usually occurs if complications arise, such as development of 
bronchiolitis and pneumonia, with bronchodilators and antibiotics, and in rare cases 
anti-viral drugs such as ribvarin. Ribvarin use is limited due to the risk of toxicity and 
variable efficacy (Olszewska and Openshaw 2009). Pavlizumab is a passive mono-
clonal antibody therapy that can be administered during the RSV season. It acts by 
preventing spread of RSV infection to the lower airways to prevent bronchiolitis 
(Olszewska and Openshaw 2009). Once infected with RSV, infections re-occur 
seasonally, impacting the subject throughout life.  
 
In normal airways these infections are not usually an issue, and recovery occurs fairly 
quickly and rarely requires hospitalisation. They are an issue for COPD, CF and asthma 
sufferers, who are more likely to require hospitalisation as the infections trigger 
exacerbations and worsening symptoms. The nature of the ‘diseased’ epithelium with 
increased mucus production often makes these infections difficult to treat. While child 
mortality for NTHi and RSV infections is low, it is unclear what role these infections 
play in mortality rates in complex chronic infections. 
 
1.3. Haemophilus influenzae 
In the asthmatic/COPD and control airways, a lot of the bacterial species identified 
belonged to the Haemophilus family, more specifically Haemophilus influenzae (Hilty, 
Burke et al. 2010). H. influenzae is divided into two specific types; encapsulate and 
non-encapsulate strains. Encapsulate strains are serotyped a-f, with serotype b being the 
most prevalent, and commonly causing systemic infections. The type b polysaccharide 
capsule acts a virulence factor, and has been shown to promote intravascular survival 
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(Moxon and Vaughn 1981). It is also known to cause bacteraemia, pneumonia, 
meningitis and septicaemia and is frequently identified as a cause of respiratory 
infections. However, the development and routine use of the Haemophilus influenzae 
type b (Hib) vaccine has reduced the number of invasive Hib infections. Strains 
categorised as non-encapsulate lack a polysaccharide capsule, and are therefore known 
as non-typeable Haemophilus influenzae (NTHi). They are frequently the causative 
agent of localised infections of the respiratory tract (Gilsdorf, Chang et al. 1992). 
 
 NTHi 1.3.1.
NTHi, one of the many causes of COPD and CF exacerbations (Sethi, Evans et al. 2002; 
Cardines, Giufre et al. 2012), is a gram-negative pleomorphic bacillus commonly 
identified as a cause of a variety of airway infections as well as being a major cause of 
otitis media. Furthermore it is routinely found to be a coloniser of the airways of 
asthmatic and bronchiectasis subjects as well as COPD and CF sufferers. A recent 
review states that Haemophilus influenzae is responsible for 20-30% of exacerbations in 
COPD (Sethi 2011), and is a major pathogen in stable disease. As NTHi is part of the 
normal human airway flora, infections can and do occur in people not suffering from an 
airway disease, however colonisation is rarely seen in these subjects.  
 
Rarely causing diseases resulting from systemic infection, such as meningitis, NTHi is 
able to adhere to the epithelium, causing respiratory infections and otitis media as 
mentioned above. It is thought that NTHi can enter the epithelial cell, remaining 
dormant until the immune response has cleared before re-emerging and causing an 
infection. NTHi have many surface antigens that aid them in establishing an infection 
and evading host defence mechanisms, including lipooligosaccharide (LOS), 
pili/fimbriae and outer membrane proteins like HMW1, HMW2, Hap and Hia. Not all 
NTHi are biofilm forming and genetic profiling using multiple strains of NTHi show 
high heterogeneity with strains having different combinations of these surface antigens, 
suggesting that there is no single defining feature responsible for infection (Clemans, 
Bauer et al. 2000).  
 
 LOS 1.3.1.1.
NTHi do not possess the typical lipopolysaccharide capsule of the encapsulate strains; 
its major surface antigen is LOS.  There is a considerable amount of antigenic diversity 
between the oligosaccharide epitopes of LOS between NTHi strains (Patrick, Kimura et 
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al. 1987). NTHi can release highly active LOS, regardless of bacterial viability, 
potentially prolonging inflammation, or gain easier access to target areas as a smaller 
molecule than the bacterium (Gu, Tsai et al. 1995). LOS plays a large role in the 
development of infection and stimulation of an immune response, though is not the only 
feature to induce proinflammatory cytokines (Clemans, Bauer et al. 2000). NTHi has 
been shown to adhere to and invade epithelial cells through interaction with the platelet-
activating factor (PAF) receptor (Swords, Buscher et al. 2000) which then initiates 
signalling in the host cell (Swords, Ketterer et al. 2001). 
 
 Haemagglutinating Pili 1.3.1.2.
Haemagglutinating pili, initially identified in Hib (Guerina, Langermann et al. 1982; 
Mason, Kaplan et al. 1985) and later NTHi strains, are encoded by the hif locus, which 
consists of five genes, hifA-hifE (van Ham, van Alphen et al. 1994). Characterisation 
studies of Hib pili show them to be approximately 5nm in diameter and up to 450nm in 
length (Stull, Mendelman et al. 1984). Many early functional studies implicated pili in 
the promotion and enhancement of adherence of Hib to human erythrocytes expressing 
the AnWj (formerly Anton) antigen (van Alphen, Poole et al. 1987), human airway 
tissues (Loeb, Connor et al. 1988; Farley, Stephens et al. 1990; Read, Wilson et al. 
1991), as well as human mucins (Kubiet, Ramphal et al. 2000). HifA (also known as 
pilin), the major structural pilus subunit, is encoded by the hifA gene. The shaft of the 
pilus consists of repeating HifA subunits, appearing to have a double-stranded structure 
similar in morphology to filamentous actin. The pilus tip fibrillum contains HifD and 
HifE subunits (St Geme, Pinkner et al. 1996) and it is suggested the HifE mediates pilus 
adherence, after antiserum was found to block pilus-mediated haemagglutination 
(McCrea, Watson et al. 1997).  Assembly of the pilus structure is mediated by HifB, 
which functions in the periplasm acting as a chaperone for the pilus subunits as they 
move from the inner membrane to the outer membrane (St Geme, Pinkner et al. 1996). 
HifC, located in the outer membrane, functions as an usher, in order to facilitate the 
incorporation of the transported subunits into the pilus structure (Watson, Gilsdorf et al. 
1994). Analysis of NTHi isolates identified the hif locus and pili expression in 
approximately 15% of strains; these strains express the whole locus or nothing at all and 
are thought to be important early in colonisation (Geluk, Eijk et al. 1998; Krasan, Cutter 
et al. 1999).  
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 Outer Membrane Proteins 1.3.1.3.
Haemophilus influenzae strains have been shown to possess many outer membrane 
proteins (OMPs); key proteins include P1, P2, P5 and P6. OMP P1 is encoded by the 
gene ompP1 which produces a heat-modifiable protein (Gonzales, Leachman et al. 
1987) approximately 47 kDa in size (Munson and Grass 1988). Studies performed with 
OMP P1 from Hib in rat models showed P1 induced protection against bacteraemia 
(Loeb 1987; Munson and Hunt 1989). Characterisation studies performed on Hib P1 
have identified some surfaces expose immunodominant epitopes (Proulx, Munson et al. 
1991; Proulx, Hamel et al. 1992; Panezutti, James et al. 1993). P1 has been shown to be 
present in outer membrane vesicles (OMVs) (Sharpe, Kuehn et al. 2011), with recent 
work investigating OMVs as potential vaccine targets showing some cross-protective 
immunity between strains in a murine model (Roier, Leitner et al. 2012). 
 
The most abundant outer membrane protein expressed by Haemophilus influenzae is the 
porin, P2, which is highly variable in size (ranging from 32kDa to 42kDa) and between 
strains (Loeb and Smith 1980), providing the basis for a subtyping system (Murphy, 
Dudas et al. 1983). This variability has been pin-pointed primarily to four large 
hypervariable regions in the gene that encode eight surface-exposed loops, with 
molecular mass correlating with size differences in these regions (Sikkema and Murphy 
1992). Persistence of the same strain in a patient with COPD showed immunological 
changes in the surface of P2 (van Alphen, Eijk et al. 1991), which may aid bacterial 
survival against the immune response and potential vaccines that may use P2 as a target. 
The P2 protein expresses highly strain-specific immunodominant epitopes on the 
surface of the bacteria (Haase, Campagnari et al. 1991), in addition to being a target for 
human serum bactericidal antibody (Murphy and Bartos 1988). P2 is considered a 
potentially useful target for a vaccine as some of the surface-exposed loops are 
relatively conserved allowing antibody generation against multiple strains. Loop 5 
contains potentially immunodominant epitopes (Yi and Murphy 1994) which have been 
shown to be a target for a prominent antibody response (Yi and Murphy 1997) and 
antibodies raised against loop 6 have shown bactericidal activity against multiple strains 
(Neary, Yi et al. 2001). P2 has also been identified in OMVs elicited by NTHi (Sharpe, 
Kuehn et al. 2011), providing another potential vaccine target alongside continuing 
work against the protein itself (Ostberg, Russell et al. 2009; Roier, Leitner et al. 2012). 
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Another major outer membrane protein in Haemophilus influenzae is the P5, a 35kDa 
heat modifiable protein, displaying antigenic variability between strains (Munson and 
Granoff 1985). It has been shown to form fimbriae, so is frequently referred to as P5 
fimbria. The P5-fimbriae have a diameter of approximately 2.4nm-3.6nm and are long 
and flexible (Bakaletz, Tallan et al. 1988; Bakaletz, Ahmed et al. 1992). They have been 
implicated in attachment to mucus and respiratory cells (Bakaletz, Tallan et al. 1988; 
Bakaletz, Tallan et al. 1989; Miyamoto and Bakaletz 1996; Reddy, Bernstein et al. 
1996), as well as cells infected with RSV (Jiang, Nagata et al. 1999). Studies performed 
using a chinchilla animal model showed the immune response to outer membrane and 
fimbrial proteins resulted in reduced occurrence of otitis media and nasopharyngeal 
colonisation (Bakaletz, Tallan et al. 1989; Sirakova, Kolattukudy et al. 1994). NTHi has 
been shown to bind to the epithelium through interaction of P5 with intracellular 
adhesion molecule (ICAM)-1 (Avadhanula, Rodriguez et al. 2006). 
 
P6 is a highly conserved, surface exposed, 16kDa peptidoglycan-associated lipoprotein 
(Kyd, Dunkley et al. 1995). It has been shown to have a protective effect, enhancing 
respiratory clearance in a rat (Kyd, Dunkley et al. 1995) and chinchilla model (DeMaria, 
Murwin et al. 1996). P6 is highly conserved between species and has been shown to 
elicit specific immune responses so has the potential to be utilised as a vaccination 
target (Hotomi, Yamanaka et al. 2002). A later study identified an induction of specific 
IgA and Th2 immune responses to P6 in a murine model (Kodama, Suenaga et al. 
2000). More recently, P6 was identified as an inducer of a variety of proinflammatory 
cytokines, its most potent and selective effect was seen on macrophage proinflammatory 
cytokines, specifically IL-8 and TNF-α (Berenson, Murphy et al. 2005). Further study 
conducted by this group using alveolar and blood macrophages from COPD patients, 
ex-smokers without COPD and non-smokers showed COPD patients had reduced IL-8, 
TNF- α and IL-1β in alveolar macrophages but not blood macrophages when stimulated 
with P6, showing a specific effect on alveolar macrophages and that the defective 
responses exhibited by COPD patients may allow for colonisation in COPD patients 
(Berenson, Wrona et al. 2006).  
 
 HMW Proteins 1.3.1.4.
Whilst working to identify major targets of human serum antibody responses to 
Haemophilus influenzae, Barenkamp and Bodor (1990) initially identified a group of 
high molecular weight (HMW) proteins. Further work identified two related HMW 
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proteins from a prototypic NTHi strain; these proteins were termed HMW1 and HMW2 
(Barenkamp and Leininger 1992). HMW1 is encoded by the hmw1 gene which 
transcribes into a 160kDa polypeptide. HMW2 is encoded by the hmw2 gene which 
gives a 155kDa polypeptide. Whilst in the periplasm, the cleavage of a 441 amino acid 
N-terminal fragment gives mature proteins of 125kDa and 120kDa respectively (St 
Geme and Grass 1998). Localised to the surface of NTHi these proteins are found in 
approximately 70-75% of NTHi isolates, and are thought to be involved in bacterial 
attachment to the epithelium (St Geme and Falkow 1990; St Geme, Falkow et al. 1993; 
Noel, Love et al. 1994). Despite this localisation, further study has shown it is unlikely 
they are responsible for eliciting the proinflammatory response (Clemans, Bauer et al. 
2000). The HMW1 adhesin has been shown to recognise sialylated glycoprotein 
receptors on epithelial cells (St Geme 1994). 
 
 Hap 1.3.1.5.
Another factor implicated in the binding of NTHi to epithelial cells is a gene identified 
as hap for Haemophilus adherence and penetration, that encodes a mature protein 
155kDa in length (St Geme, de la Morena et al. 1994). Expression of the Hap gene 
results in three proteins: an extracellular protein of 110kDa that represents the N-
terminal, and a 45kDa outer membrane protein which represents the C-terminal, and the 
mature 155kDa protein which is a serine protease that undergoes autoproteolytic 
cleavage to provide the smaller proteins (St Geme, de la Morena et al. 1994; 
Hendrixson, de la Morena et al. 1997). Initial sequence comparisons with proteins of 
known function suggested similarity to IgA1 protease of Neisseria gonorrhoeae and 
Haemophilus influenzae and also to pertactin, a protein found in Bordetella pertussis 
that promotes attachment to cells suggesting a function in attachment that has potential 
protease action (St Geme, de la Morena et al. 1994).  Further work found that Hap does 
facilitate attachment of bacteria to epithelial cells; however, it is unable to cleave human 
IgA1.  
 
The 110kDa protein acts as a monomeric autotransporter, facilitating the binding of 
NTHi to the extracellular matrix proteins, such as laminin, fibronectin and collagen IV 
(Fink, Green et al. 2002) as well as epithelial cells. It is not clear what receptor on 
epithelial cells the C-terminus interacts with, but it is thought that a region within it 
enhances autoaggregation of bacteria and formation of micro-colonies. Hap-mediated 
adherence is increased when its serine protease activity is inhibited, showing that this 
 22 
 
domain is retained on the surface of the bacterium rather than released extracellularly 
(Fink, Green et al. 2002; Fink, Buscher et al. 2003). 
 
 Hia 1.3.1.6.
Further work conducted by Barenkamp and St Geme III (1996) identified another gene 
for a predicted outer membrane protein/adhesin that they termed hia for Haemophilus 
influenzae adhesin. This gene codes for a protein of 114kDa and appears to be 
expressed in NTHi strains that do not express HMW1/HMW2 proteins; 95% of NTHi 
strains express either HMW1/HMW2 or hia (St Geme, Kumar et al. 1998). Hia 
functions as a trimeric autotransporter that remains fully associated with the cell as there 
is no capacity for C-terminal cleavage as in Hap (St Geme and Cutter 2000). Two 
binding domains are responsible for the binding activity of Hia (HiaBD1 and HiaBD2) 
both of which interact with the same host, however HiaBD1 has a higher affinity than 
HiaBD2 (Laarmann, Cutter et al. 2002; Yeo, Cotter et al. 2004). To achieve full 
adhesive activity and stability, these binding domains trimerise to give three identical 
binding pockets (Cotter, Surana et al. 2006). 
  
 IgA1 Protease 1.3.1.7.
IgA1 proteases are present in many different bacterial species known to cause infections 
on the human mucosal surfaces. They specifically cleave in the hinge region of the α-
chain of IgA, releasing intact Fab and Fc fragments (Male 1979), rendering the IgA 
unable to bind antigens so hampering the immune response. Studies examining a 
number of Haemophilus species and Streptococcus pneumoniae for synthesis of IgA1 
protease identified both capsulate and non-typeable strains of H. influenzae (Kilian, 
Mestecky et al. 1979; Male 1979). IgA protease was later identified in approximately 
98% of H. influenzae strains tested, with commensal strains appearing to be the small 
percentage that don’t synthesise it (Mulks, Kornfeld et al. 1980). Further research 
conducted by this group showed that H. influenzae strains produce distinct types of IgA 
protease that seem to correlate with specific serotypes; type 1 target the prolyl-seryl 
bond at position 231-232 and is produced mostly by the A, B, D and F serotypes, type 2 
targets the prolyl-threonyl bond at position 235-236 and is produced exclusively by C 
and E serotypes, and type 3, with no specific bond target identified, exhibits a unique 
double cleavage pattern, producing two fragments that differ in molecular weight 
(Mulks, Kornfeld et al. 1982). The type 3 activity was later identified as simultaneous 
action of type 1 and type 2 cleavage by strains that simultaneously secrete two 
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serologically different proteases, each with one type 1 or type 2 cleavage activity 
(Kilian and Thomsen 1983). Gene studies show that IgA1 protease is encoded by a gene 
designated iga. Use of hybrid type 1 and type 2 iga genes localised the exact site of 
substrate cleavage to a 370 base-pair (bp) region near the amino-terminal coding region, 
termed the cleavage specificity determinant (CSD). The CSD regions exhibit large 
sequence differences between the two types of iga genes (Grundy, Plaut et al. 1990). 
The structure of IgA1 protease is stabilised by binding to the Fc region allowing the 
hinge peptide access to the active site (Johnson, Qiu et al. 2009). The length of the CSD 
region is altered by its variability, which could determine which specific bond is 
accessible (Lomholt, Poulsen et al. 1995; Mistry and Stockley 2011). There is 
significant sequence homology between IgA1 and Hap protein (St Geme, de la Morena 
et al. 1994), showing IgA1 function as an autotransporter and is involved in the 
mediation of bacterial aggregation to form micro-colonies (Plaut, Qiu et al. 1992). This 
bacterial aggregation activity implicates IgA1 protease in biofilm formation, and has 
subsequently been identified in NTHi biofilms, where immuno-labelling and electron 
microscopy showed that the majority of labelling appeared to be associated with the cell 
membrane in the top region of the biofilm (Webster, Wu et al. 2006). Most recently, 
Murphy et al (2011) showed that NTHi that express the two different types of iga genes 
(igaA for type 1 protease and igaB for type 2) are adapted for infection and colonisation 
of the COPD airway. 
  
 NTHi and Biofilms 1.3.2.
Recently studies have been conducted into the biofilm forming capabilities and 
properties of H. influenzae in the airways. This process wasn’t initially thought to occur 
(Moxon, Sweetman et al. 2008) despite evidence showing its ability to form biofilms in 
a chinchilla model of otitis media, the model most commonly used for studying NTHi 
biofilms (Ehrlich, Veeh et al. 2002). Unlike biofilms for other bacterial species, NTHi is 
thought to switch gene expression during the attachment phase to form a glue-like 
structured matrix, composed of multiple molecules and macromolecules including 
proteins, deoxyribonucleic acid (DNA) and EPS (Moxon, Sweetman et al. 2008).  
 
Murphy and Kirkham (2002) found that P2, P5 and P6 and haemagglutinating pili are 
needed for biofilm formation, however earlier work by Gilsdorf et al (1996) suggests 
that haemagglutinating pili are not required for internalisation or adherence but help 
promote colonisation. This bacterium invades the airway by interacting with microvilli 
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that are elongated from the airway surface. This results in the formation of lamellipodia, 
in process which is halted by Cytochalasin D (Murphy and Kirkham 2002). Successful 
invasion of the airway occurs when the bacterium has entered the vacuoles of a specific 
but unidentified non-ciliated cell type (Ketterer, Shao et al. 1999). A study by Starner et 
al (2006) implicated NTHi in CF when bacterial isolates identified in BAL fluid were 
found to form biofilms on the Calu-3 cell line. They also showed that, like P. 
aeruginosa, NTHi has an increased resistance to antibiotics. Biofilm formation by NTHi 
also elicited an inflammatory response (Starner, Zhang et al. 2006).  
 
Utilisation of a chinchilla model of otitis media has shown that NTHi in a biofilm 
structure is able to survive neutrophil extracellular trap (NET)-mediated clearance, 
resulting in persistence of the bacterial community (Hong, Juneau et al. 2009). Further 
study showed that NTHi LOS is involved in stimulating NET formation, with toll-like 
receptor (TLR)-4 deficient murine neutrophils exhibiting decreased levels of NET 
formation, implicating signalling through the immune mediator MyD88 as necessary for 
NET formation. Survival of NTHi in NETs and resistance to killing by further recruited 
neutrophils was partly conferred by LOS moieties on the surface of the bacterium 
(Juneau, Pang et al. 2011). An inability to kill and/or control the bacterium results in a 
continual influx of neutrophils to the infection site, resulting in an increase in the 
number of dead neutrophils. This further stimulates recruitment of inflammatory 
cytokines, prolonging or worsening exacerbations of respiratory diseases or otitis 
media. It has also been suggested that a significant amount of the nucleic acid content 
within the extracellular matrix of an NTHi biofilm is derived from host cells such as 
neutrophils, with co-localisation of staining for NTHi and neutrophil elastase seen by 
Hong, Juneau et al. (2009) suggesting that persistence in NET structures is another 
method of the resistance to bacterial clearance. One study also suggested that NTHi 
induces neutrophil necrosis (Naylor, Bakstad et al. 2007), which could provide nucleic 
acids to the bacteria for use in biofilm formation. The NET may be implicated in the 
antibiotic resistance a biofilm structure infers to the bacterium, as the increased biomass 
related to the NET may provide an effective barrier against the actions of antibiotics 
(Juneau, Pang et al. 2011). 
 
 Immune Response and NTHi 1.3.3.
NTHi predominantly stimulates the immune response through activation of TLR2 to 
activate MyD88 and both the canonical and non-canonical NF-κB signalling pathways 
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(Shuto, Xu et al. 2001). NTHi clearance studies performed in mouse lungs identified 
MyD88-dependent signalling through TLR4 as important (Wieland, Florquin et al. 
2005), the same group however ruled out TLR9 importance in host defence against 
NTHi infection (Wieland, Florquin et al. 2010). Many studies have utilised the disease 
otitis media, which as previously mentioned NTHi is the major causative agent, to study 
the immune responses (Hernandez, Leichtle et al. 2008; Leichtle, Hernandez et al. 
2009). Activation of TLR2 by NTHi triggers both the MyD88 dependent and 
independent pathways, utilising canonical and non-canonical NF-κB signalling, 
particularly through activation of p38 MAPK to activate a plethora of pro-inflammatory 
cytokines (Jono, Xu et al. 2003; Mikami, Gu et al. 2005; Mikami, Lim et al. 2006; Lee, 
Takeshita et al. 2008; Xu, Xu et al. 2008). NTHi has also been shown to up-regulate 
expression of some mucins, including MUC5AC (Wang, Lim et al. 2002; Jono, Xu et 
al. 2003; Chen, Lim et al. 2004; Shen, Yoshida et al. 2008; Jono, Lim et al. 2012) and 
MUC1, which has also been shown to have an anti-inflammatory role (Kyo, Kato et al. 
2012). 
 
A major stimulator of the immune response is lipooligosaccharide (LOS). It stimulates 
early expression of IL-1α, IL-1β, TNF-α, IL-6, IL-8 and macrophage chemotactic 
protein (MCP)-1, leading to secretion of TNF-α, IL-6, IL-8 and MCP-1 in 9HTEo 
tracheal epithelial cells (Clemans, Bauer et al. 2000). Inhibition of LOS using 
polymyxin B showed that other factors contribute to immune response, not just LOS; 
however it was also shown that the surface proteins implicated in adherence previously 
mentioned, haemagglutinating pili, HMW1, HMW2, Hia and Hap proteins, do not 
stimulate the release of inflammatory cytokines (Clemans, Bauer et al. 2000). Studies 
conducted using the ALI human cell culture model and whole NTHi organisms found 
increased levels of the inflammatory cytokines IL-1β, IL-6, TNF-α, GM-CSF and IL-8 
in a long term culture with NTHi (Ren, Nelson et al. 2012). 
 
 TNF-α expression is induced earlier than IL-6 and IL-8 which Clemans (2000) 
suggested may be used to sustain IL-6 and IL-8 levels and activate immune cells. This 
finding was supported by Foxwell (1998) using tracheal infection in rats with formalin 
killed NTHi who found that TNF-α has disappeared 12-15h post infection. It was 
suggested that TNF-α had a priming effect to recruit immune cells quicker to the site of 
infection, to prevent progression to a more severe IL-5 mediated inflammatory response 
(Foxwell, Kyd et al. 1998). However, TNF-α causes damage to epithelial cells, and 
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NTHi preferentially adhere to damaged cells, so levels of expression are not maintained 
for an extended period of time. 
 
1.4. RSV 
RSV is a non-segmented, enveloped anti-sense ribonucleic acid (RNA) virus belonging 
to the Paramyxoviridae family, more specifically a subfamily called the Pneumovirinae 
(Zhang, Peeples et al. 2002). It is the major cause of viral respiratory infections in 
children, and is frequently associated with an increased risk of developing otitis media 
(Sagai, Suetake et al. 2004). RSV causes significant damage to the airway epithelium, 
and preferentially targets the ciliated cells, causing loss of cilia, ciliostasis and thus 
reduced function of mucociliary clearance mechanisms (Zhang, Peeples et al. 2002; 
Sajjan, Wang et al. 2008).  
 
 The RSV virion 1.4.1.
The genome of RSV, 15.2kb, has ten messenger RNAs (mRNAs) that code for eleven 
proteins, four of these are for the nucleocapsid-polymerase complex and three others are 
virion surface proteins. The nucleocapsid protein (N), phosphoprotein (P), large 
polymerase protein (L) and transcription anti-termination factor (M2-1) are the proteins 
involved in the nucleocapsid-polymerase complex. The heavily glycosylated attachment 
(G) protein, fusion (F) protein and another small hydrophobic protein (SH) makes up 
the three virion surface proteins (Zhang, Peeples et al. 2002). Other proteins include a 
matrix protein (M), the RSV transcription and replication inhibitor M2-2 and two non-
structural (NS) proteins, NS1 and NS2. 
 
 M2 Proteins 1.4.1.1.
The two proteins transcribed from the overlapping open reading frames (ORFs) of the 
M2 gene, M2-1 and M2-2 (Collins, Hill et al. 1990), are involved in the viral RNA 
synthesis process. M2-1 has transcriptional processivity and anti-termination functions 
which are critical to RSV replication. It is associated with transcription elongation, 
potentially inhibiting the polymerase from terminating at gene end signals to allow 
transcription of downstream genes (Collins, Hill et al. 1996; Fearns and Collins 1999). 
 
M2-2 inhibits transcription and replication of RSV in a mini-genome model system 
however this protein has been shown to be unnecessary for RSV replication but may 
have a role later in the infection in virion morphogenesis (Collins, Hill et al. 1996) and 
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it is also suggested that M2-2 has a regulatory role in the balance between viral RNA 
transcription and replication (Bermingham and Collins 1999). Studies performed in 
rodents using a deletion mutant showed attenuation of the virus despite formation of 
larger syncytia than wild-type viral strains, providing the potential for a live attenuated 
vaccine (Jin, Cheng et al. 2000). Overproduction of M2-2 protein resulted in an 
inhibition of viral replication (Cheng, Park et al. 2005).  
 
 M Protein 1.4.1.2.
The M protein is detected early in the infection process in the nucleus of infected cells 
(Ghildyal, Baulch-Brown et al. 2003). Further research conducted by this group 
identified that nuclear transport of M protein is mediated by importin β1 nuclear import 
receptor and Ran, a guanine nucleotide-binding protein (Ghildyal, Ho et al. 2005); and 
later in the infection process is exported from the nucleus by a Crm-1-dependent factor 
(Ghildyal, Ho et al. 2009). Whilst in the nucleus, M protein affects cell replication. Cell 
cycle analysis showed that accumulation of p53, a cell stress response factor, coincided 
with a maximal effect of M protein induced G1 and G2/M phase arrest of the cell cycle 
in primary human bronchial epithelial (HBE) cells (Bian, Gibbs et al. 2012).  
 
 P, N and L Proteins 1.4.1.3.
The P, N and L proteins are essential components of the viral RNA polymerase, and are 
all required for viral RNA replication (Grosfeld, Hill et al. 1995), they are also 
associated with the viral RNA genome in the form of nucleocapsids (Jin, Cheng et al. 
2000). P protein is approximately 241 amino-acids long and constitutively 
phosphorylated within the virion core and infected cells, a process which is required for 
P protein oligomerisation to form tetramers (Asenjo and Villanueva 2000) and for 
efficient virus replication (Lu, Ma et al. 2002). Alongside its essential function on viral 
RNA replication and transcription, N protein is a major structural protein involved in 
encapsidation of the RNA genome. It has also been identified as one of the major target 
antigens of cytotoxic T lymphocytes in mice and humans (Bangham, Openshaw et al. 
1986). A recent study showed that N protein allows continued translation of cellular and 
viral proteins by limiting phosphorylation of eukaryotic translation initiation factor 2α 
(eIF2α), preventing it from inhibiting translation of cellular and viral proteins 
(Groskreutz, Babor et al. 2010). N, P and M2-1 have been identified as components of 
cytoplasmic inclusion bodies which have been suggested to be the site of RSV 
replication (Garcia, Garcia-Barreno et al. 1993). N and P protein have been show to 
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interact, with 20 amino-acids at the carboxy-terminal of P protein identified as the key 
binding site (Slack and Easton 1998). More recent work identified 6 amino-acids near to 
the C-terminal of N protein as essential for binding ability to P protein and replication 
functions (Stokes, Easton et al. 2003).  
 
The large (L) protein is an RNA-dependent RNA polymerase, and contains multiple 
enzyme activities required for replication of RSV. The L protein is approximately 2165 
amino acids long, and consists of a single major ORF (Stec, Hill et al. 1991). The 
sequence composition was found to be similar to other negative-stand RNA viruses 
including Sendai virus, measles virus and Newcastle disease virus (Stec, Hill et al. 
1991). Six conserved regions in the L protein have been identified across the family of 
non-segmented negative-sense RNA viruses and have been associated with individual 
enzymatic activities (Tiong-Yip, Aschenbrenner et al. 2014). Most enzymatic activities 
required for RSV RNA replication are associated with the L protein, making it a target 
for drug development, most commonly L protein inhibitors to prevent viral replication 
(Liuzzi, Mason et al. 2005; Tiong-Yip, Aschenbrenner et al. 2014).   
 
 G, F and SH Fusion Proteins 1.4.1.4.
RSV G protein is heavily glycosylated and expressed in two forms; a complete 
membrane bound (mG) form and an N-terminally truncated secreted (sG) form (Teng, 
Whitehead et al. 2001). It is thought that sG is chiefly responsible for protection against 
innate immune responses, allowing the virus to replicate. Early studies suggested that G 
protein suppresses the release of the pro-inflammatory cytokines IL-10, TNF-α, IL-12 
and IL-8 from peripheral blood mononuclear cells (PBMCs) (Konig, Krusat et al. 1996; 
Konig, Streckert et al. 1996). Later studies using an RSV strain deficient in sG showed 
increased expression of ICAM-1, IL-8 and Regulated upon Activation in Normal T-cell, 
Expressed and Secreted (RANTES) from the alveolar cell line A549. An increased 
binding activity of the epithelial cells to NF-B was also observed in the mutant strain 
confirming suggestions of G proteins involvement in modification of the inflammatory 
response to promote viral replication (Arnold, Konig et al. 2004). A more recent study 
suggest that G protein acts as a decoy antigen to reduce the antibody-mediated 
neutralisation/clearance of RSV by inhibiting the effects of leukocytes that have the Fc 
receptor, and that this process involves the pulmonary macrophages and complement 
(Bukreyev, Yang et al. 2012). RSV has recently been shown to modify microRNAs that 
are known to affect the host antiviral response, and it is suggested G protein expression 
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is a partial mediator of this (Bakre, Mitchell et al. 2012). G protein has become a target 
for therapeutic use through two mechanisms: (1) direct antiviral activity or (2) 
immunomodulatory activity to reduce viral load and improve the dysfunctional immune 
response G-protein mediates (Kauvar, Harcourt et al. 2010). 
 
F protein is initially produced as a 68 kDa precursor in infected cells, which is activated 
by cleavage in either the trans-Golgi cisternae or trans-Golgi network into two 
disulphide-linked subunits; F1 is approximately 48kDa and F2 around 20kDa (Fernie, 
Dapolito et al. 1985; Gruber and Levine 1985). This cleavage is required for surface 
expression (Bolt, Pedersen et al. 2000) and it has been determined that the cytoplasmic 
domain is not essential for fusion (Branigan, Day et al. 2006). The F1 sub-unit has been 
shown to interact with LF, and the F2 sub-unit has been shown to interact with 
surfactant protein-A (SP-A) to modulate RSV infection (Sano, Nagai et al. 2003). A 
study conducted using RSV deficient in G and SH protein showed F protein to be 
associated with lipid rafts on the surface of cells to cause infection (Fleming, 
Kolokoltsov et al. 2006). It has also been shown that the F2 subunit determines the 
specificity of RSV infection, and not G protein as initially thought (Schlender, Zimmer 
et al. 2003). F protein has also been shown to trigger p53-dependent cell death, causing 
loss of epithelial integrity by cell shedding, obstruction of the airways, secondary 
necrosis and inflammation as a result of these actions. Apoptosis was reduced when a 
monoclonal antibody to F protein was administered post infection, suggesting this may 
be a useful target for therapies after infection (Eckardt-Michel, Lorek et al. 2008). 
 
The SH protein occurs in three forms: two unglycosylated species of approximately 
7.5kDa (SH0), a form that represents translational initiation (SHt) of approximately 
4.5kDa and an N-glycosylated form of SH0 approximately 13-15kDa (SHg). The 
multiple forms means that SH accumulates in both its glycosylated and unglycosylated 
forms and all forms are present as oligomers (Collins and Mottet 1993). Studies 
conducted in a bid to elucidate function found similarities to Parainfluenza virus 5, 
which also encodes an SH protein, in its ability to inhibit TNF-α signalling (Fuentes, 
Tran et al. 2007). Studies conducted on the transmembrane domain of SH in the 
presence of lipid bilayers show that SH forms pentameric alpha-helical bundles forming 
cation-selective ion channels (Gan, Ng et al. 2008). Further studies performed by this 
group suggested that SH forms viroporins, which are short viral proteins that form 
oligomers of a specific size which act as ion channels and enhance host membrane 
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permeability. They found that SH forms a pentameric ion channel, however the 
biological function of this is still unknown (Gan, Tan et al. 2012). 
 
An analysis of the role of all three proteins in fusion found that when F, G and SH were 
expressed together when fusion occurred. They also found that co-expression of F and 
SH genes elicited a high level of fusion but less than when all three genes were 
expressed (Heminway, Yu et al. 1994).  Using heparin agarose affinity chromatography 
(HAAC) Feldman et al (2001) identified two high molecular weight complexes of 
175kDa and 210 kDa that reacted with antibodies to all three proteins, suggesting that 
all three surface proteins form an oligomeric complex within infected cells; whereas 
ultracentrifugation analysis and immunoprecipitation showed F and G proteins exist on 
the cell surface as a protein complex suggesting that multiple glycoprotein complexes 
may exist in the envelope of RSV (Low, Tan et al. 2008). To facilitate attachment of 
RSV to the host cell, F and G proteins bind to cellular glycosaminoglycans (Hallak, 
Collins et al. 2000).  It is thought that RSV infects through binding of F protein to TLR4 
with G protein can acting as a fractalkine receptor agonist to mediate immune cell 
chemotaxis (Tripp, Jones et al. 2001).  
 
 Non-Structural Proteins 1.4.1.5.
The non-structural proteins, NS1 and NS2, are both type 1 IFN antagonists (Bossert and 
Conzelmann 2002) that can form homo- and heteromers (Swedan, Andrews et al. 2011). 
NS1, localised to the nuclei when expressed alone and in the mitochondria when 
expressed with NS2 (Swedan, Andrews et al. 2011), can act as an E3 ligase by forming 
a complex with E3 ligase components. This is crucial for RSVs ability to degrade signal 
transducer and activator of transcription (STAT)2 and evade the type 1 IFN immune 
response; a process for which NS2 is also required (Elliott, Lynch et al. 2007) NS2, a 
multifunction IFN antagonist localised to the mitochondria when expressed alone 
(Swedan, Andrews et al. 2011), has been identified as an important virulence 
determinant as deletion of the NS2 gene attenuates RSV (Wright, Karron et al. 2006). 
Expressed early in the infection process, NS1 and NS2 have been shown to delay 
apoptosis of cells in order to allow more viral replication. This was achieved through an 
IFN and epidermal growth factor receptor (EGFR) dependent pathway (Bitko, 
Shulyayeva et al. 2007). They have also been implicated in suppression of dendritic cell 
maturation, resulting in a weak or incomplete immune response as there would be less 
T-lymphocyte activation and antigen presentation (Munir, Le Nouen et al. 2008). In 
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their roles as an IFN antagonists, NS1 and NS2 have been shown to decrease levels of 
TRAF3, a mediator of multiple IFN signals, although NS1 achieved this much more 
efficiently. NS1, specifically the N-terminal (Swedan, Andrews et al. 2011), was also 
shown to reduce IκB Kinase (IKK), a specific activator of IFN Regulatory Factors 
(IRF)-3 (Swedan, Musiyenko et al. 2009). NS1 has also been shown to disrupt the 
association of IRF-3 with its transcriptional co-activator CBP to reduce IRF-3 binding 
to the IFN-β promoter without blocking phosphorylation, nuclear translocation and 
dimerisation of virally induced IRF-3 (Ren, Liu et al. 2011). NS2 binds to the N 
terminal of caspase recruitment domains (CARD) therefore inhibiting induction of IFN 
transcription from both the retinoic acid inducible gene (RIG)-I and TLR3 pathways 
(Ling, Tran et al. 2009). Swedan et al (2011) showed specific interactions with host 
microtubule-associated protein 1B (MAP1B) for both NS1 and NS2. 
 
 Immune Response to RSV 1.4.2.
The pathogenesis of RSV is largely driven by the presence of immune cells recruited to 
the site of infection. Neutrophils are the predominant infiltrating cell type identified in 
BAL fluid and tissues (Villenave, Shields et al. 2013). Monocytes, macrophages and 
lymphocytes are also frequently identified in debris in the lumen of arterioles and 
airways, alongside the neutrophils (Villenave, Shields et al. 2013).  
 
The activation of the immune response and recruitment of inflammatory leukocytes in 
response to RSV is initiated by activation of a number of TLRs, including TLR2 
(Murawski, Bowen et al. 2009), TLR3 (Groskreutz, Monick et al. 2006; Huang, Wei et 
al. 2009), TLR4 (Haeberle, Takizawa et al. 2002; Tulic, Hurrelbrink et al. 2007; 
Wheeler, Chase et al. 2009) and TLR7 (Huang, Wei et al. 2009). This results in 
activation of the MyD88 (Rudd, Schaller et al. 2007) and RIG-I signalling pathways 
(Ling, Tran et al. 2009). Activation of these pathways results in up-regulation of IFNs, 
predominantly type III (Okabayashi, Kojima et al. 2011), IL-6, IL-8, IFN-γ-induced 
protein 10 (IP-10), RANTES, ICAM-1 and TNF-α (Tulic, Hurrelbrink et al. 2007; Lotz 
and Peebles 2012; Smith, Kulkarni et al. 2013; Villenave, Shields et al. 2013). 
 
1.5. Modelling the Airway Epithelium 
Models are a key tool in understanding the fundamentals of many of the essential 
functions and processes of the human body, including normal and inflammatory 
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responses, disease pathogenesis and the action of potential therapies. A number of in 
vivo and in vitro models are currently used to study the airway epithelium. 
 
In vivo is defined as the use of/or taking place in the whole organism. Small mammals, 
such as mice and rats, are the most common tool for in vivo studies, which may include 
functional studies or investigations into disease pathogenesis. Genetic modification of 
animals can be used to label genes/proteins of interest, introduce mutations or knock-
down/up-regulate production to investigate function.  
 
In the cases of genetic diseases like CF, genetic mutations can be introduced into 
animals to achieve the disease phenotype. A frequently used model for CF is the 
βENaC-Transgenic mouse, in which βENaC expression is up-regulated to mimic the 
increased Na+ absorption seen in CF patients (Mall, Grubb et al. 2004). The most 
common murine model of allergic inflammation of the airway is the OVA model, in 
which the mouse inhales doses of ovalbumin to trigger the immune response (Renz, 
Smith et al. 1992). Administration of lipopolysaccharide (LPS) is used induce a disease 
state that resembles COPD. 
 
In vitro study involves the use of components of an organism that have been isolated 
from their usual biological niche. This most commonly involves the use of cells, either 
primary or immortalised cell lines, to study a particular tissue. There are various cell 
culture methods available for studying the human airway epithelium using immortalised 
cell lines or primary cells. Cells usually have a finite number of replications before they 
undergo cell death, however it is possible to immortalise these by addition of DNA 
tumour virus genes that code for regions with multiple functions, such as the simian 
virus 40 (SV40) large T protein, human papilloma virus (HPV) genes, or even the entire 
genome of some viruses, most commonly the Epstein-Barr virus (Reddel 1995). 
Examples of the most commonly used cell lines for work in the airways are Beas-2-B, 
A549 and NCI-H292 cells, of which A549s and NCI-H292s are derived from lung 
cancers. 
 
The alternative is the use of primary cells, obtained either directly from a 
patient/cadaver or from commercial companies. Primary cells, particularly bronchial 
epithelial or nasal cells are easily obtained by bronchial or nasal brushings. It is also 
possible to extract cells from explants from cadavers if processed in an appropriate time 
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frame. Cells purchased from a commercial company are usually obtained via resected 
tissue and are screened for infections. 
 
Cell lines are easy to obtain and work with, whereas primary cells are moderately easy 
to obtain if from a commercial company but are surrounded by ethical implications if 
taken from patients. Also, there is a high level of inter-donor variability to consider. 
Primary cells are also more difficult to maintain as they are more prone to infection, 
particularly those obtained from local brushings. They also have a finite lifespan and 
cannot be cultured through repeated passages. Cells obtained from explants or brushings 
may also have the added complication of contaminating cell types. Whilst both types of 
culture technique use airway cells, there are issues surrounding accurate representation 
of the human airway. It is thought that cell lines do not accurately represent the diverse 
cell types present in the airway as well as the normal airways ability to senesce and re-
new. Primary cells can be cultured using standard submerged culture methods, but still 
do not represent the varying cell types present in a normal airway. However, culture at 
an air-liquid interface (ALI) allows cells to differentiate into the cell types seen in the 
airway in representative proportions, thus forming a model for various studies relating 
to the human airways (Ross, Dailey et al. 2007). 
 
 Primary Airway Epithelial Cell Culture at the Air-Liquid Interface (ALI) 1.5.1.
The ALI culture technique was first established as a method for differentiating cells by 
Whitcutt et al (1988).  After using the technique on cells from multiple species, in 
comparison to submerged culture, they achieved cell differentiation whilst using the 
ALI technique for culture of guinea pig epithelial cells. This cellular differentiation 
resembled the mucociliary structure, secreted mucus substances and had a similar 
epithelial polarity to that in the in vivo epithelium (Whitcutt, Adler et al. 1988).  In 
humans the ALI culture technique had been used for growth of keratinocytes from skin 
and squamous carcinoma cells in 1988 (Regnier, Desbas et al. 1988), and was first 
described for use with tracheobronchial epithelial cells in 1990 (Wu, Martin et al. 1990). 
Culturing primary cells, particularly primary human tracheobronchial epithelial cells, at 
the ALI provides an in vitro model of airway differentiation. This allows for various 
studies including the response of the airway to damage and its repair mechanisms, as 
well as manifestations of bacterial/viral infections in the airway of both healthy people 
and patients with a chronic airway disease such as COPD, CF and asthma. Recent 
studies have concluded that this method of primary cell culture is important to 
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recapitulate the transcriptional profile of the airway and provides a good representation 
of the airway transcriptome in vivo (Dvorak, Tilley et al. 2011; Pezzulo, Starner et al. 
2011). 
 
There are several published methods for culturing airway cells at ALI, on different 
platforms using differing periods of time for differentiation. The most common method 
appears to be the use of polycarbonate transwells, with a porous membrane surface on 
which cells form a confluent epithelial layer, with nutrients provided from the 
basolateral compartment. The cells are allowed to differentiate for a set period of time, 
usually between 14 and 28 days. The growth medium contains many growth factors, 
including; bovine pituitary extract, human epidermal growth factor, insulin, 
hydrocortisone, epinephrine, transferrin and retinoic acid (Kettle, Simmons et al. 2010). 
One of the most important growth factors for differentiation is retinoic acid as it has 
been shown to be important for normal development and maturation of the lung by 
regulating proliferation, differentiation and morphogenesis of cells through activation of 
retinoid X receptors to activate and suppress many different genes. Cells cultured in the 
absence of retinoic acid resulted in differentiation of a stratified squamous epithelium 
(Koo, Yoon et al. 1999). The mucous phenotype can be restored to squamously 
differentiated cells through the addition of retinoic acid to culture medium. Collagen 
coated transwells have also been used as a platform (Nlend, Bookman et al. 2002; Ross, 
Dailey et al. 2007; Parker, Sarlang et al. 2010), as collagen also affects the 
differentiation of the secretory cell type but is thought to be most important for ciliated 
cell differentiation (Ross, Dailey et al. 2007). 
 
 Modulation of Differentiation with Growth Factors 1.5.2.
Initial studies using extracted primary nasal cells from surgically removed polyps 
cultured on collagen gels (Laoukili, Perret et al. 2001) showed that IL-13 increased the 
number of goblet cells through differentiation. A recent study (Turner, Roger et al. 
2011) modulated the differentiation of these cultures by stimulating the cells with IL-13 
during the differentiation period; they specifically cultured primary cells for 14 days in 
the presence or absence of IL-13 in the growth medium to see if this altered the 
proportions of each cell type once differentiated. Stimulation with IL-13 caused an 
increase in the number of mucus-secreting goblet cells, and a reduction in ciliated cells 
after which the cells reverted back to their ‘normal’ proportions of cell numbers upon 
removal of IL-13 (Turner, Roger et al. 2011). This has provided a model for studies of 
 35 
 
diseased airways as exacerbations of asthma and CF are associated with an increase in 
the number of mucous cells, known as mucous cell metaplasia. Mucous cell metaplasia 
has been extensively studied in animals, specifically mice, in order to understand the 
underlying signalling mechanisms that cause increased differentiation of Clara and 
ciliated cells into goblet cells. It is thought that cytokines released by T helper 2 (Th2) 
cells are involved in the development of mucous cell metaplasia as an inflammatory 
response to allergic reactions and asthma, for example.  
 
IL-13 and IL-4 share the receptor subunit IL-4Rα1. IL-13 induces STAT6 release 
through the IL-4Rα1, which in turn causes increased expression of goblet cell markers 
(e.g. SPDEF and GABAAR) and decreased expression of ciliated cell markers (e.g. 
FoxA2) (Curran and Cohn 2010) to start transformation into a goblet cell. STAT6 is 
also thought to be associated with MUC5AC expression. Murine models ruled out IL-4 
as a major cause of this, suggesting the involvement of IL-13 (Curran and Cohn 2010). 
However it is thought that IL-13 is the second signal required to induce mucous cell 
metaplasia. It is hypothesised that EGFR release prevents the cell from undergoing 
apoptosis, allowing IL-13 to have an effect as a second signal (Curran and Cohn 2010). 
A recent publication by Kettle et al (2010) found that neuregulin1β1, part of the EGFR 
signalling pathway, also induces increased goblet cell differentiation, further suggesting 
both are involved in the induction of mucous cell metaplasia. 
 
1.6. The Immune Response 
A pathogen is a bacterium, virus, or other microorganism that can cause disease in 
another organism. As the resultant evolutionary development of the defence 
mechanisms known as the immune system occurred, so did evolution of the pathogen in 
an attempt to evade the actions of the immune response.  
 
Broadly, the immune response is made up of two components: the adaptive (specific) 
response and the innate (non-specific) response. The adaptive response takes time to 
generate a specific response to pathogens, inferring long-lasting protection to future 
challenges. The innate response generates an immediate inflammatory response to 
invading foreign material or endogenous signalling. This inflammatory response 
recruits and activates immune cells at the site of injury/pathogen invasion, resulting in 
oedema and erythema as well as causing the capillaries to dilate, and allowing 
movement of white blood cells. This inflammatory response is a crucial first line 
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response to infection and foreign material, attempting to prevent spread of infection 
while the adaptive immune system responds. Despite this essential role in host defence, 
aberrant immune responses, both innate and adaptive, are also in part the cause of 
diseases such as COPD and asthma. 
 
 Neutrophils 1.6.1.
Neutrophils, also known as polymorphonuclear neutrophils, are one of the major 
leukocytes that contribute to the immune response. They are short lived, fast moving 
polymorphonuclear (PMN) granulocytes representing around 50-60% of the total 
number of leukocytes circulating in the blood (Smith 1994). The main function of 
neutrophils is to engulf and degrade bacteria either to prevent infection or control 
commensal populations. They achieve this function through use of one of three 
mechanisms of action upon contact with targets. (1) Upon recruitment to the appropriate 
site, extracellular bacteria and debris is engulfed into the phagosome. The phagosome 
fuses with the lysosome to form the phagolysosome, in which a process known as 
respiratory burst occurs (Segal 2005). During respiratory burst, nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase produces the reactive oxygen species 
superoxide, which decays to form hydrogen peroxide and is then converted by 
myeloperoxidase to form hypochlorous acid which kills the bacteria (Segal 2005). (2) 
The neutrophil cytoplasm contains granules which contain a variety of potentially 
harmful proteases, including elastase, which are involved in the degradation of 
pathogens and extracellular matrix proteins. A process called degranulation releases the 
granules when the neutrophil is activated. In the absence of activation signals they go 
through programmed cell death and are then engulfed and cleared by macrophages 
(Savill, Wyllie et al. 1989). Apoptosis is a tightly controlled anti-inflammatory process 
as it promotes clearance of neutrophils by macrophages to prevent tissue damage 
(Akgul, Moulding et al. 2001). (3) The formation of NETs was first described by 
Brinkmann et al (2004). They trap and kill bacteria extracellularly through the 
formation of web like structures consisting of fibres of chromatin and serine proteases 
and were found to form as early as 10 minutes after activation, a process which is 
quicker than apoptosis (Brinkmann, Reichard et al. 2004). NETs may provide a 
localised collection of anti-microbial components that can be used to control infection 
by trapping and killing bacteria independently of phagocytosis, as well as prevention of 
further infection in neighbouring areas by formation of a physical barrier to limit 
bacterial spread. 
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 Macrophages 1.6.2.
Macrophages are traditionally thought to differentiate from PBMCs which are initially 
released from the bone marrow into the peripheral blood. As monocytes transmigrate to 
the tissues they differentiate into macrophages (Mosser and Edwards 2008). 
Macrophages are much longer-lived than neutrophils, often remaining in tissues for 
several months. As a result of this, macrophages have a key role in the adaptive immune 
response, interacting with T- and B-cells to function as antigen-presenting cells, as well 
as roles in the innate immune response. The major function of macrophages is to 
phagocytose dead/dying cells, cellular debris and pathogens, during tissue remodelling 
and especially in the early stages of chronic inflammation when neutrophils are present. 
After ingestion, the pathogen is trapped in a phagosome, which fuses with a lysosome to 
form a phagolysosome, in the same way as neutrophils. Phagolysosomes contain a 
variety of enzymes and toxic agents used to kill the bacteria contained within it 
(Aderem and Underhill 1999). Eventually the macrophage produces enough of these 
digestive compounds, as a result of repeated bacterial ingestion and killing, to kill itself. 
Most phagocytosis is performed by macrophages that are localised to the specific tissue; 
these are then responsible for production of a range of cytokines to recruit more 
macrophages and neutrophils to the site of inflammation (Mosser and Edwards 2008).  
 
Macrophages are also key molecules in generating long lasting immunity via the 
adaptive immune system by acting as antigen presenting cells. After ingestion of a 
pathogen the macrophage ‘presents’ the antigen from the pathogen by incorporating 
parts of it into its surface, resulting in the production of antibodies to provide a memory 
of the pathogen. The next encounter of this pathogen results in recruitment and 
proliferation of the specific antibody to aid phagocytosis. 
 
1.7. The Inflammatory Response 
Predominantly the inflammatory response is initiated by pattern recognition receptors 
(PRRs) present on the surface of innate immune cells (Medzhitov and Janeway 2000; 
Akira, Uematsu et al. 2006). PRRs are activated upon exposure to/recognition of, one of 
two signals: the pathogen-associated molecular pattern (PAMP) triggers inflammation 
in response to infection, while the damage associated molecular pathogen (DAMP) 
triggers inflammation as a result of tissue injury (Medzhitov and Janeway 2000; Akira, 
Uematsu et al. 2006). This results in secretion of inflammatory cytokines and 
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chemokines. Key PRRs that recognise both PAMPs and DAMPs are Toll-like receptors 
(TLRs).  
 
 Toll-Like Receptors 1.7.1.
TLRs are a family of trans-membrane proteins/receptors. The toll gene was initially 
identified in Drosophila where it is crucial for normal development (Anderson, Bokla et 
al. 1985). Initially there were five sequences identified with sequence homology and 
protein architecture to the Drosophila Toll that were designated as TLRs (Rock, 
Hardiman et al. 1998), however it is now known there are ten human TLRs distinctly 
recognising a variety of extracellular and endosomal PAMPs to induce nuclear factor 
(NF)-B and IFN signalling and the mitogen activated protein kinase (MAPK) pathway 
to secrete pro-inflammatory cytokines, chemokines and co-stimulatory molecules. Most 
cells express at least one TLR and cell surface expression of TLRs is up-regulated by 
proinflammatory cytokines (Muzio, Bosisio et al. 2000). The association of TLRs with 
the immune response results in a tightly controlled signalling system to prevent 
impaired responses that may lead to disease. 
 
 Interleukin-1 Receptors 1.7.2.
There are two types of receptor to the potent pro-inflammatory cytokine IL-1: IL-1RI 
and IL-1RII. They bind to the ligand at three extracellular immunoglobulin-like 
domains at the N-terminal, a key feature of the immunoglobulin class they belong to. 
 
IL-1RI (80kDa) is exclusively responsible for IL-1 signalling (Sims, Gayle et al. 1993). 
It binds IL-1 with high affinity in the presence of the IL-1 accessory protein (AcP). The 
AcP does not have any affinity for IL-1 itself, but is recruited as the ligand binds to 
form a heterotrimeric complex, resulting in signal transduction (Greenfeder, Nunes et al. 
1995) 
 
IL-1RII (67kDa) acts as a ‘decoy’ receptor, attenuating the potency of IL-1 by acting as 
a sink (Colotta, Re et al. 1993). With its high avidity for IL-1β it is able to form the 
heterotrimeric signalling complex; however this does not result in signal transduction or 
cellular responses (Lang, Knop et al. 1998). Both types are structurally similar, but IL-
1RI has a much longer cytoplasmic tail (215 amino acids for IL1-R1 and 19 amino acids 
for IL-1RII), and are predominantly found on different cell types (IL-1RI is 
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predominantly found on T cells and fibroblasts and IL-1RII on B cells and neutrophils) 
(Greenfeder, Nunes et al. 1995). 
 
 TIR Domain 1.7.3.
TLR and IL-1 receptors function to identify and detect danger signals, resulting in 
initiation of the immune response. The connection between TLRs and IL-1R is shown 
through the use of common signalling components, more specifically TLR/IL-1R (TIR) 
cytoplasmic receptor domain. The TIR domain is a stretch of approximately 200 amino 
acids arranged in three conserved domains, known as boxes, in the intracellular portion 
of TLR/IL-1R. The signature sequence of the family is box1, however box2 and box3 
are also important in signalling (Fitzgerald and O'Neill 2000). The most common 
inflammatory route involving this domain utilises the adaptor molecule myeloid 
differentiation factor 88 (MyD88), triggering the MyD88 dependent signalling pathway. 
 
 MyD88-Dependent Signalling 1.7.4.
MyD88 was initially discovered as a myeloid differentiation response gene induced in 
response to IL-6 stimulation in M1 myeloblastic leukaemia cells (Lord, Hoffman-
Liebermann et al. 1990). Sequence analysis of MyD88 identified a C-terminal TIR 
domain, that mediates interactions between receptor and adaptor TIR domains and is 
critical for signalling (Xu, Tao et al. 2000) and a ‘death domain (DD)’ containing N-
terminus which is now known to mediate protein-protein interactions (Feinstein, Kimchi 
et al. 1995). These link MyD88 to functions as an adaptor molecule for downstream 
signalling actions.  
 
Activation of the receptor causes MyD88 to recruit and interact with IL-1R-associated 
kinases (IRAKs) (Wesche, Henzel et al. 1997). The IRAK family consists of four 
members, IRAK-1, IRAK-2, IRAK-4 and IRAK-M (also known as IRAK-3), which are 
encoded from different areas of the genome, transcribing separate gene products with 
similar amino-acid sequences that are all associated with TLR/IL-1R signalling. IRAK-
4 and IRAK-1 are recruited by binding with the death domain of MyD88, where IRAK-
4 rapidly phosphorylates IRAK-1 to activate IRAK-1s kinase domain leading to auto-
phosphorylation of IRAK-1 (Burns, Janssens et al. 2003). Phosphorylation of IRAK-1 
causes a reduction in its affinity to MyD88 but increases affinity to TNF receptor-
associated factor 6 (TRAF6) (Cao, Xiong et al. 1996; Wesche, Henzel et al. 1997). 
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TRAF6 belongs to a family of TNF receptor-associated adaptor proteins that are 
evolutionary conserved. It is recruited to the TIR domain by the TRAF-C domain, 
which mediates binding between the C-terminal TRAF6-binding motif (Pro-X-Glu-X-
X-aromatic/acidic residue) in IRAK-1 and TRAF6 (Ye, Arron et al. 2002). Upon 
binding to IRAK-1, the zinc-finger and RING effector domains within the N-terminus 
(Rothe, Wong et al. 1994; Cao, Xiong et al. 1996) are activated, allowing the 
IRAK:TRAF6 complex to dissociate from the receptor complex and bind to the 
membrane bound transforming growth factor β (TGFβ)-activated kinase 1 (TAK1) 
signalling complex (Ninomiya-Tsuji, Kishimoto et al. 1999). 
 
TAK1 is a mitogen-activated protein kinase kinase kinase (MAPKKK or MAP3K) 
family member directly linked to the activation of NF-κB and its subsequent up-
regulation of pro-inflammatory cytokines (Yamaguchi, Shirakabe et al. 1995; 
Ninomiya-Tsuji, Kishimoto et al. 1999). For its functions in signalling, TAK1 is 
associated with adaptor proteins: TAK1-binding protein-1 (TAB1) (Shibuya, 
Yamaguchi et al. 1996), TAB2 (Takaesu, Kishida et al. 2000) and TAB3 (Cheung, 
Nebreda et al. 2004). As the IRAK:TRAF6 complex binds to the TAK1 signalling 
complex, phosphorylation (by an as of yet unknown kinase) of TAK1 and TAB2 
releases all components except IRAK-1 into the cytosol (Jiang, Ninomiya-Tsuji et al. 
2002). TAB2 and TAB3 act as adaptor molecules, allowing TRAF6 to activate the 
kinase domain of TAK1 (Kanayama, Seth et al. 2004) TAB1 enhances activation of 
TAK1 (Shibuya, Yamaguchi et al. 1996), resulting in release of NF-κB (a nuclear factor 
kappa enhancer binding protein) from inhibitory proteins.  
 
 Canonical NF-κB Activation 1.7.5.
NF-κB is the primary transcription factor activated by TLR/IL-1R signalling. The NF-
κB family of transcription factors consists of five proteins, RelA (p65), RelB, c-Rel, 
p105 (p50/NF-κB1) and p100 (NF-κB2), characterised by the presence of an N-
terminus region of around 300 amino acids known as the Rel-homology domain (RHD). 
When activated, NF-κB exists as a dimer in the cytosol of most mammalian cell types, 
the most common consisting of RelA and p105 (Mercurio and Manning 1999). It also 
exists in the cytoplasm in resting cells, where it is held in its inactive form by a complex 
of inhibitory proteins termed IκBs (Baeuerle and Baltimore 1988). There are six 
mammalian IκB family members, however only three of these, IκBα, IκBβ and IκBε 
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appear to be important for controlling NF-κB activity (Baeuerle and Baltimore 1996; 
Whiteside, Epinat et al. 1997).  
 
IKKs are large (700-900kDa) cytoplasmic complexes that phosphorylate IκBs at the N-
terminal sites to control turnover (Zandi, Rothwarf et al. 1997). They contain two serine 
kinases IKKα (IKK1) and IKKβ (IKK2) and a regulatory component IKKγ (NEMO). 
The IKK complex is targeted by activated TAK1, where it phosphorylates serine 
residues in the activation loop of IKKα and IKKβ, marking these molecules for 
proteasomal degradation by the 26S proteasome (Chen, Hagler et al. 1995). This allows 
NF-κB to translocate to the nucleus and up-regulate target genes, including pro-
inflammatory cytokines 
 
 MAPK Activation 1.7.5.1.
There are also other targets activated by TLR/IL-1R signalling, such as mitogen-
activated protein kinases (MAPKs), which are also involved in many essential 
processes, including cell growth, differentiation, stress and inflammatory responses. 
MAPKs are serine/threonine protein kinases that are activated by phosphorylation of 
both threonine and tyrosine residues (Anderson, Maller et al. 1990). MAPKs are divided 
into three sub-categories: the extracellular signal regulated kinase (ERK), p38 MAPK 
and the Jun N-terminal kinase (JNK), also known as the stress-activated protein kinase 
(SAPKs). 
 
The first MAPK family member to be cloned were the ERKs (Boulton, Yancopoulos et 
al. 1990; Boulton, Nye et al. 1991) Further study showed the phosphorylation of ERKs 
led to activation of other transcription factors, for example Elk-1 (Gille, Sharrocks et al. 
1992; Marais, Wynne et al. 1993). The MAPK activation system is a three-tiered 
phosphorylation cascade. MAPKKK phosphorylates MAP kinase kinases (MAPKKs) in 
order to activate MAPK. TAK1, as mentioned previously (Section 1.3.4.) is a key 
molecule in NF-κB signalling and is a MAPKKK and is responsible for the branching 
of the signalling pathways.   
 
The p38 MAPK was originally identified in mammalian cells as a 32kDa protein that 
underwent tyrosine phosphorylation in response to endotoxin stimulation and 
extracellular changes in osmolarity (Han, Lee et al. 1994). The p38 MAPKs consist of 
four isoforms, p38α, which is the original form of p38 and shown to be activated in 
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response to IL-1 (Freshney, Rawlinson et al. 1994), p38β (Jiang, Chen et al. 1996; 
Stein, Yang et al. 1997), p38γ (Lechner, Zahalka et al. 1996; Li, Jiang et al. 1996) and 
p38δ (Goedert, Cuenda et al. 1997; Jiang, Gram et al. 1997; Kumar, McDonnell et al. 
1997). 
 
The JNK family of proteins are encoded by three genes, JNK1, JNK2 and JNK3 (also 
known as SAPKγ, SAPKα and SAPKβ respectively) which exist as ten spliced isoforms 
(Derijard, Hibi et al. 1994; Kyriakis, Banerjee et al. 1994; Gupta, Barrett et al. 1996). 
Activation by phosphorylation is initiated by a variety of cellular stresses, including 
inflammation. 
 
Both the p38 MAPKs and JNKs are involved in activation of the transcription factor 
activator protein-1 (AP-1). AP-1 exists as a heterodimer and is activated by 
phosphorylation of the trans-activating domain of ATF2, resulting in up-regulation of 
transcription of AP-1 components (Karin, Liu et al. 1997). Activated AP-1 is 
translocated to the nucleus where it is involved in transcription of genes for the 
inflammatory response (IL-1, TNF), cell adhesion molecules (E-selectin) and proteases 
(Karin, Liu et al. 1997; Read, Whitley et al. 1997). 
 
An overview of NF-κB signalling can be found in Figure 1.3. 
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Figure 1.3: An overview of canonical NF-κB signalling 
Activation of TLR/IL-1R at the membrane results in formation of complex I as 
MyD88 is recruited to the receptor complex. This leads to hyperphosphorylation (P) 
of IRAK-1 by IRAK-4 and subsequent binding of TRAF6. The IRAK-1:TRAF6 
heterodimer leaves the receptor to bind to TAK1 and its associated binding proteins 
TAB1, TAB2 and TAB3 to form complex II.  Formation of complex III occurs 
when IRAK-1 releases TRAF6:TAK1:TAB1/2/3 from the membrane, where it 
activates the IKK complex by phosphorylation. Phosphorylated IKK activates NF-
κB by targeting the inhibitory proteins bound to it, the IκBs, for degradation. This 
allows NF-κB to translocate to the nucleus where it is responsible for up-regulating 
target genes. 
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 MyD88-Independent Signalling Pathways 1.7.6.
All TLR/IL-1R signalling occurs through MyD88, except TLR3, which signals through 
the TIR domain-containing adaptor inducing IFN-β (TRIF) (also known as TICAM-1), 
and TLR4, which signals through both MyD88 and TRIF (Yamamoto, Sato et al. 2002; 
Oshiumi, Matsumoto et al. 2003). The TRIF sequence contains a TIR domain for TIR-
TIR interactions and a receptor interacting protein (RIP) homotypic interaction motif 
(RHIM) in the C-terminus to mediate interactions of the RIP family (Meylan, Burns et 
al. 2004), which leads to activation of TAK1 and subsequently the IKK complex as seen 
in canonical NF-κB (Cusson-Hermance, Khurana et al. 2005). 
 
TRIF was discovered using MyD88 deficient mice, which activated NF-κB and MAPKs 
as a late phase response associated with activation of Type I IFNs, in response to LPS 
and viral stimuli (Kawai, Adachi et al. 1999; Kawai, Takeuchi et al. 2001). Mice 
deficient in functional TRIF show early phase activation of NF-κB and MAPK 
signalling, but reduced proinflammatory cytokine and Type I IFN production, 
suggesting a requirement for TRIF for Type I IFN induction/responses and maximal 
production of cytokines in response to LPS (Hoebe, Du et al. 2003; Yamamoto, Sato et 
al. 2003).  
 
TRIF and TLR4 do not bind directly; they require an adaptor molecule, TRIF-related 
adaptor molecule (TRAM), to activate TRIF-dependent signalling processes in response 
to LPS (Yamamoto, Sato et al. 2003). TLR3 binds to double stranded RNA (dsRNA), a 
product of replication by many viruses, and poly(I:C), a synthetic dsRNA TLR3 agonist 
(Alexopoulou, Holt et al. 2001). In response to poly(I:C), TRIF knockout mice do not 
elicit a response, whereas MyD88 and TRAM knockout mice respond normally, leading 
to the conclusion that TRIF is the only required adaptor for signalling through TLR3 
(Yamamoto, Sato et al. 2003). A summary of MyD88 independent signalling can be 
found in Figure 1.4. 
 
 Non-Canonical NF-κB Signalling 1.7.7.
Non-canonical NF-κB signalling was discovered during study of p100 processing (Xiao, 
Harhaj et al. 2001). Two NF-κB family members, p100 and p105, are produced as 
precursor proteins that undergo proteolytic processing to become the active transcription 
factors, p52 and p50 respectively, and are involved in activating non-canonical NF-κB 
signalling pathways. The precursor proteins function in the same manner as IκB in  
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Figure 1.4: An overview of MyD88-independent signalling 
TLR3 is activated in response to viral dsRNA, resulting in activation of TRIF.TRIF 
recruits RIP1 which leads to activation of NF-κB transcription through TAK1 and 
the IKK complex. Activated TLR3 can also activate the transcription factor IRF3 
through IKKε/TBK kinases. TLR can also activate MyD88-independent pathways 
through TRIF, to activate NF-κB, and TRAM, to activate IRFs. 
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canonical signalling, by holding them in an inactive form in the cytoplasm. Activation 
of the p100/p105 signalling pathways causes partial degradation of the precursors C-
terminal domains, removing the IκB like ankyrin repeats to release active p52/p50 
fragments. Although the unmasked RHD allows the proteins to bind to DNA, 
transactivation domain (TAD) required for activating gene transcription is not present 
(Zhong, May et al. 2002). To overcome this, p52/p50 fragments form heterodimers with 
RelB, c-rel or p65, whereas homodimers of p52 and p50 have been shown to inhibit 
gene transcription (Zhong, May et al. 2002). 
 
The transcription factor p105 undergoes constitutive processing, by partial degradation 
by the proteasome, to generate p50 fragments. This is thought to be a co-translational 
mechanism to generate p50 fragments for formation of the p50/p65 heterodimers 
utilised in canonical NF-κB signalling (Fan and Maniatis 1991; Palombella, Rando et al. 
1994; Lin, DeMartino et al. 1998). This processing is inhibited by formation of homo- 
or heterodimers with other NF-κB proteins (Harhaj, Maggirwar et al. 1996; Cohen, 
Orian et al. 2001), suggesting its role is dependent upon the cells availability of NF-κB.  
 
The processing of p100, however, is much more tightly regulated by both positive and 
negative domains, with only minimal amounts of processing in unstimulated cells 
(Heusch, Lin et al. 1999; Xiao, Harhaj et al. 2001). The functions of p100 are to prevent 
nuclear translocation of RelB and regulate its transcriptional activity (Dobrzanski, 
Ryseck et al. 1995; Solan, Miyoshi et al. 2002). The processing of p100 has been linked 
to receptor activation of immune response molecules, including BAFF-R (Kayagaki, 
Yan et al. 2002), CD40 (Coope, Atkinson et al. 2002) and LTβR (Dejardin, Droin et al. 
2002). BAFF-R and CD40 activation is linked to B-cell maturation and survival and 
LTβR binds to TNF superfamily members. The pathway is also activated by some TNF 
family members, however, TNFα does not induce p100 processing (Coope, Atkinson et 
al. 2002), but does lead to up-regulation of p100 and RelB (Derudder, Dejardin et al. 
2003).  
 
Activation of the p100 non-canonical signalling pathway has been linked to expression 
of the NF-κB inducing kinase (NIK); overexpression leads to p100 processing to p52 
(Senftleben, Cao et al. 2001), whereas deficiencies in functional NIK result in 
significantly reduced levels of p52 but normal p100 levels (Xiao, Harhaj et al. 2001). 
NIK contain a kinase domain that has some conserved sequence homology to the kinase 
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domains of MAP3Ks; it has also been shown to interact with (Regnier, Song et al. 1997) 
and phosphorylate IKKα (Ling, Cao et al. 1998). This interaction of IKKα and NIK is 
independent of factors known to be required in canonical NF-κB signalling such as 
IKKβ and IKKγ (Senftleben, Cao et al. 2001; Xiao, Harhaj et al. 2001). Upon binding 
with NIK, IKKα has been shown to directly phosphorylate p100, which leads to its 
processing to p52 (Senftleben, Cao et al. 2001).  
 
Non-canonical signalling has not been studied as extensively as canonical NF-κB 
signalling, therefore it is likely there are many as of yet unidentified factors that act as 
mediators and activators, however, key molecules identified so far are summarised in 
Figure 1.5.  
 
 TLR3 Signalling 1.7.8.
TLR3 could play a prominent role in detection of viruses as it has been shown to bind 
double-stranded RNA (dsRNA) (Alexopoulou, Holt et al. 2001), which is a product of 
viral replication or part of the viral genome. TLR3 has also been shown to bind to 
poly(I:C) the stable synthetic dsRNA, which it does preferentially over dsRNA derived 
from viral sources (Okahira, Nishikawa et al. 2005). Binding of dsRNA and TLR3 is 
dependent on an acidic pH (de Bouteiller, Merck et al. 2005). It was originally shown to 
not recognise single stranded RNA (ssRNA) (Alexopoulou, Holt et al. 2001), however, 
more recent work showed that mRNA, which is predominantly singled stranded acts as 
a ligand to TLR3, showing that it is capable of binding to ssRNA (Marshall-Clarke, 
Downes et al. 2007). TLR3 activation leads to induction of type I IFN and NF-κB 
activation through distinct pathways. 
 
TLR3 is a type I transmembrane receptor so has a similar structure to the other TLR 
family members (Jin and Lee 2008). Structural studies show that in solution it exists as 
a monomer, however can form homomultimers in the membrane, which takes place 
upon ligand binding (Bell, Botos et al. 2005; Bell, Botos et al. 2006; Leonard, 
Ghirlando et al. 2008; Liu, Botos et al. 2008).  
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Figure 1.5: The key mediators of non-canonical NF-κB signalling 
Activation of the non-canonical signalling pathway is mediated through the kinase 
NIK. NIK is involved in phosphorylating an IKK complex that only consists of two 
IKKα units. The activated IKK complex phosphorylates p100, causing processing of 
p100 to its active form p52, which then dimerises with RelB, which contains the 
transactivation domain (TAD) required for nuclear translocation and subsequent up-
regulation of target genes. 
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TLR3 activation results in phosphorylation at two C-terminal tyrosine residues (Sarkar, 
Peters et al. 2004), leading to recruitment of TRIF. Stimulation of TLR3 leads to 
activation of distinct pathways that result in activation of NF-κB and the IRFs (See 
section 1.3.7.1). NF-κB is activated by TLR3 through receptor interacting protein 1 
(RIP1) protein but has been shown to be negatively regulated by RIP3, another RIP 
protein family member (Meylan, Burns et al. 2004). TRIF contains a RIP homotypic 
interaction motif in it C-terminus that mediates its binding to RIP proteins in order to 
activate signalling. This recruits RIP1 to the TLR3-TRIF signalling complex (Meylan, 
Burns et al. 2004). RIP1 recruitment activates TAK1 and subsequently the IKK 
complex which leads to the degradation of IκB, as seen on canonical NF-κB signalling 
(Cusson-Hermance, Khurana et al. 2005). There are likely to be other mediators 
involved in interactions between RIP1 and TAK1 that are yet to be identified. However, 
TRAF6 has been suggested as a likely candidate as TRIF contains three TRAF6 binding 
motifs and over expression of dominant negative TRAF6 has shown inhibition of TRIF-
induced NF-κB activation (Sato, Sugiyama et al. 2003; Jiang, Mak et al. 2004). IRF 
activation and subsequent activation of both type I and III IFNs occurs when TRIF 
binds to TRAF3. TRAF3 recruits kinases involved in phosphorylating and activating 
IKKε and TANK binding kinase 1 (TBK1) IRF family members (Hacker, Redecke et al. 
2006; Oganesyan, Saha et al. 2006). 
 
 IRFs 1.7.8.1.
The IRF family consists of nine different transcription factors (IRF1-9) that are all 
involved in induction of Type I and III IFNs. They all contain a DNA binding domain 
consisting of five conserved tryptophan-rich repeats in the N-terminus forming a helix-
turn-helix that recognises the IFN regulatory element upstream of IRF-regulated genes 
(Mamane, Heylbroeck et al. 1999; Taniguchi, Ogasawara et al. 2001). The C-terminal 
domains, which are less conserved, mediate interactions with other signalling mediators 
and transcription factors. 
 
The key IRFs involved in antiviral immunity are IRF3 and IRF7 (Marie, Durbin et al. 
1998; Yoneyama, Suhara et al. 1998; Au, Yeow et al. 2001); both of which have been 
found to activate type I and III IFNs in response to viral stimuli, however IRF1 and 
IRF5 have also been associated with type I IFN reduction in response to viruses 
(Mamane, Heylbroeck et al. 1999; Taniguchi, Ogasawara et al. 2001; Takaoka, Yanai et 
al. 2005). Upon viral infection, phosphorylation at specific serines in IRF3s C-terminal 
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regulatory domain results in homodimerisation or heterodimerisation with IRF7 and 
subsequent assembly of the nuclear holocomplex. This holocomplex consists of IRF 
dimers associated with co-factors, either cyclic adenosine monophosphate (AMP) 
responsive element binding protein (CREB) binding protein (CREBBP) or p300, which 
are involved in binding to DNA and up-regulating target gene transcription (Lin, 
Heylbroeck et al. 1998; Sato, Tanaka et al. 1998; Weaver, Kumar et al. 1998; 
Yoneyama, Suhara et al. 1998). 
 
IRF7 is strongly induced by type I IFN-mediated signalling but in contrast to IRF3 it is 
expressed in small amounts in most cell types. Binding of type I IFNs to the IFN 
receptor results in IRF7 up-regulation, suggesting that IRF7 is involved in late-phase 
IFN production as part of a positive feedback loop. Activation of IRF7 is similar to that 
of IRF3, with phosphorylation of C-terminal serine domains leading to production of 
homodimers or heterodimers with IRF3 which then translocate to the nucleus to up-
regulate transcription of target genes. Different combinations of IRF3 and IRF7 homo- 
and heterodimers have different effects on target gene transcription; IRF7 activates both 
IFNA and IFNB genes, whereas IRF3 is a potent IFNB gene activator, but not IFNA 
(with the exception of IFNA4) (Marie, Durbin et al. 1998; Sato, Hata et al. 1998; Sato, 
Suemori et al. 2000). 
 
Originally, it was thought that only IRF3 was involved in the early phase of IFNB gene 
induction and that this type I IFN production leads to production of IRF7 for the late 
phase induction of IFNA and IFNB genes. However, a study conducted using an irf7 
deficient (irf7-/-) mouse model, specifically irf7 deficient mouse embryonic fibroblasts, 
showed a severe impairment in type I IFN induction in response to an ssRNA viral 
stimulus, suggesting the constitutively produced small amount of IRF7 is vital for early 
phase IFN production (Honda, Yanai et al. 2005). 
 
 RIG-1/MDA5 Signalling 1.7.9.
It was initially thought that TLR3 was the key mediator involved in viral detection in 
host cells until a study conducted using TLR3 knockout cells showed production of IFN 
in response to both the dsRNA viral mimic poly(I:C) and viral infection (Yoneyama, 
Kikuchi et al. 2004). This led to identification of the involvement of retinoic acid-
inducible gene-I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5), 
members of the RIG-I-like receptor family of proteins, in sensing viral RNA in the 
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cytoplasm (Yoneyama, Kikuchi et al. 2004). RIG-I and MDA5 both contain two 
repeated CARDs in the N-terminal and a DExD/H-box RNA helicase domain in the C-
terminal. The CARD domains have been implicated in IRF3, IRF7 and NF-κB 
activation, and subsequent activation of IFN-β (Yoneyama, Kikuchi et al. 2004). The 
RNA helicase domain has been shown to bind in an ATP dependent manner to 
poly(I:C) (Saito, Hirai et al. 2007). The C-terminus of RIG-I has been to shown to act as 
a repressor domain (RD) in order to keep it in the cytosol in its latent form (Saito, Hirai 
et al. 2007).  
 
RIG-I deficient mouse embryonic fibroblasts were shown to exhibit impaired IFN 
release when infected with Sendai virus (SeV), Newcastle disease virus (NDV), 
vesicular stomatitis virus (VSV), influenza virus or Japanese encephalitis virus (JEM) 
or stimulated with dsRNA transcribed in vitro. IFN release was unaffected in MDA5 
deficient mouse embryonic fibroblasts showing that RIG-I and MDA5 recognise 
different viruses. MDA5 deficient mouse embryonic fibroblasts did show impaired IFN 
release in response to infection with Picornaviridae virus family members, which isn’t 
seen in the RIG-I deficient cells (Loo, Fornek et al. 2008). Recent studies have 
identified the binding site for RIG-I as a 5’-triphosphate moiety in viral RNA. This 5’-
triphosphate moiety is usually capped in host endogenous mRNA (Hornung, Ellegast et 
al. 2006; Pichlmair, Schulz et al. 2006). The structure recognised by MDA5 has yet to 
be elucidated. 
 
 Final Stage of Signalling: Cytokine and Chemokine Production  1.7.10.
Cytokines are intracellular signalling peptides (8-30kDa) that act at any range (auto-, 
para- and endocrine) on a variety of cell types including leukocytes and epithelial cells. 
Their main function is to manage the immune response by activating, inhibiting or 
drawing leukocytes to a site of infection by chemotaxis. Cytokines can be produced by a 
variety of nucleated cell types (Cannon 2000).  
 
Infections stimulate the TLR/IL-1R signalling pathway to activate various transcription 
factors, including NF-κB, to produce cytokines, some of which have a pro- or anti-
inflammatory effect. Local proinflammatory responses stimulate leukocyte activity, 
including proliferation, cytotoxicity and proteolytic enzyme release. They also 
synthesise prostaglandins and initiate a cascade of “secondary” anti-inflammatory 
cytokine synthesis and secretion. Systemic pro-inflammatory cytokine release induces 
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fever by raising the thermoregulatory set point and creates a hostile growth environment 
for growth of some bacterial species by redistributing iron from extracellular to 
intracellular sites. The central nervous system is targeted to cause a reduction in energy 
consumption and skeletal muscle is broken down to provide amino acids for acute phase 
plasma proteins which function to work with leukocytes to remove pathogens (Cannon 
2000). 
 
Chemokines are a subset of cytokines that act as chemoattractants to immune cells to 
recruit them to the site of infection/injury. They are small proteins (8-10kDa) sub-
grouped based on their primary structure. The four sub-groups are labelled CC, CXC, 
CX3C and C, which are defined by the position of two N-terminal conserved cysteine 
residues (Murphy 1994; Choi and An 2011). Chemokines exert their effects by binding 
to G-protein receptors on the cell surface, triggering cellular responses including 
chemotaxis. The two major groups are the CC and CXC groups; CC chemokines are 
involved in monocyte, lymphocyte and basophil recruitment, whereas CXC chemokines 
are involved in neutrophil recruitment (Choi and An 2011).  
 
The cytokines and chemokines that are utilised as a stimulus or measure of 
inflammatory responses throughout this thesis are discussed individually.  
 
 Interleukin-1 1.7.10.1.
IL-1 is produced by cells in response to pathogens via the NF-κB pathway. There are 
two agonist forms of IL-1, IL-1α and IL-1β, both are found in the same 430kb gene 
cluster (in humans chromosome 2q13) but are produced as independent gene products 
(Nicklin, Weith et al. 1994). Both forms bind the same receptors, however IL-1β is the 
most common mediator of systemic inflammation. 
 
Transcription of the IL-1β gene produces an inactive proform protein that is activated 
by caspase-1 cleavage. It is largely produced by immune cells but can also be produced 
by epithelial and endothelial cells (Cannon 2000). It is a potent pro-inflammatory 
cytokine, capable of inflicting detrimental effects on host tissues; therefore evolution of 
a network of regulatory mechanisms was necessary to attenuate its potency. The IL-1 
receptor antagonist (IL-1ra) (a 17kDa protein) acts as competitive inhibitor to regulate 
potency by binding with high affinity to IL-1RI, and with lower affinity to IL-1RII 
(Dripps, Verderber et al. 1991). All three proteins share similar amino acid sequences, 
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gene structure and chromosomal location (Arend 1993; Nicklin, Weith et al. 1994) IL-
1ra restricts IL-1β activity through competitive inhibition. 
 
 Interleukin-6 1.7.10.2.
Interleukin-6 (IL-6) is a 212 amino-acid member of the 4 α-helix haematopoietic family 
of cytokines. IL-6 is another gene regulated by NF-κB; is not expressed constitutively 
but is up-regulated in response to a wide range of PAMPs and DAMPs, including LPS, 
viral infection, IL-1β, TNF-α and IFN-γ. It is produced by both immune and non-
immune cells, including macrophages, lymphocytes, dendritic cells, fibroblasts and 
endothelial and epithelial cells (May, Ndubuisi et al. 1995; Jawa, Anillo et al. 2011). 
 
IL-6 acts in both a pro- and anti-inflammatory capacity with knock-out murine studies 
demonstrating that it has a key role in mediating the immune and acute phase response 
(Kopf, Baumann et al. 1994). One of the many effects it has on the immune response is 
involvement in immune cell maturation, including T cell differentiation and antibody 
production in B-cells, but it doesn’t appear to be involved in proliferation of activated B 
cells (Muraguchi, Hirano et al. 1988; Naka, Nishimoto et al. 2002). Its targeting of 
endothelial cells causes an induction of chemokines and adhesion molecules that attract 
and recruit leukocytes to the site of inflammation (Cronstein 2007). IL-6 also induces 
phospholipase A2 (PLA2) (Crowl, Stoller et al. 1991), leading to the production of key 
pro-inflammatory mediators including prostaglandins and PAF (Tilg, Dinarello et al. 
1997), which is involved in neutrophil priming, a process  potentiated by IL-6 (Biffl, 
Moore et al. 1994). 
 
Inflammation is tightly controlled in order to avoid unnecessary damage to the host. The 
pleiotropic effects of IL-6 are important anti-inflammatory functions. It has been shown, 
in vivo, to down-regulate the potent effects of IL-1 and TNFα by inducing production of 
IL-1ra and TNFR (Tilg, Trehu et al. 1994). It has also been shown to induce the tissue 
inhibitor of matrix metalloproteinase(MMP)s (TIMP) which reduces damage to cells 
(Jawa, Anillo et al. 2011). 
 
IL-6 is activated by binding to a receptor complex containing IL-6R and gp130 
subunits. Activation of the IL-6 receptor results in activation of the JAK/STAT pathway 
and transcription of IL-6 stimulated genes.  
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 Interleukin-8 1.7.10.3.
Interleukin-8 (IL-8 or CXCL8) is a CXC chemokine that is a potent chemoattractant for 
neutrophils, but not monocytes, and is produced by a wide range of cell types, including 
monocytes, neutrophils, T lymphocytes, fibroblasts, endothelial cells and epithelial cells 
(Schroder, Mrowietz et al. 1987; Walz, Peveri et al. 1987).  
There is a strong link between IL-8 and inflammatory diseases in the respiratory tract as 
increased levels of IL-8 have been identified in BAL fluid obtained from asthma (Fahy, 
Kim et al. 1995) and COPD patients (Keatings, Collins et al. 1996). This is a key factor 
in the establishment of a neutrophilic inflammatory environment within the airways of 
these patients (Fahy, Kim et al. 1995).  
 
IL-8 has the ability to bind to two different receptors, CXCR1 and CXCR2. These 
receptors are expressed on a variety of cell types including a variety of leukocytes and 
non-haematopoietic cells such as endothelial and epithelial cells. However, they are 
much more commonly associated with cells of a myeloid lineage, especially 
chemoattraction of neutrophils (Stillie, Farooq et al. 2009). Transduction of signals 
through both receptors plays a role in antimicrobial activity of neutrophils (Baggiolini 
and Clark-Lewis 1992), but CXCR1 plays a more dominant role in neutrophil 
chemotaxis than CXCR2 (Hammond, Lapointe et al. 1995; Quan, Martin et al. 1996). 
 
 RANTES 1.7.10.4.
Also known as CCL5, RANTES is a CC- type chemokine discovered in a differential 
screen between T- and B- leukocytes. It is an IRF-stimulated gene that exerts its effects 
by binding to four different chemokine receptors, CCR1 (Gao, Kuhns et al. 1993; 
Neote, DiGregorio et al. 1993), CCR3 (Daugherty, Siciliano et al. 1996), CCR4 (Power, 
Meyer et al. 1995) and CCR5 (Combadiere, Ahuja et al. 1996; Raport, Gosling et al. 
1996). Production is inducible upon mitogen or antigen stimulation of T-cell lines and 
circulating lymphocytes and viral stimulation of epithelial cells (Schall, Bacon et al. 
1990). It functions as a potent chemoattractant for monocytes, but is less effective than 
monocyte chemotactic protein (MCP)-1 (Schall, Bacon et al. 1990; Uguccioni, 
D'Apuzzo et al. 1995) and has no effect on neutrophils. It is an important chemotactic 
agent for many T-lymphocyte subsets including CD4
+
 and CD45R0
+
 in endothelial free 
assays (Schall, Bacon et al. 1990) and CD4
+
 and CD8
+
 in trans-endothelial systems, 
where it has been shown to be the most potent CC chemokine for CD8
+ 
T-cells (Roth, 
Carr et al. 1995).As well as attracting and activating natural killer (NK) cells (Taub, 
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Sayers et al. 1995; Maghazachi, Al-Aoukaty et al. 1996), it also attracts and is secreted 
by eosinophils (Rot, Krieger et al. 1992; Lim, Wan et al. 1996) and it targets basophils, 
causing them to release histamine (Kuna, Reddigari et al. 1992). 
 
 IP-10 1.7.10.5.
Produced in response to viral stimulus, the IRF-stimulated gene IP-10, also known as 
CXCL10, is a CXC chemokine that binds to the G-protein coupled receptor CXCR3 
(Loetscher, Gerber et al. 1996). IP-10 is produced from a variety of cell types including 
monocytes, keratinocytes, T-lymphocytes, fibroblasts and endothelial and epithelial 
cells in response to IFNγ stimulation (Luster, Unkeless et al. 1985). It does not attract or 
activate neutrophils (Dewald, Moser et al. 1992), but has been linked to chemotaxis of 
T-lymphocytes (Murphy, Tian et al. 1996; Taub, Longo et al. 1996) and tumour-
infiltrating leukocytes (Liao, Rabin et al. 1995).  
 
 MCP-1 1.7.10.6.
 MCP-1, also known as CCL2, exists in two forms, a precursor and mature form, of 23 
and 76 amino acids in length (Furutani, Nomura et al. 1989; Yoshimura, Yuhki et al. 
1989). Dominant negative inhibition studies showed that it functions as a dimer (Zhang 
and Rollins 1995). It is primarily secreted by monocytes, macrophages and dendritic 
cells; however it requires cleavage by the metalloproteinase MMP-12 to become 
activated. It is linked to chemotaxis and activation of monocytes (Uguccioni, D'Apuzzo 
et al. 1995), CD4
+
 and CD8
+
 T-lymphocytes (Loetscher, Seitz et al. 1994) and basophils 
(Bischoff, Krieger et al. 1992), however it does not attract neutrophils or eosinophils. 
Activation of basophils results in histamine release (Alam, Lett-Brown et al. 1992; 
Bischoff, Krieger et al. 1992; Kuna, Reddigari et al. 1992). MCP-1 exerts its effects by 
binding to CCR2 (Charo, Myers et al. 1994; Yamagami, Tokuda et al. 1994) and CCR4 
(Power, Meyer et al. 1995). 
 
 Interferons (IFNs) 1.7.10.7.
The IRF stimulated family of cytokines, the IFNs, share significant amino acid 
homology and exhibit similar cellular effects on target cells including modulation of the 
immune response, anti-viral immunity and anti-proliferative effects. There are three 
major IFN subgroups: Type I (INFα, IFNβ, IFNω, IFNκ and IFNε), Type II (IFNγ) and 
Type III (IFNλ1, IFNλ2 and IFNλ3).  
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The genes encoding all Type I IFNs share significant sequence homology and are 
located in a cluster on chromosome 9 (Diaz, Pomykala et al. 1994; Stark, Kerr et al. 
1998). Type I IFN have been shown to possess potent anti-viral activity which includes 
up-regulation of proteins that bind to dsRNA (Williams 1999), inhibition of protein 
translation (Kerr and Brown 1978; Jacobs and Langland 1996), inhibition of viral 
ribonucleoprotein complex trafficking (Weber, Haller et al. 2000) and induction of 
apoptosis in virally infected cells (Takizawa, Ohashi et al. 1996; Der, Yang et al. 1997; 
Balachandran, Kim et al. 1998; Gil and Esteban 2000), showing them to possess potent 
anti-viral activity. The essential role of these cytokines is confirmed in the Type I IFN 
receptor knockout mouse, which is highly susceptible to viral infections (Hwang, 
Hertzog et al. 1995; Steinhoff, Muller et al. 1995).  
 
IFNγ, the only Type II IFN, shares little amino acid sequence homology with the Type I 
IFNs (Stark, Kerr et al. 1998). Studies using an IFNγ receptor knockout mouse (Huang, 
Hendriks et al. 1993; Lu, Ebensperger et al. 1998) and humans with IFN-γ receptor 
mutations (Dorman, Picard et al. 2004) show that it does not play a significant role in 
anti-viral immunity. It has been associated with both cell-mediated immune responses 
to intracellular pathogens and anti-tumour immune responses (Donnelly and Kotenko 
2010). 
 
The more recently discovered Type III IFNs have also been shown to be involved in 
anti-viral responses (Kotenko, Gallagher et al. 2003; Sheppard, Kindsvogel et al. 2003). 
The genes encoding all three IFNλs are clustered on chromosome 19, with proteins 
sharing between 5-18% sequence homology to the Type I IFNs (Donnelly and Kotenko 
2010) and induction occurs in response to the same stimuli as Type I IFNs (Coccia, 
Severa et al. 2004; Ank, West et al. 2006). They are often co-expressed in viral infected 
cells, confirming their joint roles in anti-viral immunity (Kotenko, Gallagher et al. 2003; 
Sheppard, Kindsvogel et al. 2003). Type III IFNs have been strongly associated with 
responses of human primary epithelial cells to RSV infection (Spann, Tran et al. 2004). 
 
Each IFN type binds a specific receptor; Type I bind to the IFNR1α and IFNRα 
heterodimeric complex, Type II to the IFNγR1/IFNγR2 tetrameric receptor complex 
that consists of two of each of the receptor domains, and Type III IFNs bind to the 
IFNλR1/IL-10R2 heterodimeric receptor complex. Activation of any of these receptors 
activates the JAK/STAT pathway and leads to transcription of IFN stimulated genes 
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(ISG) through STAT binding to IFN stimulated response elements (IRSE) for Type I 
and III IFNs or IFNγ associated sequence (GAS) for Type II IFNs (Donnelly and 
Kotenko 2010).  
 
 TNFα-Signalling 1.7.11.
Tumour necrosis factor-α (TNF-α), a member of the TNF-related superfamily of 
proteins is a pro-inflammatory cytokine up-regulated in response to acute inflammation. 
First identified as a lymphocyte and macrophage product that caused lysis of certain cell 
types, including tumour cells (Granger, Shacks et al. 1969; Carswell, Old et al. 1975), it 
has since been shown to be produced by a wide variety of cells, including macrophages, 
CD4
+
 and CD8
+
 T-lymphocytes, B lymphocytes, NK cells, neutrophils, smooth muscle 
cells and endothelial cells (Vilcek and Lee 1991). It plays important roles in the immune 
system include activation of immune cells, including monocytes and platelets, and 
enhancement of macrophages and NK cells abilities to kill viral, bacterial and parasitic 
pathogens. TNF-α has also been associated with causing cell death via apoptosis and 
necrosis (Fiers 1991; Beyaert and Fiers 1994). Membrane bound TNF-α is 
proteolytically cleaved by TNF-α converting enzyme (TACE) to produce a 17kDa 
soluble form which forms a homotrimer with two other soluble TNF-α proteins to 
activate the TNF receptor (TNFR) (Vilcek and Lee 1991). 
 
There are two different TNF receptors that bind TNF-α: TNFR1 and TNFR2 and both 
bind with high affinity to the TNF-α homotrimer. TNFR1 and TNFR2 are type I 
transmembrane glycoprotein receptors, however they have very little sequence 
homology in their intracellular domains, suggesting activation of separate signalling 
pathways. Most of the biological effects of TNF-α occur through TNFR1; the few 
specific actions of TNFR2 include proliferation of thymocytes and possible sink activity 
for TNF-α as a way to reduce inflammation-mediated host damage (Peschon, Torrance 
et al. 1998). TNFR1 activation leads to NF-κB activation. 
 
TNF-α signalling through TNFR1 is essential for a successful defence response to a 
variety of invading pathogens (Flynn, Goldstein et al. 1995; Marino, Dunn et al. 1997). 
Overproduction of TNF-α or membrane TNFR1 accumulation can result in damage to 
the host. This damage has been associated with the pathogenesis of some diseases, 
including multiple sclerosis and rheumatoid arthritis (Korner, Lemckert et al. 1997; 
McDermott, Aksentijevich et al. 1999). 
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TNF-receptor-associated protein with a death domain (TRADD) and the 74kDa serine-
threonine kinase receptor interacting protein (RIP1) are recruited to the receptor 
complex upon activation of TNFR1 by TNF-α (Chan 2007). When this receptor 
complex has been assembled, the N-terminal TRAF binding domain of TRADD 
facilitates binding to the homotrimer TRAF2. 
 
The role of RIP1 in this signalling pathway remains somewhat controversial with 
conflicting data arising from a number of studies. One group found normal NF-κB 
activation in RIP1 knockout mouse embryonic fibroblasts (Wong, Gentle et al. 2010); 
whereas another group, using the same model, showed RIP1 is an essential part of NF-
κB activation (Devin, Cook et al. 2000). A third group showed abolishment of NF-κB 
signalling in RIP1 deficient Jurkat cells (Ting, Pimentel-Muinos et al. 1996). Binding 
studies show that recruitment of the IKK complex is unaffected by RIP1 deficiency 
(Devin, Cook et al. 2000). Later reconstitution studies showed the kinase activity of 
RIP1 is not necessary for activation of NF-κB through the TNFR1 signalling pathway 
(Lee, Shank et al. 2004) suggesting its activation may mediate signalling activity in 
other pathways. It has also been implicated in TRIF-dependent TLR3 antiviral 
responses (Meylan, Burns et al. 2004). 
 
To activate NF-κB, the TNFR1-TRADD-RIP1 complex assembles and is subsequently 
ubiquitinated with Lys-63 polyubiquitin chains (Ea, Deng et al. 2006). The IKK 
complex and its activating complex (TAK1-TAB2-TAB3) are recruited to the activated 
TNFR1 receptor through the ubiquitin binding domains. This then undergoes 
phosphorylation and lysine 63 ubiquitination (Fan, Yu et al. 2010), activating TAKs 
kinase domain resulting in IKKα and IKKβ phosphorylation. The activated IKKs 
phosphorylate the IκBα (the NF-κB inhibitory protein) resulting in its proteasomal 
degradation, finally leading to activation to NF-κB. 
 
1.8. What was known 
Prior to the start of this project, NTHi had been shown to elicit a response through 
TLR2 and TLR3, however very little work had been performed to characterise the 
cytokine response to NTHi, with only one study identifying early expression IL-1α, IL-
1β, TNF-α, IL-6, IL-8 and MCP-1, resulting in secretion of TNF-α, IL-6, IL-8 and 
MCP-1 by the cells. RSV had been well characterised in cell line models, identifying 
 59 
 
up-regulation of type III IFNs, IL-6, IL-8 IP-10, ICAM-1, RANTES and TNF-α from 
the airway epithelium, however studies in more complex airway models were more 
limited. The virus was known to have selective preference for ciliated cells in 
differentiated epithelial cell cultures but had been shown to infect undifferentiated (non-
ciliated) cells as well. Both these pathogens had been shown to co-infect ‘diseased’ 
airways, with studies showing that an initial RSV infection aids the establishment of an 
NTHi infection. 
 
1.9. Aims and Objectives 
The airway epithelium functions as a respiratory surface in the lower airways and as a 
defensive tool in the upper airways. The thickness and cellular structure of the airway 
relates to the function. In the upper airways the epithelium consists of basal, secretory 
and ciliated cell types, producing mucus to trap particles that are moved towards the 
oropharynx by mucociliary clearance. ‘Diseased’ airways undergo cellular remodelling, 
altering the composition of the mucociliary phenotype and increasing the susceptibility 
of the airway to structural damage and infection with a variety of respiratory pathogens. 
 
We hypothesise that airway epithelial cells can be used as models for the study of host 
pathogen interactions in vitro.  We hypothesise that primary airway epithelial cells 
cultured at the ALI may represent a better model than established cell lines. 
Furthermore growth of these cultures can be modulated by altering growth factors to 
simulate the diseased airway. Exposing these cultures to pathogens could aid 
understanding of poorly understood disease processes and innate defence mechanisms. 
 
The main aim of this study was to model the airway epithelium in vitro in order to use it 
as a tool to understand pulmonary innate defence mechanisms. Regardless of the disease 
state/phenotype of the airway, RSV is a major causative pathogen of respiratory 
infections in children, the immune-compromised and the elderly, specifically targeting 
ciliated cell types within the airway epithelium. Exhibiting a seasonal infection pattern, 
RSV manages to evade host defences and recur periodically throughout life. NTHi has 
also been found to be a leading bacterial cause of respiratory infection, particularly in 
the ‘disease’ phenotype, where it is frequently found colonising the airways, often in 
biofilm form. My initial objective was to establish the effectiveness of cell lines for use 
as an airway model, and optimise bacterial and viral doses. 
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As a result of the potential limitations of cell line studies my second objective was to 
reproducibly establish the ALI culture model with primary cells to allow for further 
studies; and characterise the differences between the ‘normal’ cultures and those 
differentiated in the presence of IL-13 to give a ‘diseased’ phenotype. 
 
 Upon establishment of the ALI culture model with primary cells, my third objective 
was to expose the cultures to the pathogens RSV and NTHi in order to establish 
infection to investigate the immune responses. These two pathogens have also been 
implicated in co-infections, particularly in ‘diseased’ airways. Thus a key objective 
through use of the ALI culture model was to establish RSV and NTHi infections, a 
biofilm-type infection/colonisation of the NTHi, and establish co-infections with both 
RSV and NTHi. 
 
These models were subsequently used to understand early progression of the infections 
and the roles of specific host factors involved in the establishment and prevention of the 
infection process in both the normal and diseased airway. 
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2. Materials and Methods 
 
2.1. Materials 
A full list of materials can be found in Appendix 1 
 
2.2. Cell Biology 
 Initial culture from frozen stock 2.2.1.
 Cell Lines 2.2.1.1.
The appropriate medium (Appendix 2) was made, and a T75 flask containing 20mls was 
placed in an incubator to pre-warm. Cells were removed from liquid nitrogen storage 
and placed immediately on ice. The vial was then placed in water at 37
o
C and agitated 
for 90 seconds until cells were thawed. The cells were then added to the pre-warmed 
media and replaced into the incubator to grow.  
 
 Primary uHBE Cells 2.2.1.2.
100mls of bronchial epithelial growth medium (BEGM) was made (Appendix 2) and 2  
T25 flasks containing 10mls placed in the incubator and pre-warmed. Primary human 
bronchial epithelial (HBE) cells were removed from liquid nitrogen storage and placed 
immediately on ice. The vial was then placed in water at 37
o
C and agitated for 90 
seconds until the cells were thawed. They were then opened in the laminar flow-hood 
and resuspended by pipetting up and down gently. Half the cells were placed in each 
pre-warmed T25 and placed back in the incubator. The BEGM was replaced after 24 
hours and then every 2-3days until the flasks were approximately 80-90% confluent. 
Upon achieving 80-90% confluence, one T25 flask was sub-cultured to passage 3 and 
the other was frozen down for later use. Lower cell numbers in the vials required use of 
T25 flask as opposed to the T75 flask used for cell lines in section 2.2.1. 
 
 Sub-culture of cells 2.2.2.
 Cell Lines 2.2.2.1.
After removing the media from the flask, the cells were gently washed with 5mls of 
Phosphate Buffered Saline (PBS) without Calcium/Magnesium. The PBS was then 
removed and 2mls of Trypsin-Ethylenediaminetetraacetic acid (EDTA) was added to 
the flask and placed back in the incubator until the cells began to detach. The side of the 
flask was tapped gently to detach any remaining loose cells and the trypsin was 
quenched with complete medium. This was pipetted up and down to re-suspend cells 
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and break up any clumps. Cells were counted using a haemocytometer, centrifuged, and 
seeded into T75 flasks at 10,000cells/cm
2
. The flasks were then incubated at 37
o
C and 
passaged upon reaching 70-80% confluence. 
 
 Primary uHBE Cells 2.2.2.2.
Cells were only sub-cultured to a maximum of Passage 4 as cells could not be used for 
ALI culture beyond passage 5. After removing the BEGM from the flask, the cells were 
gently washed with 5mls of PBS. The PBS was removed and 1ml of trypsin-EDTA was 
added to the flask which was then placed back in the incubator for 5-10minutes to allow 
the cells to begin to detach. The side of the flask was tapped gently to detach any 
remaining loose cells and the trypsin was quenched with 5ml serum-containing media. 
This was pipetted up and down to re-suspend cells and break up any clumps.  Cells were 
counted using a haemocytometer, centrifuged, and seeded into T75 flasks at 
10,000cells/cm
2
. The flasks were then incubated at 37
o
C replacing the BEGM after 24 
hours and then every 2-3 days until 80-90% confluent. Upon reaching confluence, the 
flasks were used to seed further flasks to Passage 4 or seeded onto transwells for ALI 
Culture. 
 
 Freezing of cells 2.2.3.
The cells were detached using trypsin-EDTA as in 2.2.2 and counted. Cell lines were 
centrifuged and re-suspended in freezing medium (Appendix 2) at a cell density of 
1x10
6
cells/ml. Primary cells were centrifuged and re-suspended in Cryo-SFM at a cell 
density of 0.5x10
6
cells/ml. Cells were placed in cryovials in 1ml aliquots and placed in 
a Mr Frosty in the -80
o
C freezer overnight so they could freeze gradually and stored in 
liquid nitrogen. Primary cells were frozen at a lower density and in different medium to 
cell lines.  
 
 Isolation of Human Neutrophils 2.2.4.
Density gradient centrifugation coupled with negative magnetic selection, using a 
custom antibody cocktail (Stem Cell Technologies, Vancouver, Canada), was used to 
isolate human neutrophils from the venous blood of healthy human volunteers (Sabroe, 
Prince et al. 2003; Basran, Jabeen et al. 2013) using a protocol approved by the 
Sheffield Research Ethics Committee (UK). 
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2.3. Protein Analyses 
 Western Blot Analysis 2.3.1.
 Generation and characterisation of human-specific SPLUNC1 and 2.3.1.1.
LPLUNC1 antibodies 
Two affinity purified anti-rabbit, peptide-specific, polyclonal antibodies against human 
SPLUNC1 and LPLUNC1 were generated by Eurogentec (Seraing, Belgium) using 
their DoubleX strategy. This involved the generation of two peptides from the same 
antigen which are immunized into the host animal together to improve success rate. 
 
For SPLUNC1, the peptide sequences used for antibody A corresponded to amino acids 
169-179 (AVRDKQERIHL) and to amino acids 192-207 (DGLGPLPIQGLLDSL) for 
antibody B. For LPLUNC1, the peptide sequences used for antibody A corresponded to 
amino acids 139-154 (TIRMDTSASGPTRLV) and to amino acids 472-484 
(ASLWKPSSPVSQ) for antibody B; which is located at the extreme C-terminus of the 
protein in the second BPI domain. All peptides were chosen to have minimal sequence 
conservation between man and mouse (Appendix 3) and no similarity with other 
members of the PLUNC family. Bioinformatic analysis also showed that these epitopes 
had no significant sequence identity with any other human proteins. 
 
 Validation of antibodies by Western blotting of ALI cell culture secretions 2.3.1.2.
and BAL 
Antibodies were validated using apical secretions from ALI cells provided by Dr 
Michael Campos (University of Miami) or by Dr Phillip Monk (Synairgen, 
Southampton). Secretions were collected, every 2-3 days, from differentiated TBE cells 
cultured at the ALI by washing each well of a 12-well plate with 100µl of PBS. Samples 
were centrifuged at 600xG to remove cellular debris and 5µl aliquots used for Western 
blotting as outlined below. BAL samples (provided by Dr Michael Campos, University 
of Miami) were obtained by instilling 60ml of normal saline in the non-diseased middle 
lobe or lingula of subjects with lung cancer undergoing clinically indicated 
bronchoscopy as part of their diagnostic work-up, under a protocol approved by the 
University of Miami’s Institutional Review Board. They were collected and processed 
under standard conditions (Meyer, Raghu et al. 2012).15µl of BALs were subjected to 
Western blotting. Aliquots of ALI cell culture secretions and BAL were digested 
overnight with PNGaseF according to the manufacturers’ instructions and Western 
blotted.  
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 Separation by Sodium Dodecyl Sulphate-Polyacrylamide Gel 2.3.1.3.
Electrophoresis (SDS-PAGE) 
Protein separation was performed using the Bio-Rad Mini-PROTEAN 3 Gel 
Electrophoresis System. Glass plates for casting a 1.5mm thick gel were cleaned with 
70% Industrial Methylated Spirits (IMS) and assembled in the casting stand. A 
resolving gel (Appendix 2) was prepared and transferred to the casting equipment using 
a Pasteur pipette to approximately 1.5cm below the top of the short plate. This was then 
overlaid with a thin layer of propan-2-ol to remove oxygen and allowed the gel to set as 
well as bursting any bubbles that may have formed; this was then washed off with 
distilled water. A stacking gel (Appendix 2) was prepared and transferred to the top of 
the resolving gel using a Pasteur pipette to the top of the glass plates. This helped to 
eliminate air bubbles upon insertion of a 1.5mm thick, 10-well comb which was 
carefully removed upon setting of the gel. The complete gel was then removed from the 
casting equipment and assembled in the running tank, which was filled with SDS-PAGE 
running buffer.  
 
Samples for separation were prepared by addition of equal volumes of 2x SDS Lysis 
Buffer (Appendix 2) and heated to 100
o
C for 5 minutes. The samples were loaded 
alongside ColorPlus Prestained Protein Ladder (New England BioLabs). The gel was 
run at 120V until the blue dye front of the lysis buffer had passed through the stacking 
gel; it was then turned up to 150V-200V until the dye front had reached the bottom of 
the gel. 
 
 Transfer of Proteins to a membrane 2.3.1.4.
Proteins were separated using SDS-PAGE as previously described. When 
electrophoresis was complete, the apparatus was disassembled and the stacking gel 
separated from the resolving gel. The resolving gel was then placed in transfer buffer 
(Appendix 2). Six pieces of Whatman blotting paper and polyvinylidene fluoride 
(PVDF) membrane were cut to the approximate size of the resolving gel. The PVDF 
was activated by soaking in methanol for 2 minutes and placed in transfer buffer. The 
Whatman paper was also soaked in transfer buffer. These components were placed on 
the surface of a Bio-Rad Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell in the 
following order: (1) three pieces of Whatman paper (2) PVDF (3) the resolving gel and 
(4) three pieces of Whatman paper. Air bubbles were squeezed out to ensure efficient 
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transfer. For two gels transfer was conducted at 15V for 50 minutes, this was reduced to 
40 minutes at 15V for one gel. 
 
2.3.1.4.1. Dot-blotting 
A grid of 1cm x 1cm boxes was drawn in pencil on a 0.2µM nitrocellulose membrane. 
2µl of samples were spotted into the centre of the box and allowed to dry before being 
immuno-blotted as below. 
 
 Immunoblotting and Detection 2.3.1.5.
Upon completion of transfer, the membrane was placed in blocking buffer (Appendix 2) 
on an orbital shaker for 1 hour in order to reduce non-specific binding of antibodies to 
the membrane. The membrane was then washed for 5 minutes in TBS (Appendix 2). 
The primary antibody was diluted in 5mls of blocking buffer and incubated overnight 
on a rolling platform at +4
o
C (a full list of antibodies, including where they were 
purchased from and dilution factors, can be found in Appendix 1). Membranes were 
washed 3 times for 5 minutes in TBS-Tween (Appendix 2) on an orbital shaker, and 
then incubated with the appropriate horse-radish peroxidase (HRP)-conjugated 
secondary antibody, diluted in 5mls blocking buffer, (Table 2.1) on a rolling platform 
for 1 hour at room temperature. 
 
After a further 3 washes in TBS-Tween HRP activity was detected by 
chemiluminescence using the EZ-ECL Chemiluminescence Detection Kit according to 
the manufacturers’ instructions. The treated membranes were then placed between two 
pieces of acetate and any excess ECL and air bubbles eliminated. In the dark room the 
membrane was positioned in a Hypercassette and exposed to X-ray film (Hyperfilm) for 
varying periods of time to attain an optimum exposure with discrete bands and 
developed. 
 
 Human Cytokine Array 2.3.2.
The human cytokine array was performed using a Human Cytokine Array Panel A Kit 
(R&D Systems). The cytokines and chemokines included in this kit are all involved in 
pro-inflammatory signalling in the innate and adaptive immune systems. Signalling 
pathways include both canonical and non-canonical NF-κB signalling, JAK/STAT 
signalling, the complement system and IFN/IRF signalling. 
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Reagents from the kit were diluted or reconstituted according to the manufacturers’ 
instructions. Hybridisation of the array was performed in accordance with the 
manufacturers’ instructions. The Sample-Antibody-HRP bound cytokines were detected 
using the EZ-ECL Chemiluminescence Detection Kit for HRP as stated in section 2.4.3 
and exposed to X-ray film in the dark room for 1, 5 and 10 minutes, before developing 
(section 2.4.3). 
 
2.4. Histological Staining and Imaging 
 Fixation of membranes 2.4.1.
Media was removed from the basal compartment of ALI cultures and replaced with 1ml 
of PBS, with a further 500µl added to the apical surface. Cultures were then placed on a 
plate shaker at 150rpm for 10 minutes to wash the cells. This wash was repeated twice 
to ensure all media was removed. Cells were fixed by the addition of 1ml 10% 
phosphate buffered formalin to the basolateral compartment and 500µl to the apical 
surface (Villenave, Touzelet et al. 2010). Plates were sealed with parafilm to prevent 
dehydration and stored at +4
o
C. Wells containing fluorescent-labelled pathogens were 
fixed for 15 minutes with 10% phosphate buffered formalin as mentioned above; this 
was then removed and replaced with PBS before storage at +4
o
C. 
 
 Haematoxylin and Eosin Staining 2.4.2.
Transwell membranes supporting ALI cultures were formalin fixed and paraffin 
embedded. Processing, embedding and serial sectioning was performed by the Core 
Histology Facility in the Medical School at the University of Sheffield. After 
processing, the membranes were cut in half prior to embedding in paraffin blocks, with 
the straight (cut) edge towards the cutting surface, to provide lateral sections of the 
membrane. Sections were de-waxed by immersion in xylene for 5 minutes, and 
rehydrated to tap water by immersion for 5 minutes in 100%, 70% and 50% ethanol and 
finally tap water. Slides were immersed in Gills Haematoxylin for 2 minutes, washed in 
tap water, immersed in Scott’s tap water for 10 seconds to ‘blue’ and washed in tap 
water. Sections were then stained with 1% aqueous Eosin for 5 minutes, quickly rinsed 
with tap water and dehydrated back through the alcohols to xylene before mounting 
under coverslips with DPX mountant. 
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 Immunohistochemistry 2.4.3.
The methods outlined in this section are the standard conditions used by and outlined in 
Bingle, Cross et al. (2005) and Bingle, Barnes et al. (2007). 
 
 Preparation 2.4.3.1.
Serial sections were cut from formalin fixed and paraffin embedded membranes and 
mounted onto slides by the Core Histology Facility in the Medical School at the 
University of Sheffield. The sections were then drawn round using a solvent resistant 
pen and placed in a slide rack. These were de-waxed twice in xylene for 5 minutes. 
Slides were then immersed twice in 100% ethanol for 5 minutes to rehydrate the 
sections. The slides were finally immersed in 3% hydrogen peroxide diluted in 
methanol for 20 minutes to quench any endogenous peroxidises present in the samples. 
Some sections were subjected to antigen retrieval by boiling the slides in a microwave 
for 8 minutes in 0.01M tri-sodium citrate (Bingle, Barnes et al. 2007). Sections were 
then incubated in 100% normal serum for 30 minutes in a humidified chamber at room 
temperature (Bingle, Cross et al. 2005; Bingle, Barnes et al. 2007). The species of 
serum chosen was that from the animal used to raise secondary antibody. Blocking with 
normal serum is important as it blocks non-specific activity. 
 
 Primary Antibody 2.4.3.2.
During the blocking period, the primary antibody was diluted with 100% normal serum 
(again from the animal used to raise the secondary antibody) (a full list of antibodies, 
including where they were purchased from, dilution factors and normal serum used, can 
be found in Appendix 1). After blocking, sections were incubated with primary 
antibody overnight at +4
o
C in a humidified chamber. Control slides were incubated with 
100% normal serum overnight at +4
o
C (Bingle, Cross et al. 2005; Bingle, Barnes et al. 
2007). Slides were then placed in a slide rack and washed in PBS twice for 5 minutes 
each. The slide rack was raised inside the wash container to allow for the use of a 
magnetic stirrer to mix the PBS during the washing step. 
 
 Secondary Antibody 2.4.3.3.
A biotinylated secondary antibody was provided in a Vectastain Elite ABC kit for the 
appropriate species. The Elite ABC Reagent is a complex avidin and HRP conjugated 
biotin to enhance signal. Slides were then placed in a slide rack and washed twice for 5 
minutes in PBS as before.  
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 Colour Development 2.4.3.4.
The Vector NovaRed Substrate kit was used for colour development. The reagent was 
mixed according to the manufacturers’ instructions and applied to the sections for no 
more than 5 minutes before submersion in distilled water to stop the reaction. Sections 
were then counterstained with haematoxylin, dehydrated to xylene, mounted using DPX 
mountant and allowed to dry (Bingle, Cross et al. 2005; Bingle, Barnes et al. 2007).  
 
 Immunofluorescent staining of ALI cultures 2.4.4.
 Immunostaining 2.4.4.1.
In the presence of fluorescently labelled pathogens, the plate was covered in foil 
throughout the following steps to preserve fluorescence. The formalin/PBS was 
aspirated from the apical and basolateral compartments of fixed membranes, washed by 
the addition of 1ml PBS to the basolateral compartment and 500µl PBS to the apical 
surface and placed on a plate shaker at 150rpm for 10 minutes. This was repeated twice 
to ensure thorough removal of formalin. The cells were then permeabilised by addition 
of 200µl of permeabilisation buffer to the apical surface. The plate was then placed on a 
plate shaker at 150rpm for 1 hour at room temperature. The permeabilisation buffer was 
removed and replaced with 200µl of primary antibody diluted in permeabilisation buffer 
and placed on a plate shaker at +4
o
C overnight.  
 
Antibody was removed from the apical surface, and the cells washed 3 times with PBS, 
on a plate shaker for 20 minutes at 150rpm at room temperature. The secondary 
antibody was diluted in permeabilisation buffer, and 200µl added to the apical surface. 
The plate was covered in foil (to prevent photo-bleaching of the secondary antibody) 
and placed on a plate shaker at 150rpm at +4
o
C for 1 hour. The secondary antibody was 
removed and the cells washed 3 times in PBS for 30 minutes at room temperature on a 
plate shaker at 150rpm, (the plate remained covered in tin foil to shield the secondary 
antibody). The membrane was then cut out using a scalpel and placed on a microscope 
slide with the cell side facing up. The filter was mounted by addition of 1 drop of 
Vectashield mounting medium containing DAPI (4',6-diamidino-2-phenylindole), a 
coverslip added and sealed with nail polish. Slides were covered with tin foil until the 
nail varnish had set. Slides were stored in the refrigerator until they could be viewed on 
an Olympus FV-1000 Confocal Microscope and imaged in the Light Microscope 
Facility in the Department of Biomedical Science at the University of Sheffield. This 
protocol was adapted and optimised from Villenave et al (2010). 
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2.5. Molecular Biology 
 RNA isolation and purification 2.5.1.
Samples lysed in TRI reagent first underwent phase separation by the addition of 200µl 
of chloroform per ml of TRI reagent used. The sample was mixed vigorously for 15 
seconds and allowed to stand for 2- 15 minutes at room temperature before centrifuging 
at 13,000 rpm for 15 minutes at 4
o
C, this resulted in separation of the mixture into three 
phases; a protein containing red organic phase, a DNA containing interphase and a clear 
RNA containing upper aqueous phase. The upper aqueous phase was transferred to a 
fresh tube and 500µl of isopropanol added per ml of TRI reagent used in the initial lysis. 
This was mixed, allowed to stand at room temperature for 5-10 minutes and then 
centrifuged at 13,000 rpm for 10 minutes at 4
o
C. The supernatant was carefully 
removed without touching the pellet. A minimum of 1ml 75% ethanol per ml of TRI 
reagent was added to wash the RNA pellet and centrifuged at 13,000 rpm for 5 minutes 
at 4
o
C. The supernatant was removed and the pellet air-dried for 5-10 minutes. The 
RNA pellet was not allowed to dry completely as this reduces solubility. The pellet was 
resuspended in up to 50µl of sterile water by repeated pipetting and stored at -20
o
C for 
the short-term and -80
o
C for long-term storage. RNA quality and yield was measured 
using a Nanodrop-1000 spectrophotometer (Thermo Fisher Scientific, Loughborough, 
UK) and a small amount of sample visualised (using RNA gel electrophoresis) to 
further examine quality. 
 
 RNA Gel Electrophoresis 2.5.2.
A gel tank was cleaned and set up for casting. A gel was prepared by mixing an 
appropriate amount of RNase-free agarose in water and heating in a microwave until the 
agarose had fully dissolved. This was allowed to cool before the addition of 10x MOPS 
and formaldehyde (Appendix 2). The gel was poured in the fume hood and allowed to 
set. The pouring apparatus was removed and the gel tank filled with 1xMOPS as 
running buffer. 1μl of sample was mixed with 2μl of RNA loading buffer and loaded 
into the wells. The gel was run at 70V until the dye front had travelled approximately 
1.5cm. The gel was then visualised using a Bio-Rad Chemi-Doc
™
 XRS
+
 system and an 
image was captured. 
 
 cDNA synthesis by Reverse Transcription 2.5.3.
All work involving RNA was performed using RNase-free filter pipette tips. RNA was 
reverse transcribed into complementary DNA (cDNA). RNA samples were quantified 
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using a Nanodrop-1000 spectrophotometer and an aliquot diluted to 200ng/µl-
1000ng/µl depending on amount when quantified. 2µl of RNA was added to 0.75µl of 
oligo(dT) and 8µl of RNase free water . This was then heated at 70
o
C for 5 minutes to 
anneal the oligo(dT) and then placed in ice for 5 minutes. A master mix; containing 5µl 
of AMV-RT buffer, 0.75µl of AMV-RT enzyme, 0.75µl of RNasin, 10µl 10mM 
deoxyribonucleotide triphosphate (dNTP)s and 5.75µl RNase-free water per reaction 
was made and 15µl was added to the tubes containing RNA, oligo(dT) and water. The 
reactions were placed in a GRI PTC-200 DNA Engine PCR machine in ‘block’ mode at 
42
o
C for 1 hour, followed by 95
o
C for 5 minutes to inactivate enzyme activity, and 
finally at 4
o
C until the reactions could be removed and stored at -20
o
C. The cDNA was 
not quantified after reverse transcription. 
 
 Polymerase Chain Reaction (PCR) 2.5.4.
Primers (Appendix 2) were reconstituted by adding an equal volume of water to weight 
(µg) to give a final concentration of 1µg/µl. These were then diluted 1:10 to provide a 
0.1µg/ml working dilution. A master mix; containing 5µl of 5X Green GoTaq®Flexi 
Buffer, 2µl MgCl2, 0.25µl of GoTaq® DNA Polymerase, 2µl 10mM dNTPs and 
12.75µl of water per reaction, was prepared. 1µl of cDNA, 1µl of forward primer and 
1µl of reverse primer were added together in individual reaction tubes, water was used 
in place of cDNA in the negative control. 22µl of master mix was added to each tube 
and mixed. The tubes were then placed in the PCR machine for 35 cycles (as a default 
program); consisting of a 94
o
C denaturation step for 1 minute, a 60
o
C annealing step for 
1 minute and a 72
o
C extension step for 1 minute; reactions were then subjected to a 
prolonged extension step of 7 minutes at 72
o
C and cooled to 12
o
C until removed. Exon-
spanning RT-PCR primers were designed using Primer3 (http://simgene.com/Primer3) 
and were chosen to have a default annealing temperature of 60
o
C. 
 
 Agarose Gel Electrophoresis 2.5.5.
Successful amplification of DNA by PCR was assessed using agarose gel 
electrophoresis. A gel tank was set up for casting of a gel and a 1-2% gel was prepared 
by mixing an appropriate amount of agarose in 1x Tris-acetate-EDTA (TAE) (Appendix 
2) and heating in a microwave until the agarose had fully dissolved. This was allowed to 
cool before the addition of ethidium bromide (1µl per 100ml of gel mixture). The gel 
was poured and allowed to set, the pouring apparatus removed and the gel tank filled 
with 1xTAE buffer. Samples were loaded alongside size markers, either Hyperladder I 
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or Hyperladder IV, and run at 70-90V until fully resolved. The gel was visualised using 
a Bio-Rad Chemi-Doc
™
 XRS
+
 system and an image was captured.  
 
 qPCR 2.5.6.
Primers were reconstituted by the addition of an equal volume of sterile water per 
weight (μg) to give a final concentration of 1μg/μl and diluted 1:10 to provide a 
0.1µg/ml working dilution. A master mix; containing 10μl of Luminaris Color HiGreen 
High ROX qPCR Master Mix (SYBR green), 7μl of sterile water, 1μl of forward primer 
and 1μl of reverse primer per reaction were mixed by vortex. 19μl of master mix was 
added to the appropriate well in a 96-well plastic qPCR plate. 1µl of sample was added 
in triplicate per primer pair. The plate was sealed and centrifuged at 13,000 rpm for 1 
minute to ensure the sample was at the bottom of the well. The plate was placed in an 
Applied Biosystems 7900HT Fast Real-Time PCR System for amplification. The data 
generated was analysed using the 2
-ΔΔC
T method (Livak and Schmittgen 2001).  
 
2.6. Respiratory Syncytial Virus (RSV) 
Red-tagged RSV (rr-RSV) stock was gifted to us by Mark Peeples from the Nationwide 
Children’s Hospital in Columbus, Ohio (Guerrero-Plata, Casola et al. 2006). 
 
 Propagation of RSV 2.6.1.
HeLa cells were grown to 60-80% confluence in a minimum of 4 T75 flasks in 5% 
Serum HeLa medium (Appendix 2). Media was removed from the cells and replaced 
with 5mls of a 1:2500 dilution of virus (8µl in 19992µl 2% Serum HeLa medium). This 
was incubated at 37
o
C for 2 hours, gently shaking the flasks every 15 minutes. 8mls of 
2% Serum HeLa medium was then added and cells were incubated for 3 days at 5% 
CO2 and 37
o
C. On day 3, the approximate percentage of fluorescent cells was 
calculated, and if less than 80% then 10mls of media were added to prevent cell death, 
and infection of cells was monitored by fluorescent microscopy. If more than 80% then 
virus was harvested from cell as on day 5. On day 5, the media was removed from the 
flask into a 50ml Falcon tube.  5mls of the original media was put back into the flask 
and cells were then removed with a cell scraper and pipette and then passed through a 
21 and 19 gauge needle 2-3 times in order to shear the cells. Cells were then ‘snap’ 
frozen in liquid nitrogen, thawed at 39
o
C to prevent killing the virus with large hot/cold 
rapid temperature changes and centrifuged at 300rpm for 10 minutes at 4
o
C to pellet the 
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cell debris. The supernatant was removed (as this contains the virus), aliquoted into 8ml 
samples and snap frozen in liquid nitrogen. These aliquots were then stored at -80
o
C. 
 
 Purification of RSV 2.6.2.
To ensure complete dissolution, I-block (0.1% Casein Solution) was prepared at least 
three days before virus purification. Vivaspin tubes were washed in ethanol and air 
dried in a tissue culture hood. 5mls of I-block were added to each tube, centrifuged at 
1000g for 5 minutes at 4
o
C, and then removed from the collecting tube of the vivaspin. 
20mls of a 1:10 dilution of RSV stock in cold serum free Dulbecco’s Modified Eagle 
Medium (DMEM) was added to the vivaspin tube and centrifuged at 2500g for 40 
minutes at 4
o
C. The filtrate in the bottom contained the HeLa cells and cytokines, and 
the retentate in the top chamber contained the RSV. The RSV was removed from the 
top chamber and any remaining virus washed off with 1ml of serum free DMEM. The 
purified virus was then diluted 1:2 with serum free media, aliquoted into 1ml or 500µl 
samples, snap frozen in liquid nitrogen and stored at -80
o
C. 12mls of the filtrate (3mls 
from each vivaspin tube) were also stored to use as controls to ensure successful virus 
purification.  
 
 RSV Plaque Assay 2.6.3.
 HeLa cell Infection 2.6.3.1.
HeLa cells were seeded at a density of 2.5x10
5
 cells/ml (100µl well of a 96-well plate in 
5% serum HeLa medium) and incubated overnight at 37
o
C. The plate was inverted to 
remove the media and 90µl of 2% Serum HeLa medium added to each well. The stock 
of RSV was thawed quickly as previously described (section 2.10.1). 10µl diluted virus 
was added in triplicate to row A to give a concentration of 1x10
-1
 and pipetted up and 
down gently to mix. 10µl from each of these wells was removed and placed in row B, 
mixed gently and the process repeated to row H to give final concentrations between 
1x10
-1 
to 1x10
-8
. Filtrate from the purification was also added to the plate in triplicate of 
neat filtrate and dilutions of 1x10
-1
 and 1x10
-2
. The plate was then incubated for 48 
hours at 37
o
C. 
 
 Immunostaining 2.6.3.2.
The plate was inverted to remove the media and fixed in 200µl of ice cold 50:50 PBS: 
acetone solution for 5 minutes at room temperature. The plate was washed 3 times with 
200µl of wash buffer (0.1% BSA solution diluted in PBS), 5 minutes per wash. 50µl of 
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RSV antibody (AbD Serotec, 7950-0004) diluted 1:500 in wash buffer was added to the 
wells and incubated for 1 hour at room temperature on a rotating platform. The wells 
were washed a further 3 times for 5 minutes. 50µl rabbit anti-goat peroxidase 
conjugated antibody (diluted 1:500) was added to the wells and incubated for 1 hour at 
room temperature on a rotating platform. The plate was then washed 3 times for 5 
minutes with wash buffer. 
 
A 30mg 4-chloronaphthol substrate tablet was dissolved in 10ml of methanol and 1 ml 
was added to 10mls of 1x TAE buffer along with 12µl of 30% hydrogen peroxide. The 
plate was incubated for 10-20 minutes with 50µl of substrate until black colonies 
appeared. Cells were washed with distilled water and allowed to air dry. To determine 
the plaque forming units (pfu)/ml, the number of black colonies was counted at each 
dilution in triplicate, the mean number calculated, and multiplied by 10 to calculate the 
pfu/ml.  
 
2.7. Non-Typeable Haemophilus influenzae (NTHi) 
 Culture of NTHi 2.7.1.
Strains of Non-typeable Haemophilus influenzae were obtained from the Medical 
Microbiology Department in the Royal Hallamshire Hospital on chocolate agar plates. 
For broth culture, the bacteria were grown in brain heart infusion (BHI) broth 
supplemented with yeast extract, hemin and β-NAD. Strains were maintained on 
chocolate agar plates (Appendix 2). A 5% CO2 level was required in the incubator 
(37
o
C) for growth.  
 
The NTHi strain, 86-028NP-GFP, was a gift from Dr Glen McGillivary and Dr Lauren 
Bakaletz at the Nationwide Children’s Hospital, Columbus, Ohio (Mason, Munson et al. 
2003). Provided in frozen glycerol stock the bacteria was streaked onto chocolate agar 
plates (Appendix 2) containing 20µg/ml of kanamycin (required to preserve the green 
fluorescent protein (GFP) tag), and added to BHI broth supplemented with yeast extract, 
hemin, β-NAD and 20µg/ml of kanamycin (Appendix 2). Both plate and broth were 
incubated at 37
o
C with a 5% CO2 level overnight. Growth was maintained on 
kanamycin supplemented chocolate agar at regular intervals, never longer than two 
weeks. 
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In order to make glycerol stocks for long term storage, 86-028NP-GFP was grown 
overnight in two broth cultures (as before). These were centrifuged at 13000 rpm for 2 
minutes. The pellets were resuspended in 1ml of BHI broth and 1ml of 60% glycerol 
added to give a final glycerol percentage of 30%. 1ml aliquots in cryovials were stored 
at -20
o
C in the short term and in liquid nitrogen for long term storage. 
 
2.8. Statistics 
All statistics are listed in the figure legends. We assumed normal distribution of data 
therefore despite the small replicate numbers parametric statistical analyses were 
performed as they test group means as opposed to medians. They are a more ‘powerful’ 
statistical test, making them more likely to detect a significant effect when one exists. 
 
 Paired t test  2.8.1.
There was only one viral dose to compare against the control in gene expression studies. 
As the samples obtained were ‘matched pairs’ a paired t test was used to analyse the 
differences between control and treated/ RSV infected samples.  
 
 ANOVA 2.8.2.
Repeated measures one-way ANOVA with Dunnetts multiple comparisons test was 
performed on expression data from NTHi infections. ANOVA was used as there are two 
different doses being compared to a control (3 independent groups); it is possible to 
have performed multiple t tests, however this increases the chance of committing a type 
1 error. 
 
ANOVA was used to analyse the variation in bacterial count data. One-way ANOVA 
was used to analyse variance in bacterial count data from independent 1 hour, 3 day and 
7 day infections. Two-way ANOVA was used to analyse the variation in bacterial count 
data from two different doses of bacteria over independent short term infections.  
 
 
 
 
 
 
 
 3. Establishment of an infection model using cell lines and 
undifferentiated primary human bronchial epithelial cells (uHBE) 
 
3.1. Introduction 
In vitro studies provide a means of examining biological effects using components of an 
organism taken from their biological niche. In lung research, in vitro studies have 
traditionally employed established cell lines which are generally derived from lung 
tumour tissue and as such can be considered immortal. Cell lines no longer possess the 
usual senescence apparatus, allowing them to undergo infinite replication, making them 
a useful tool for optimisation studies, and generating replicate data as there are no issues 
of inter-donor variability. This obvious advantage has to be balanced against the 
concern that such immortal cells will, by definition, have abnormal growth 
characteristics that may result in them generating inappropriate responses to stimuli. In 
addition cell lines have undergone genetic mutation to become tumorigenic, the impact 
upon the cell type specific characteristics found in the tissue of origin is unclear. This is 
particularly true with respect to airway epithelial gene expression, for example, study 
performed by Stewart, Torr et al. (2012) showed the BEAS-2B cell line did not form the 
tight junctions between cells in the airway, and in Calu-3 cells evidence of secretory cell 
types was clear with the identification of MUC5AC, however β-tubulin staining 
suggested cilia had not formed. 
 
Two established cells lines that have been used extensively to study the airway 
epithelium are A549 and NCI-H292. A549 cells are a human adenocarcinoma, alveolar 
basal cell line (Giard, Aaronson et al. 1973) and NCI-H292 cells are mucoepidermoid 
carcinoma cells (Yoakum, Korba et al. 1983; Banks-Schlegel, Gazdar et al. 1985; 
Carney, Gazdar et al. 1985).  
 
Primary HBE cells purchased from commercial companies or when freshly isolated 
from tissue, undergo a period of de-differentiation and can be considered to provide 
cultures of cells with an undifferentiated/basal cell phenotype. These cells do however 
have a finite lifespan, and exhibit significant donor variability.  
 
The A549 and NCI-H292 cell lines and undifferentiated primary human bronchial 
epithelial (uHBE) cells can be used to model aspects of the airway epithelium, eliciting 
responses upon stimulation or infection.  
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RSV is a common respiratory pathogen, frequently infecting children, the elderly and 
immuno-compromised. RSV exhibits a seasonal infection pattern, whilst evading host 
defence mechanisms between periods of exacerbations. The mechanism by which the 
virus infects the lung and is able to evade the immune system remains only partially 
characterised. Previous work from Sheffield has focused on the role that dendritic cells 
may play in this process, finding high numbers of dendritic cells during and after an 
RSV infection in hospitalised infants. We have found that RSV is able to infect 
dendritic cells with viral replication re-activated by stimulation with nitric oxide (Jones, 
Morton et al. 2006; Hobson and Everard 2008; Everard, Ugonna et al. 2009; Ugonna, 
Bingle et al. 2014). These studies focussed on the possibility that dendritic cells may be 
where the virus is able to lie dormant between infections but latterly our lab has become 
interested in the role that the epithelium plays. 
 
Haemophilus influenzae species, both encapsulate serotypes (a-f) and non-encapsulate 
(non-typeable, NT) strains are readily identified in the flora of normal airways (Hilty, 
Burke et al. 2010). Routine use of the Hib vaccine against type b strains, which was the 
most common cause of respiratory infection by encapsulate strains, reduced the number 
of invasive Hib infections. NTHi strains are more frequently identified as the causative 
agent in localised respiratory tract infections (Gilsdorf, Chang et al. 1992). They are 
frequently the cause of COPD exacerbations and are involved in colonisation of the CF 
airway. They are thought to be the first pathogen to infect the CF airway, allowing 
further pathogens to colonise. The large amount of heterogeneity between strains results 
in different combinations of surface antigens/features, therefore no single feature has 
been identified as essential for establishment of infection (Clemans, Bauer et al. 2000). 
 
With specific relevance to the studies contained in my thesis, these three cell lines have 
a history of use in infection studies. A549 cells have frequently been used to study RSV 
infections (Fiedler, Wernke-Dollries et al. 1996; Choudhary, Boldogh et al. 2005; 
Spann, Tran et al. 2005; Martinez, Lombardia et al. 2007; Eckardt-Michel, Lorek et al. 
2008; Gibbs, Ornoff et al. 2009; Munday, Emmott et al. 2010), and have also been used 
to introduce NTHi infections to RSV-infected cells to study adherence (Jiang, Nagata et 
al. 1999; Fukasawa, Ishiwada et al. 2009). NCI-H292 cells have also been subject to 
viral sensitivity testing, including for RSV (Hierholzer, Castells et al. 1993) and have 
also been used in NTHi adherence assays (Buscher, Burmeister et al. 2004). 
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Undifferentiated primary cells have been used to study NTHi infections (Jono, Xu et al. 
2003; Chen, Lim et al. 2004; Teng, Slavik et al. 2010; Morey, Cano et al. 2011) and 
have also been used to study RSV, to identify immune responses and signalling 
mechanisms activated in response to infection, and to investigate which RSV proteins 
cytokine  responses were elicited against (Becker, Reed et al. 1997; Kong, San Juan et 
al. 2003; Oshansky, Barber et al. 2010).  
 
 Aims 3.1.1.
The aims of the data presented in this chapter were to:  
(1) Establish NTHi and RSV infections in A549 and NCI-H292 cell lines and 
uHBE cells and to potentially establish biofilms 
(2) Characterise NTHi and RSV infections in A549 and NCI-H292 cell lines and 
uHBE cells to determine the representativeness of cell lines for use as an airway 
epithelial model. 
 
3.2. Methods 
 Infection with RSV 3.2.1.
Prior to infection with RSV, A549 and H292 cells and undifferentiated primary human 
bronchial epithelial (uHBE) cells underwent a media change, RSV was diluted to 
concentrations of 5x10
5
, 1x10
6
 and 5x10
6
 pfu in 50µl of serum free media prior to 
addition to the surface of the cells. 
 
 Short term infections 3.2.1.1.
A549 and H292 cells and uHBE cells were infected with 1x10
6
pfu of virus as described 
above. At time points of 1, 2, 4, 8, 24 and 72 hours post infection, media was collected 
and cells were lysed in TRI reagent for later RNA extraction. 
 
 Long term infections 3.2.1.2.
A549 and H292 cells and uHBE cells were infected with RSV in 4-well chamber slides 
(and transwells for the undifferentiated primary cells only). The media was changed 48 
hours after infection. At 5 days post infection, the experiment was terminated by 
collecting the media and fixing the cells with 10% phosphate-buffered formalin for 10 
minutes. The fixative was then replaced with PBS for longer-term storage. For the 
transwells (uHBE infections) membranes were cut from the transwell using a scalpel 
and mounted with Vectashield containing DAPI, sealed with nail polish and imaged 
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using the Olympus FV-1000 Confocal Microscope (see section 2.4). Infections 
performed in chamber slides were also stored in PBS long-term. The chambers were 
removed and counter-stained and mounted in the same way as the transwell membranes.  
 
 Infection of cells with NTHi 3.2.2.
A549 and H292 cells and uHBE cells underwent an antibiotic free media change for at 
least 3 days prior to infection. An appropriate amount of overnight broth growth was 
taken, diluted to an OD600 of 0.38 and centrifuged at 13000 rpm for 2 minutes to pellet 
the bacteria. This was resuspended in PBS and diluted to provide approximate MOIs of 
5, 25 and 50 per 50µl. 
 
 Short term infections 3.2.2.1.
A549 and H292 cells and uHBE cells were infected with bacterial doses of approximate 
MOI of 5 and 25 for periods of 1, 2, 4, 8, 24 and 72 hours. After which the media was 
removed and frozen. Prior to freezing some samples were used to perform serial 
dilutions and obtain viable bacterial counts. Two wells were lysed in 200µl of 2xSDS 
lysis buffer and two were lysed in TRI reagent for later RNA extraction.  
  
 Long term infections 3.2.2.2.
A549 and H292 cells and uHBE cells were seeded onto transwells to allow for 
basolateral media changes during the long-term infection. Infections were conducted on 
cells that had been cultured in antibiotic free media for at least three days. Cells were 
infected with approximate MOIs of 5, 25 and 50 for 1 hour, 3 days and 7 days. After 
which the media was removed from the surface of the transwell and frozen. Wells were 
washed basolaterally in PBS to remove excess media and fixed for 10 minutes in 10% 
phosphate-buffered formalin (basolateral and apical compartments). After 10 minutes 
the formalin was removed and replaced with PBS for longer term storage. Membranes 
were cut from the transwell using a scalpel and mounted with Vectashield containing 
DAPI, sealed with nail polish and imaged using the Olympus FV-1000 Confocal 
Microscope (see section 2.4). 
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3.3. Results 
 Establishing infections in cell lines and uHBE cells 3.3.1.
 NTHi infections 3.3.1.1.
The first series of studies were designed to develop protocols for reproducibly infecting 
lung derived cell lines with NTHi. As we were ultimately interested in establishing mid-
term cultures with a view to generating biofilms, we initially studied infections up to 7 
days post infection without any post infection washing of the cultures. 
 
A549 (Figure 3.1), NCI-H292 (Figure 3.2) and uHBE (Figure 3.3) cells were infected 
for 1 hour (A and B), 3 days (C and D) and 7 days (E and F) with NTHi at an MOI of 
25 and imaged using confocal imaging, to examine the effects of long term exposure on 
cell numbers/confluence and the development of biofilms on these cultures.  
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Figure 3.1: Infection A549 cells with NTHi for 1h, 3d and 7d 
A549 cells were infected with NTHi at an MOI of 25 for 1 hour, 3 days and 7 days. 
Green fluorescence shows the presence of bacteria, blue fluorescence shows DAPI 
staining of nuclei. Control wells showed no green fluorescence. (Images are 
representative of n=3 infections). 
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Figure 3.2: Infection of NCI-H292 cells with NTHi for 1h, 3d and 7d 
NCI-H292 cells were infected with NTHi at an MOI of 25 for 1 hour, 3 days and 7 
days. Green fluorescence shows presence of bacteria, blue fluorescence shows DAPI 
staining of nuclei. Control wells showed no green fluorescence. (Images are 
representative of n=3 infections). 
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Figure 3.3: Infection uHBE cells with NTHi for 1h, 3d and 7d 
uHBE cells were infected with NTHi at an MOI of 25 for 1 hour, 3 days and 7 days. 
Green fluorescence shows the presence of bacteria, blue fluorescence shows DAPI 
staining of nuclei. Control wells showed no green fluorescence. (Images show 
infection of cells from Donor 4, and are representative of =3 infections) 
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In all three cell types, cells at the 1 hour time point (A and B) were confluent, with 
small amounts of green fluorescence in the infected wells (A) showing that NTHi were 
beginning to establish an infection. By three days there appeared to be more green 
fluorescence in the wells. The A549 cell mono-layer was less tightly packed in the 
infected wells (C) compared to controls (D). The nuclei of NCI-H292 cells appeared 
enlarged, with some spaces in the mono-layer beginning to appear. There was also a 
higher level of NTHi (as shown by green fluorescence) in the uHBE cells at 3 days post 
infection. The uHBE cell layer did not appear to be adversely affected with spaces 
appearing in both the infected and control wells.  By 7 days, all three cell types showed 
dramatically reduced cell numbers, although the presence of green fluorescence showed 
that there were still bacteria present. The bacteria appeared to have clustered around the 
remaining cells.  
 
As the uHBE cells did not appear to be adversely affected by infection and showed a 
higher level of green fluorescence, imaging of the surface of uHBE cells infected for 3 
days with NTHi at an MOI of 25 was performed. This showed clustering of bacteria 
within what appeared to be a fluorescent mesh-like structure that could perhaps 
represent a biofilm (Figure 3.4). 
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Figure 3.4: Surface of uHBE cells infected for 3 days 
uHBE cells were infected with NTHi at an MOI of 25 for 3 days. Green 
fluorescence shows presence of bacteria and blue fluorescence shows DAPI staining 
of nuclei.(Donor 4) 
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 RSV infections 3.3.1.2.
To study whether we were able to infect A549, NCI-H292 and uHBE cells with RSV 
and to establish an effective dose for further studies, cells were seeded into chamber 
slides at an initial density of 10,000 cells per cm
2
 for the cell lines and 20,000 cells per 
cm
2
 for uHBE cells. This was necessary to achieve confluence at the same time as the 
primary cells grow much more slowly than cell lines. At approximately 80% confluence 
cells were infected with RSV at doses of 5x10
5
, 1x10
6
 and 5x10
6
 pfu for 5 days. Cells 
were fixed and imaged using a confocal microscope. An example of images captured 
with the 1x10
6
pfu dose show red fluorescence in all three cell lines (Figure 3.5A, C and 
E), and no fluorescence in the controls (Figure 3.5B, D and F). 
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Figure 3.5: A549, NCI-H292 and uHBE Cells are susceptible to RSV infection 
A549 (A), NCI-H292 (C) and uHBE (E) cells were infected with 1x10
6 
pfu of red 
recombinant RSV for 5 days alongside controls (B, D and F). Red fluorescence 
shows infection with RSV and blue fluorescence shows DAPI staining of nuclei. 
(Images show infections from uHBE Donor 5, and are representative of n=3 
infections). 
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 Characterisation of NTHi and RSV infections in cell lines and uHBE cells 3.3.2.
To obtain some quantitative measurement of the levels of bacteria present in cultures 
during the development of infection, viable bacterial counts were performed, and 
although none of the changes seen were significant, in A549 cells, the viable bacterial 
numbers had increased slightly by 3 days, but decreased to their lowest levels by 7 days 
but not lower than the initial inoculum (Figure 3.6A). Counts for NCI-H292 cells 
showed a small increase from 1 hour to 3 days and a sharp increase between 3-7 days 
(Figure 3.6B) and uHBE cells showed a decrease in viable bacteria by 3 days but this 
had increased to more than the 1 hour time point by 7 days (Figure 3.6C), suggesting 
that numbers of NTHi reach and maintain a threshold level.  
 
Due to the loss of viable cells in the longer term cultures, shorter term infections with 
MOI’s of 5 and 25 for periods up to 72 hours were also conducted on A549, NCI-H292 
and uHBE cells with viable bacterial counts performed at 0, 1, 2, 4, 8 and 24 hours. All 
cell lines showed a slight decrease (approx. 1x10
6
cfu/ml
 
in MOI 5 and 1x10
7
cfu/ml
 
MOI 25) in viable bacteria during the initial stages of infection which increased through 
log phase and began to plateau by 8 hours as a result of bacteria utilising all available 
nutrients.  By 24 hours the levels began to drop, as the media was not changed and the 
bacteria began to die.  However, there were more viable bacteria remaining in the 
washes from wells initially infected with NTHi at an MOI of 5 (Figure 3.7).  
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Figure 3.6: Viable Counts of 7day NTHi infections in A549, NCI-H292 and 
uHBE cell lines 
Viable counts were taken at 1h, 3d and 7d in A549 (A), NCI-H292 (B) and uHBE 
(C) cells. A one-way ANOVA using T=1h as the control showed no significant 
difference between samples (n=3). Error bars show SEM.  
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Figure 3.7: Viable bacterial counts during a 24h infection in A549, NCI-H292 
and uHBE cells 
Viable counts were taken at the start, 1h, 2h, 4h, 8h and 24h of short term infections 
performed using A549 (A), NCI-H292 (B) and uHBE (C) cells. Two way ANOVA 
with Dunnetts multiple comparisons test performed using T=0h as the control 
showed significance in the MOI of 25 at 4 hours in A549 cells and 8 hours in NCI-
H292 cells (p<0.05 for all) (n=3). Error bars show SEM. 
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Cells were cultured on transwells in these experiments to allow changing of media 
during the infection period. In order to gain information about the responses that the 
cells made to the infections, conditioned medium taken from the apical surface of A549 
and NCI-H292 cells 7 days after infection, alongside controls, was used to perform a 
cytokine array. These studies were performed at the same time for all samples and thus 
all films were developed for the same length of time allowing accurate analysis of any 
differences.  
 
Control A549 conditioned medium showed the presence of strong signals for GRO-α, 
MIF and SerpinE1 with less intense signals for CD40 ligand IFN-γ, IL-8 and IL-23 
(Figure 3.8B). Infected A549 cells had similar levels of GRO-α, MIF and SerpinE1 and 
reduced signals for CD40 ligand, IFN-γ and IL-23. There was however, a 4-fold 
induction of IL-8 (Figure 3.8A), which is reflected in densitometry analysis (Figure 
3.9A) Densitometry showed a small increase in GRO-α protein expression but a small 
reduction in MIF and SerpinE1 protein expression. Conditioned medium from control 
NCI-H292 cells showed the presence of GRO-α, MIF and SerpinE1 (Figure 3.8D. In the 
infected NCI-H292 cells SerpinE1 was increased and there was an induction of IL-8 
release into the medium (Figure 3.8C) as shown by densitometry analysis, which also 
showed small increases in GRO-α and SerpinE1 but a reduction in MIF protein 
expression (Figure 3.9B). It is important to understand that as these results are from a 
single experiment they cannot be assessed for significance). 
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Figure 3.8: Cytokine Array from A549 and NCI-H292 cells with NTHi for 7d 
A549 (A and B) and NCI-H292 (C and D) were infected with NTHi (A and C) 
alongside controls (B and D) for 7 days. The cytokine array data table is also shown 
(E) (n=1).  
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Figure 3.9: Densitometry analysis performed on Cytokine Array from A549 
and NCI-H292 cells infected with NTHi for 7d 
A549 and NCI-H292 were infected with NTHi alongside controls for 7 days (Figure 
3.7). Densitometry was used to show the differences in levels of cytokines relative 
to the control in A549 cells (A) and NCI-H292 cells (B) (n=1). 
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Having examined cytokine secretion from the infected immortalised cell lines we went 
on to determine at the response generated by the primary airway cells (uHBE cells). 
Conditioned medium from the 24 hour infections in uHBE cells infected with NTHi at 
an MOI of 5 and 25 and RSV, were used in cytokine arrays alongside an uninfected 
control. Again arrays were performed at the same time so that differences between 
samples would be analysed from the same exposure of films. Uninfected uHBE cells 
showed protein expression of GRO-α, IL-8, MIF and SerpinE1, with less robust signals 
from G-CSF, GM-CSF, IL-1α, IL-1ra and IL-6 (Figure 3.10D). As such these cells 
appeared to produce more cytokines than either A549 or NCI-H292 cells. Cells infected 
with both doses of NTHi appeared to generate a very limited cytokine response at this 
time point (Figure 3.10 A and B). NTHi infected wells expressed the same cytokines as 
the controls but in differing amounts, with NTHi showing changes in IL-6, IL-1α, GM-
CSF and SerpinE1 (these results are n=1 so cannot confirm significance) (Figure 3.11) 
Conditioned medium from the RSV infected cells (Figure 3.10C) showed induction of 
IP-10, decreased production of IL-1α (1.75 fold) and increased GM-CSF production 
(1.75 fold) than the control cells (Figure 3.11).  
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Figure 3.10: Cytokine Array of uHBE cells infected with NTHi and RSV for 
24h 
uHBE cells were infected with two different doses of NTHi  (A and B) and RSV (C) 
for 24h alongside an uninfected control (D). The cytokine array data table is also 
shown (E). (Washes taken from an infection of Donor 3 uHBE cells) (n=1). 
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To complement the protein secretions studies, RNA extracted from A549, NCI-H292 
and uHBE cells 24 hours after infection was used to quantify gene expression of IP-10, 
IL-6 and MUC5AC by qPCR IL-6 was chosen as it had previously been identified as 
being up-regulated in response to NTHi LOS stimulation of human tracheal epithelial 
cells (Clemans, Bauer et al. 2000) and was also identified in our cytokine array data 
from 24h uHBE infections. IP-10 mRNA expression was not identified in our cytokine 
array of 24h uHBE infection, but it has previously been shown to be induced when 
cigarette smoke-exposed mice were challenged with NTHi, not in the lungs of control 
mice airways (Gaschler, Skrtic et al. 2009). MUC5AC has previously been shown to be 
induced by NTHi in multiple studies (Wang, Lim et al. 2002; Jono, Xu et al. 2003; 
Chen, Lim et al. 2004; Shen, Yoshida et al. 2008; Jono, Lim et al. 2012).  
 
Figure 3.11: Densitometry analysis performed on the Cytokine Array of uHBE 
cells infected with NTHi and RSV for 24h 
uHBE cells were infected with two different doses of NTHi  and RSV for 24h 
alongside an uninfected control (Figure 3.10). Densitometry shows the differences in 
cytokines relative to the control (E) (n=1). 
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IP-10 and IL-6 mRNA expression was increased in A549 cells infected with NTHi at an 
MOI of 5 and 25 (Figure 3.12A and B), with IL-6 mRNA expression being lower in the 
MOI of 25 than in the MOI of 5. MUC5AC was decreased in the MOI of 5 and slightly 
increased in the MOI of 25 in comparison to the control (Figure 3.12C).  
 
 
 
Figure 3.12: Comparison of IP-10, IL-6 and MUC5AC in A549 cells infected 
with two doses of NTHi 
Quantitative data was generated using qPCR performed with primers against IP-10 
(A), IL-6 (B) and MUC5AC (C) in samples from A549 cells infected with NTHi at 
two different doses for 24h. Repeated measures one way ANOVA with Dunnetts 
multiple comparisons test showed no significance between any samples (n=3). Error 
bars show SEM. 
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Expression of IP-10 (Figure 3.13A), IL-6 (Figure 3.13B) and MUC5AC (Figure 3.13C) 
all increased in NCI-H292 cells after infection with MOI 5 (4-fold increase in IP-10, 6-
fold in IL-6 and 2-fold in MUC5AC) but infection with MOI 25 led to lower expression 
of MUC5AC than the control and expression of IP-10 and IL-6 was less marked with 
this higher dose of NTHi (Figure 3.13).  
 
 
 
Figure 3.13: Comparison of IP-10, IL-6 and MUC5AC in NCI-H292 cells 
infected with two doses of NTHi 
Quantitative data was generated using qPCR performed with primers against IP-10 
(A), IL-6 (B) and MUC5AC (C) in samples from NCI-H292 cells infected with 
NTHi at two different doses for 24h. Repeated measures one way ANOVA with 
Dunnetts multiple comparisons test showed no significance between any samples 
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IP-10 (Figure 3.14A) and IL-6 (Figure 3.14B) mRNA expression was increased in 
uHBE, while MUC5AC mRNA expression is decreased (Figure 3.14C). IP-10 mRNA 
expression was higher in the lower NTHi dose (MOI 5) and lower in the higher dose 
(MOI 25), but both levels were increased in comparison to the control, similar to NCI-
H292 cells. IL-6 increased with increasing MOI, and MUC5AC mRNA expression 
decreased more with the higher dose like IP-10 (Figure 3.14).  
 
Figure 3.14: Comparison of IP-10, IL-6 and MUC5AC in uHBE cells infected 
with two doses of NTHi 
Quantitative data was generated using qPCR performed with primers against IP-10 
(A), IL-6 (B) and MUC5AC (C) in samples from uHBE cells infected with NTHi at 
two different doses for 24h. Repeated measures one way ANOVA with Dunnetts 
multiple comparisons test showed no significance between any samples (n=3). Error 
bars show SEM. (Data from Donor 1 and Donor 3 infections). 
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Statistical analysis showed that none of these differences were significant as a result of 
the high variability seen between replicates, the fold change data from the qPCR 
reactions for each individual replicate, for all cell lines, can be found in Appendix 4 
alongside dissociation curves and DNA gels for some of the primer pairs. 
 
To focus on the early cell responses, RNA extracted from uHBE cells exposed to 
1x10
6
pfu of RSV at 1, 2, 4, 8 and 24 hour time points was reverse-transcribed and used 
PCR. Based on our cytokine array data (Figure 3.10) and because it had previously been 
shown to be up-regulated during RSV infection (Oshansky, Barber et al. 2010), we used 
primers against IP-10. As the changes in IP-10 in the cytokine array showed marked 
induction of IP-10, we chose to use standard RT-PCR to identify differences between 
time points. The results suggested that more relative induction was seen in latter time 
points (4, 8 and 24 hours post infection) but induction was present from 1 hour post 
infection (Figure 3.15). We decided to quantify this difference more definitively using 
qPCR. Based on this data and a study published by Seibold, Smith et al. (2013) qPCR 
was performed with primers for IP-10 and additionally IL-6 (Figure 3.16). There was an 
increase in IP-10 and IL-6 in all cell types at 24 hours. A paired t test showed a 
significant increase in I IP-10 in uHBE cells (p<0.05) (Figure 3.16E). 
 
Figure 3.15: Comparison of gene expression in early time points using IP-10 
PCR was performed on RNA extracted from RSV infected and control uHBE cells 
at 1, 2, 4, 8 and 24 hours using primers against IP-10 and actin to compare mRNA 
expression across the time points. Bands appear at the expected size for both primer 
pairs in all samples. (n=1) 
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Figure 3.16: Comparison of expression of IP-10 and IL-6 in A549, NCI-H292 
and uHBE cells infected with RSV 
Quantitative data was generated using qPCR performed with primers against IP-10 
(A, C and E) and IL-6 (B, D and F)  in samples from A549 (A and B), NCI-H292 (C 
and D) and uHBE (E and F) cells infected with RSV for 24 hours. A paired t test 
showed a significant increase in IP-10 in uHBE cells (p<0.05) (n=3). Error bars 
show SEM. (For uHBE cells data is from Donor 1 and Donor 3 infections). 
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3.4. Discussion 
The aim of this chapter was to establish and characterise NTHi and RSV infection in 
cell lines, specifically the adenocarcinoma human alveolar basal cell line A549 (Giard, 
Aaronson et al. 1973), the mucoepidermoid carcinoma cell line NCI-H292 (Yoakum, 
Korba et al. 1983; Banks-Schlegel, Gazdar et al. 1985; Carney, Gazdar et al. 1985)  and 
primary uHBE cells. These cells all showed poor survival when challenged with 
pathogens, and showed limited cytokine responses. 
 
Lung derived cell lines can be used to study the biological effects of infectious agents 
and potential therapies in vitro. Cell lines essentially undergo infinite replication, 
making them useful tools for optimisation studies, and studying processes without the 
confounding problems of donor variability. Both of these lines have previously been 
utilised to study the effects of RSV and NTHi infection. Primary HBE cells have not 
been immortalised so do have a finite lifespan, and the use of these cells may introduce 
an element of inter-donor variability, however such cells are not transformed and are 
thought by many people to more closely represent the normal cells of the lung. Using 
these as an airway model, alongside immortalised cell lines, provides a direct 
comparison between cell types when establishing an infection model.  
 
One of the aims of this project was to establish NTHi biofilms in an appropriate airway 
model; therefore infections with NTHi were performed on cell lines for periods of up to 
7 days as it was felt that longer periods of infection would allow the best chance for 
biofilm formation. Infection studies performed on A549, NCI-H292 and uHBE showed 
that NTHi was able to establish an infection on these cells, but the prolonged infection 
period resulted in reduced cell numbers, affecting the confluence of the cell mono-layer, 
suggesting that the infection was leading to loss of cell numbers with a parallel 
reduction of viable bacteria. We could have assessed cell death/loss of cell numbers 
using a number of techniques, including live/dead staining such as Hoescht pI, flow 
cytometry, analysis of cell death markers such as lactate dehydrogenase and counting 
the number of DAPI stained nuclei in confocal imaging. However, we did not quantify 
cell death as they would not have allowed the use of the well for imaging and counting 
nuclei would require more images than were able to be taken.  
 
As noted in the introduction, biofilms are a complex of aggregated cells, enclosed in 
EPS matrix. In vivo biofilms consist of multiple bacterial species and micro-organisms 
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that perform different condition related metabolic functions, however some bacterial 
species will form single-species biofilms. Not all bacterial species are able to form 
biofilms and initial doubts about the ability of NTHi to form biofilms were disproved in 
work conducted using a chinchilla model of otitis media (Ehrlich, Veeh et al. 2002). 
NTHi is thought to switch gene expression during the attachment phase to form a glue-
like structured matrix, composed of multiple molecules and macromolecules (Moxon, 
Sweetman et al. 2008). No specific gene or factor has yet been identified as necessary 
for NTHi biofilm formation as heterogeneity of strains suggests that multiple 
combinations of factors are involved (Plaut, Qiu et al. 1992; St Geme, Falkow et al. 
1993; Noel, Love et al. 1994; Gilsdorf, Tucci et al. 1996; Clemans, Bauer et al. 2000; 
Murphy and Kirkham 2002; Fink, Buscher et al. 2003; Webster, Wu et al. 2006).  Our 
confocal imaging of a 3 day (and later) uHBE infections showed clustering of bacteria 
together within a structure that had a mesh-like appearance. The mesh-like structure 
could represent the glue-like matrix observed by Moxon, Sweetman et al. (2008).  
Comparing this to biofilm studies performed on NTHi and other bacterial species, this 
appears to be consistent with initiation of the formation of a biofilm structure (Starner, 
Zhang et al. 2006; Hall-Stoodley, Nistico et al. 2008; Ma, Conover et al. 2009; Juneau, 
Pang et al. 2011).   
 
It was also important to ensure that all three cell types used in this study were 
susceptible to RSV infection. To do this we used a virus that expresses a red fluorescent 
protein tag when it is actively replicating. Confocal imaging showed that infecting both 
these cell lines and uHBE cells results in expression of the red florescent protein 
showing that they were successfully infected and could be used to study RSV infections 
in our hands. This is consistent with previous data as A549 lung epithelial cells have 
been used extensively to study RSV infections (Fiedler, Wernke-Dollries et al. 1996; 
Choudhary, Boldogh et al. 2005; Spann, Tran et al. 2005; Martinez, Lombardia et al. 
2007; Eckardt-Michel, Lorek et al. 2008; Gibbs, Ornoff et al. 2009; Munday, Emmott et 
al. 2010; Bian, Gibbs et al. 2012; Chirkova, Boyoglu-Barnum et al. 2013; Krzyzaniak, 
Zumstein et al. 2013), NCI-H292s have also been shown to be sensitive to RSV 
infection (Hierholzer, Castells et al. 1993) and primary airway epithelial cells obtained 
using bronchial brushings from children have also been shown to be highly susceptible 
to RSV infection (Fonceca, Flanagan et al. 2012).  
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During the initial work with NTHi, bacteria were sub-cultured into the growth media 
preferred by the cells (Complete culture medium-Appendix 2) but this did not result in 
significant growth of the bacterium. Haemophilus influenzae has been shown to require 
a chemically defined media for growth (Coleman, Daines et al. 2003) which may have 
explained the absence of growth in the cultures. The growth of the bacteria in the 
presence of cells suggests that they need some factor produced by the cells in order to 
replicate in the airway model cultures.  
 
Confocal images of all three cell types showed the presence of bacteria which appeared 
to increase (as judged by microscopy) by 3 days and were still present at 7 days. Viable 
bacterial counts showed that there were still live bacteria present in 7 day cultures; 
however there did not appear to be large differences between 3 and 7 day washes. Cell 
death in the 7 day cultures could have caused lifting of the adhered bacteria when 
washes were performed that may have given a falsely low level of viable bacterial 
counts. The viable bacterial counts did not take into account the bacteria clustered and 
associated with the epithelium in the form of biofilms, so in making these counts we 
were just taking viable counts of the planktonic bacteria present in the infected cultures. 
This may well have led to an underestimation of bacterial numbers in the cultures. The 
long term nature of these infections showed that some cells were able to survive the 
longer infection period required to form biofilms, however there were not enough cells 
to maintain a confluent mono-layer. Different times and infective doses are important in 
establishing infection models, to ensure infection is achieved without losing large 
numbers of cells.  MOIs of 25 and 50 were investigated for 1 hour, 3 days and 7 days. 
As there was better cell survival in the MOI of 25 experiments we decided to show the 
results from these infections. No additional infection studies were performed in this 
work, but in order to effectively utilise cell lines as airway model, further studies using 
different doses and times might allow minimum dose and time required for successful 
infection/biofilm formation to be determined.  
 
To investigate the cellular responses in long term infection of A549 and NCI-H292 
cells, conditioned medium from day 7 infections was analysed using cytokine arrays. 
Strikingly, these cell lines were not influenced by the infection, as only IL-8 protein 
expression altered. As cytokines are released early in the response to pathogens it seems 
likely that the major cytokine responses elicited during these infections had been missed 
 104 
 
by analysing the 7 days post infection samples. It is also possible that the infection had 
overcome the cells at this late time point. 
 
To begin to address the cell survival issues, all three cell types were infected with NTHi 
and RSV for shorter periods of time. In the NTHi infections, viable bacterial counts 
were made up to the 24 hour time point and showed growth of bacteria in the first 8 
hours, which plateaued by 24 hours. The number of bacteria present at 24 hours in the 
short term infection was similar to those in the previous studies of longer term 
infections. The data also showed that infections with a lower dose of NTHi (MOI 5) 
have higher viable counts by 24 hours (on average twice as many viable bacteria). 
Washes from the 24 hour infection of uHBE cells with the two doses of NTHi and a 
single dose of RSV as well as a control wash were used to perform a cytokine array. 
Cells infected with NTHi secreted the same cytokines as the control cells, however 
densitometry analysis showed varying levels of cytokine secretion. In the RSV infected 
cells, the most notable change was the induction of IP-10, an observation that has been 
shown previously (Oshansky, Barber et al. 2010; Smith, Kulkarni et al. 2013). IL-6 and 
GM-CSF were also increased the most. IL-6 and GM-CSF were frequently identified in 
immune studies against RSV infection using cell lines or undifferentiated primary cells 
(Cromwell, Hamid et al. 1992; Noah and Becker 1993; Arnold, Humbert et al. 1994).  
IL-6 acts in both a pro- and anti- inflammatory manner and is important in regulating 
the inflammatory response, preventing tissue damage. Bukreyev, Belyakov et al. (2001) 
generated a recombinant strain of RSV that expressed GM-CSF and found that viral 
replication was attenuated by GM-CSF, and they also saw increased levels of antigen 
presenting cells.  
 
As a result of the cytokine array data (predominantly the uHBE cell data) showing 
alterations on secreted proteins we also studied the effect on gene expression, qPCR 
was performed with primers against IP-10 and IL-6 as both have previously been shown 
to be changes in mRNA expression compared to non-infected cells in NTHi and RSV 
infections (Clemans, Bauer et al. 2000; Gaschler, Skrtic et al. 2009; Oshansky, Barber 
et al. 2010; Smith, Kulkarni et al. 2013). MUC5AC expression was also studied as this 
has previously been shown to up-regulate MUC5AC mRNA expression (Wang, Lim et 
al. 2002; Jono, Xu et al. 2003; Chen, Lim et al. 2004; Shen, Yoshida et al. 2008; Jono, 
Lim et al. 2012). In contrast to the cytokine array for A549 cells, which did not identify 
either IP-10 or IL-6, the qPCR data showed increases in IP-10 and IL-6 mRNA 
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expression suggesting that they are expressed but not secreted at levels sufficient for the 
array membrane to detect them. MUC5AC mRNA expression was reduced in the lower 
dose infections but significantly changed in the higher dose infection. This does not 
agree with the study by Wang, Lim et al. (2002), which shows increased MUC5AC 
transcription in NTHi infected A549 cells by qPCR, although this study only infected 
cells for 5 hours. Further studies in A549 cells in response to NTHi reported induction 
of ICAM-1 (Avadhanula, Rodriguez et al. 2006) and activation of p38 MAPK and NF-
κB resulting in induction of cyclooxygenase (COX)-2 and prostaglandin E2 (PGE2) 
(Xu, Xu et al. 2008).  
 
The NCI-H292 cell data was inconsistent. Cells infected with NTHi at an MOI of 5 
showed increases in IP-10, IL-6 and MUC5AC whereas with an MOI of 25, IP-10 was 
increased slightly in comparison to the control; IL-6 increased to a lower level than that 
with an MOI of 5 and MUC5AC mRNA expression was decreased in comparison to the 
control. The cytokine array data did not identify either IP-10 or IL-6 as being secreted in 
detectable amounts by these cells. Only one study has used NCI-H292 cells with NTHi 
and this was to identify a putative toxin-antitoxin locus of NTHi (Daines, Jarisch et al. 
2004) thus there is no confirmation of cytokine profiling data.  
 
NTHi infected uHBE cells show increased mRNA expression of IP-10 and IL-6, but 
decreased mRNA expression of MUC5AC with both doses. IP-10 was not identified in 
the cytokine array data. IL-6 shows a different pattern. Densitometry showed more IL-6 
secretion in the MOI of 5 whereas the highest expression is in the MOI of 25 sample, 
suggesting increased expression but reduced secretion. The decrease in MUC5AC is in 
contrast to the study of Jono, Xu et al. (2003) which noted an increase in MUC5AC in 
normal primary human airway epithelial cells infected with NTHi. As in the study by 
Wang, Lim et al. (2002), cells were infected for 5 hours which could explain the 
discrepancy with our data. Other studies in uHBE cells identified pathways involved in 
regulating NTHi induced MUC5AC transcription and the involvement of TLR3 in 
response to NTHi (Wang, Lim et al. 2002; Jono, Xu et al. 2003; Teng, Slavik et al. 
2010).  
 
RSV infected A549 cells showed increased expression of both IP-10 and IL-6, as did 
NCI-H292 cells and uHBE cells. A549 cells have frequently been used for RSV studies, 
which have characterised cytokine and chemokine responses over time (Arnold, 
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Humbert et al. 1994; Jiang, Kunimoto et al. 1998; Zhang, Luxon et al. 2001; Martinez, 
Lombardia et al. 2007). Increases have been noted in IP-10 (Rudd, Burstein et al. 2005) 
and IL-6 (Arnold, Humbert et al. 1994; Jiang, Kunimoto et al. 1998) and more recently 
the use of clinical isolates has identified strain specific responses including RANTES 
induction (Levitz, Wattier et al. 2012). Few studies have utilised the NCI-H292 cell line 
for RSV infection. One such study showed that the cells were sensitive to RSV infection 
(Hierholzer, Castells et al. 1993) and the other that type 1 and 2 cytokines regulate 
expression of  programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3 and inducible co-
stimulator ligand (ICOS-L) (Stanciu, Bellettato et al. 2006). uHBE cells have also been 
used to study RSV infections; IP-10 expression increased upon RSV infection 
(Oshansky, Barber et al. 2010) and in a more recent study changes were noted in a range 
of chemokines including increases in IP-10 and IL-6 (Smith, Kulkarni et al. 2013). 
uHBE cells have not been extensively used to study the effects of RSV infections. A 
preference has been shown towards the use of primary cells in an ALI culture model, of  
differentiated airway epithelium as this is felt to generate a more accurate model of the 
airways for study (Villenave, Thavagnanam et al. 2012; Smith, Kulkarni et al. 2013).  
 
Analysis of the control cytokine array data show the limited cytokine profiles of the cell 
lines used prior to infection. As cytokine secretion did not change much upon infection, 
under the conditions we have investigated this suggests that the cell lines exhibit a 
limited response to infection. 
 
The aims of this chapter were to establish and characterise NTHi and RSV infections in 
cell lines and uHBE cells. In doing this we had to establish how representative/effective 
the cells were as an airway model, as well as investigate their ability to withstand 
infection. Infections were performed multiple times, encompassing time periods ranging 
from 1 hour to 7 days. Confocal imaging and characterisation of the responses of the 
cells indicated that the cell lines and uHBE cells could not tolerate high infection MOIs 
for prolonged periods of time. This coupled with exhibition of limited inflammatory 
responses suggested that cell lines and uHBE cells were not a representative model of 
the human airway epithelium. This led to the conclusion that the model needs to be able 
to withstand the infection process and elicit the complex responses seen in the human 
airway. This further suggests that a better model of the airway epithelium is required to 
successfully establish an infection model.  
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4. Establishment of the Air-Liquid Interface (ALI) Culture Model 
 
4.1. Introduction 
Culture of differentiated primary cells at an ALI was first performed using human 
tracheobronchial cells in 1990 (Wu, Martin et al. 1990). The key feature of this 
technique was the development of a mucociliary phenotype, such that the epithelial 
layer developed a pseudostratified appearance mimicking the human airway. As a result 
of this phenotypic organisation, the model is becoming an increasingly popular 
experimental tool. Since its initial description a number of varying protocols have been 
established (Koo, Yoon et al. 1999; Nlend, Bookman et al. 2002; Campos, Abreu et al. 
2004; Ross, Dailey et al. 2007; Kettle, Simmons et al. 2010; Parker, Sarlang et al. 2010; 
Dvorak, Tilley et al. 2011; Pezzulo, Starner et al. 2011; Turner, Roger et al. 2011; 
Horani, Nath et al. 2013; Villenave, Shields et al. 2013). In general, these subtly 
different methods allow the cells to achieve similar levels of differentiation as judged by 
morphology and through the use of gene expression analysis. Whole genome 
transcriptional analysis, through the use of microarrays, has identified a number of 
genes specifically induced during the process of differentiation, including SPLUNC1, 
LPLUNC1, MUC5B, MUC5AC and tubulin (Ross, Dailey et al. 2007). These are ideal 
candidates to monitor and confirm differentiation of specific cell types within the 
cultures.  
 
The ALI culture method can be performed using primary cells from a variety of sources, 
including commercially available cells as wells as those directly obtained from patients 
via bronchoscopic brushing or from resected tissue. A major drawback in the use of 
primary cells, particularly those from human volunteers, is inability to obtain sufficient 
cells for replicates of experiments to be performed, particularly when the inter-donor 
variations of cell phenotype and responses are considered. However, the responses that 
ALI cells make to stimuli are considered to be representative of the airway epithelial 
lining than those from cell lines making their use invaluable.  
 
 Multiple growth factors mediate proliferation and differentiation of airway epithelial 
cells, and identification of the pathways involved has provided an understanding of the 
pathophysiology of a number of airway diseases. The initial cell culture studies 
identified key roles for retinoic acid, T3 and EGF (Koo, Yoon et al. 1999; Takeyama, 
Dabbagh et al. 1999; Gray, Koo et al. 2001) and modification of levels of these in the 
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culture medium allows phenotypic alteration of the cultures at will. Other exogenous 
mediators can modulate cell growth and differentiation for example the rho-associated 
protein kinase (ROCK) inhibitor Y27632. ROCKs are downstream effectors of Rho-A 
GTPase, which directly affects the cells cytoskeletal proteins. ROCK inhibitors also 
enhance basal cell proliferation in human airway epithelial cells at ALI without any 
subsequent effects on the differentiation of the cells (Horani, Nath et al. 2013).  
 
Multiple immune molecules are able to act on the cultures to alter cell growth and 
differentiation. Two key molecules shown to regulate differentiation and gene 
expression in these cultures are IL-13 and IFN-γ. Culturing primary epithelial cells in 
the presence of IL-13, during the differentiation period, has been shown to result in 
increased numbers of goblet cells with a corresponding increase in the expression of 
goblet cell markers (Laoukili, Perret et al. 2001; Turner, Roger et al. 2011).  IL-13 is a 
Th2 cytokine that has been implicated in the development of mucous cell metaplasia in 
murine models and is frequently detected in airway diseases such as CF and during 
exacerbations of asthma when there is an inflammatory response (Whittaker, Niu et al. 
2002; Berry, Parker et al. 2004; Tyner, Kim et al. 2006; Curran and Cohn 2010). 
Therefore, treatment of the cultures with IL-13 can potentially provide an effective 
model for studying diseased airways. Recent work investigating the role of SPLUNC1 
in the respiratory tract showed inhibition of SPLUNC1 expression in differentiated 
mouse tracheal epithelial cells treated with IFN-γ. This finding was partially 
corroborated in humans, through use of the NCI-H292 cell line treated in the same 
manner (Britto, Liu et al. 2013) as these cells also showed a reduced expression of 
SPLUNC1 following treatment with IFN-γ. 
 
 Aims 4.1.1.
The aims of this chapter were to: 
(1) Reproducibly culture primary HBE cells at an ALI, to modulate the phenotype 
of these cultures through the addition of IL-13 and to validate these cultures 
using a variety of markers.  
(2) Investigate the effect of IFN-γ on the expression of SPLUNC1, LPLUNC1 and 
IP-10 (a molecule that is dependent on IFN-γ for induction) in differentiated 
primary HBE cells. 
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4.2. Methods 
 Culture of Primary Human Bronchial Epithelial Cells at ALI 4.2.1.
Primary HBE cells were purchased from Promocell, who provided 500,000 cells at 
passage 2. The cells are from the healthy lungs of deceased subjects.  
 
 Seeding cells onto transwells  4.2.1.1.
Cells were detached from the flasks using trypsin-EDTA as detailed in section 2.2.3, 
counted and centrifuged. They were re-suspended in ALI media (Appendix 2) to a cell 
density of 0.5x10
6
cells/ml. Transwell inserts (transparent PET membrane with 0.4µm 
pores (BD Falcon)) were placed into the central wells of a 24-well-plate. 100µl of 
0.5x10
6
cells/ml were added to the apical surface of the transwell with additional media 
to make a final volume of 250µl, and 750µl of ALI media was added to the basolateral 
compartment of each well. The media was changed in both compartments after 24 hours 
and every 2 days and cultured in sub-merged conditions until confluence was reached; 
typically 7 days. At confluence, the media was removed from the apical surface to 
expose the cells to an ALI. Apical medium was frozen for further studies.. Non-
confluent cells do not undergo differentiation.  
 
 Differentiation at the ALI 4.2.1.2.
Some cells were stimulated with 20ng/ml of IL-13 in the basolateral compartment to 
modulate differentiation to generate a more mucous phenotype which consists of a more 
‘goblet’ cell-rich culture (Turner, Roger et al. 2011). IL-13 was added to an appropriate 
amount of media immediately prior to each media change; any remainder was disposed 
of and made fresh each time. After exposure to the air apical washes of all cells were 
performed daily or at most every 48 hours, for the duration of the differentiation period. 
Washes were frozen from three wells at each time point. ALI media was changed in the 
basolateral compartment every 48 hours during the differentiation period of a minimum 
of 21 days. This was either ALI media, or ALI media supplemented with IL-13 (Wu, 
Martin et al. 1990; Koo, Yoon et al. 1999; Kettle, Simmons et al. 2010; Dvorak, Tilley 
et al. 2011; Pezzulo, Starner et al. 2011). 
 
Overall the culture of cells at ALI was performed eighteen times and each complete 
differentiation experiment took 5-6 weeks to perform (Figure 4.1). Primary cells 
obtained from five individual donors were used throughout these studies (details of 
which can be found in Appendix 1). The progress of mucociliary differentiation was 
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initially studied through Western blotting for SPLUNC1 and LPLUNC1 as they have 
been shown to be tightly associated with the process of differentiation (Campos, Abreu 
et al. 2004; Bingle, Barnes et al. 2007; Candiano, Bruschi et al. 2007; Ross, Dailey et al. 
2007; Kesimer, Kirkham et al. 2009; Bingle, Wilson et al. 2010). 
 
 Stimulation of ALI cells with IFN-γ 4.2.2.
ALI cells were media changed prior to stimulation. The apical surface of the cells was 
washed with 180µl of PBS and the washes frozen.  IFN-γ was diluted to a concentration 
of 50ng/ml with sterile PBS and 30µl added to the apical surface of the cells in 
duplicate for 18 hours (based on the study by Britto, Liu et al. (2013)), sterile PBS was 
used as controls. After 18 hours, the apical surface of the cells was washed with 180µl 
of PBS. The wells were then lysed in TRI reagent, which was pooled to give greater 
volume for RNA extraction. 
 
 
  
Figure 4.1: Schematic to show timeline of ALI culture experiments 
uHBE cells were purchased from Promocell and cultured in flasks to increase 
numbers through to Passage 4. At a maximum passage of 5, cells were seeded onto 
transwells (100µl of cells at 0.5x10
6
cells/ml) and cultured in sub-merged conditions 
until confluence was reached. After removal of apical medium, cultures were 
differentiated for 21 days before being used experimentally. 
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4.3. Results 
 Validation of PLUNC antibodies 4.3.1.
At the beginning of this study there were limited commercial antibodies available to 
PLUNC proteins. As we wished to use these markers to follow the process of 
differentiation we therefore generated antibodies against SPLUNC1 and LPUNC1 for 
use in the validation of our ALI cultures. We chose to generate two affinity-purified 
antibodies using unique peptide epitopes present in each of the two proteins. The 
antibodies were generated by Eurogentec and the epitopes used are shown in Appendix 
Figure 2. 
 
 SPLUNC1 antibodies 4.3.1.1.
The SPLUNC1 antibodies were initially validated by Western blotting with samples of 
ALI washes taken from fully differentiated cultures using a range of antibody dilutions. 
Similar immuno-reactive products of the appropriate size were clearly seen with both 
antibodies, although the SPLUNC1B antibody also generated a smaller product (Figure 
4.2A). We directly compared these products with those generated in a blot probed with 
a commercial SPLUNC1 monoclonal antibody which gave very similar reactive 
products (Figure 4.2B), suggesting that our antibodies were indeed reacting with 
SPLUNC1. 
Figure 4.2: Validation of SPLUNC1 antibodies 
The two SPLUNC1 antibodies were used to probe 2 ALI wash samples. 
SPLUNC1A was used at 1:1000 and SPLUNC1B at 1:200 (A). The R&D 
monoclonal SPLUNC1 antibody and SPLUNC1A was used to probe 2 ALI wash 
samples (B). Both blots show presence of bands at the appropriate size for all 
samples.  
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 LPLUNC1 antibodies 4.3.1.2.
The LPLUNC1 antibodies were initially validated by Western blotting with 
recombinant proteins (LPLUNC1, SPLUNC1 and SPLUNC2) produced both by in vitro 
transcription/translation and by transfected mammalian cells. These samples were 
provided by Dr Frances Barnes. An example of this validation is presented in Appendix 
Figure 1 (Appendix 3). We chose to do this for LPLUNC1 as at the time this was the 
first antibody generated and used against LPLUNC1. 
 
Western blots of ALI washes from cultures as they underwent the process of 
differentiation were performed to validate the LPLUNC1 antibodies with ALI 
secretions and biological samples (BAL fluid) provided by Michael Campos at the 
University of Miami. ALI secretions were collected every 2-3 days by washing each 
well of a 12-well plate with 100μl of PBS, pooled and centrifuged to remove cellular 
debris. BAL fluid was obtained by instilling 60ml of saline in the non-diseased lingula 
or middle lobe from subjects undergoing clinically indicated bronchoscopy using a 
protocol approved by the University of Miami Institutional Review Board. LPLUNC1 
protein was readily detectable as two distinct immuno-reactive products (Figure 4.3A) 
and levels increased as the cells underwent differentiation. Both protein bands were 
larger than the predicted size of LPLUNC1 (52.4kDa) suggesting that the protein might 
be subjected to post-translational modification. To investigate this PNGaseF (which 
hydrolyses most N-glycan chains) was added to the LPLUNC1, after which both 
immuno-reactive bands reduced in size (Figure 4.3B). BAL fluid (obtained from the 
non-diseased middle lobe (or lingula) of patients undergoing clinically indicated 
bronchoscopies and provided by Michael Campos at the University of Miami) treated 
with PNGaseF demonstrated similar immuno-reactive LPLUNC1 bands, suggesting that 
the protein product of the differentiated ALI cells is glycosylated in the same way as 
that secreted into the airways in vivo (Figure 4.3B). 
 
Having validated the PLUNC antibodies we were then able to use them to study the 
differentiation of the ALI cell cultures. 
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Figure 4.3: Validation of LPLUNC1 antibodies 
Secretion of LPLUNC1 into apical secretions harvested from ALI cell cultures was 
shown by Western blotting. Samples were harvested from the cells every 2-3 days 
(A). Deglycosylation studies were performed using BAL fluid and ALI secretions as 
described in the materials and methods section. The resultant reaction products were 
subjected to Western blotting and detected with the LPLUNC1B antibody (B). Both 
blots show presence of bands at the appropriate size for all samples with a reduction 
in size for those samples used in deglycosylation reactions as expected. 
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 ALI Cell Model 4.3.2.
To follow differentiation in cell cultures, ALI washes from Day 0, 7, 14 and 21 were 
separated using SDS-PAGE, Western blotted and probed for SPLUNC1 and LPLUNC1. 
The results showed bands at the expected size in the day 14 and day 21 washes for 
LPLUNC1 and in the day 21 wash for SPLUNC1 (Figure 4.4A). To identify when 
transcription of LPLUNC1 and SPLUNC1 genes was induced during the differentiation 
process, PCR data was generated using RNA samples isolated from day 0, 2, 7 and 14 
of ALI differentiation experiments. This data showed transcriptional activation of both 
LPLUNC1 and SPLUNC1 genes from day 2 of the differentiation process (Figure 4.4B) 
which is consistent with studies previously performed in our lab using cell samples 
provided by the Campos Lab in Miami, USA (Bingle, Barnes et al. 2007). 
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To compare differences between the relative amounts of SPLUNC1, LPLUNC1, 
MUC5AC and MUC5B secreted from cells undergoing differentiation with and without 
IL-13 treatment, 2μl samples of apical secretions (from three experiments) were spotted 
onto nitrocellulose membranes and probed. A clear variation in SPLUNC1 and 
LPLUNC1 secretion between individual cultures can be seen in Figure 4.5 A and C. 
Densitometry analysis showed increased SPLUNC1 (Figure 4.5 A and B), LPLUNC1 
(Figure 4.5 C and D) and MUC5AC (Figure 4.5 E and F) in 14 day cultures following 
the addition of IL-13. There was no difference in the secretion of MUC5B (Figure 4.5 G 
and H). While the fold change data is portrayed, a ratio paired t test performed on the 
Figure 4.4: Western blot and PCR of ALI samples to track differentiation 
status 
(A) 10µl of day 0, 7, 14 and 21 daily apical washes taken from throughout the 
differentiation period show bands at the appropriate size for LPLUNC1 and 
SPLUNC1, as well as bands at the correct size in the positive control (an apical 
secretion from ALI cells cultured by Synairgen and provided to us for a previous 
study).  (B) RNA samples from Day 0, 2 7 and 14 were reverse transcribed and PCR 
performed with primers against LPLUNC1 and SPLUNC1 show presence of bands 
from day 2 (data generated by and taken from the Master’s dissertation of Miss 
Varsha Ganesan) (Images representative of all Donors (18 replicates), as all were 
successfully differentiated).  
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raw data values showed differences in LPLUNC1 (p<0.01) and MUC5AC (p<0.05) are 
significant but not the SPLUNC1 levels. 
 
To further monitor the differentiation status and examine the morphology of the 
epithelium during the differentiation 0, 7, 14 and 21 days ALI cultures were fixed in 
10% phosphate-buffered formalin and paraffin embedded. Serial sections were cut from 
day 0, 7 and 14 samples, but not day 21 as initial differentiations became infected at day 
16, and stained using haematoxylin and eosin to examine the morphology of 
differentiated cultures (Figure 4.6). This clearly shows different morphologies and cell 
compositions between day 0 (Figure 4.6A), day 7 (Figure 4.6B) and day 14 cultures 
(Figure 4.6C and D). The simple single celled epithelial layer seen initially undergoes 
significant thickening by day 7 and gains a pseudostratified appearance with ciliated 
cells (indicated by red arrow) clearly visible by day 14. Increased numbers of goblet 
cells (denoted by black arrows) are visible in 14 day cultures following the addition of 
IL-13 (Figure 4.C and D). Immunohistochemistry with antibodies against LPLUNC1  
was performed only on day 14 cells cultured in the presence of IL-13 and showed 
positive staining in goblet cells (Figure 4.6E) with no staining in the control section 
(Figure 4.6F).  
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Figure 4.5: Dot blot to compare SPLUNC1, LPLUNC1, MUC5AC and MUC5B 
in cells cultured in the presence and absence of IL-13. 
2µl of secretions was spotted onto nitrocellulose membrane and probed with 
antibodies to SPLUNC1 (A), LPLUNC1 (C), MUC5AC (E) and MUC5B (G) to 
compare protein levels between ALI cells cultured in the presence and absence of 
IL-13. Densitometry analysis was used to quantify levels of SPLUNC1 (B), 
LPLUNC1 (D) and MUC5AC (F) and MUC5B (H) expression in cells cultured with 
IL-13 than those without. A ratio paired t test performed on the raw data values 
showed significant increases in LPLUNC1 (p<0.01) and MUC5AC (p<0.05) (n=3). 
Error bars show SEM. (Secretions from differentiations performed using Donor 3 
cells). 
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Figure 4.6: Staining of ALI cultures at Day 0, 7 and 14 cultured in the absence 
and presence of IL-13 
Haematoxylin and eosin staining showed that Day 0 (A) cultures are a single cell 
mono-layer. By day 7 (B) the cell layer appears thicker and by day 14 (C and D) 
have developed ciliated and goblet cells. Cells cultured for 14 days in the presence 
of IL-13 (D) visibly have more goblet cells than those without (C). Sections from 
cells cultured in the presence of IL-13 showed positive (red) staining for LPLUNC1 
(F). The control shows no positive staining for LPLUNC1 (E). The red arrow shows 
a ciliated cell and the black arrows show goblet cells. (Images are of cells from 
Donor 1)  
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Immunofluorescence and confocal microscopy allowed closer examination of the 
differentiated cells. β-tubulin (Figure 4.7A and B) and MUC5AC (Figure 4.7C and D) 
stained cilia and mucus, respectively, which allowed for comparisons between the cells 
cultured in the presence (Figure 4.7B and D) or absence (Figure 4.7A and C) of IL-13.  
Higher levels of MUC5AC were found following the addition of IL-13 but no 
difference was detected in the level of β-tubulin staining. The differentiation status of 
the cells was confirmed by immunofluorescent staining for ZO-1 (Figure 4.8A), which 
stains the tight junctions formed between cells, α-tubulin (Figure 4.8B) staining of 
ciliated cells, MUC5B positive (Figure 4.8C) goblet cells, and SPLUNC1 positive 
(Figure 4.8D) serous cells. Z-stack images were not taken of these sections. Controls for 
all staining were section stained incubated with secondary antibody only (Figure 4.7E 
and F and Figure 4.8E) 
 
To obtain more quantitative of the effects of IL-13 on the cells, RNA from 
differentiated cultures was reverse transcribed and qPCR performed using primers for 
SPLUNC1, LPLUNC1, MUC5AC and MUC5B and actin as an endogenous control. IL-
13 treatment had no effect on levels of SPLUNC1 (Figure 4.9A) or MUC5B (Figure 
4.9D) while LPLUNC1 and MUC5AC was increased (0.75 and 14-fold difference 
respectively) in IL-13 cultured cells (Figure 4.9B and C); a ratio paired t test performed 
on the raw data values (fold change data shown in graphs for better comparison) showed 
the increase in MUC5AC was significant (p<0.05).  
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Figure 4.7: Immunofluorescent staining of 21-day differentiated cell cultures to 
compare effects of IL-13 
Positive (green) immunofluorescent staining was seen for β-tubulin (A and B) and 
MUC5AC (C and D) in cells cultured in the absence and presence of IL-13. Controls 
were stained with Anti-mouse secondary antibody only (E and F). Nuclei were 
stained blue with DAPI. (Cells from Donor 2) 
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Figure 4.8: Immunofluorescent staining of 21-day differentiated cultures with 
other markers 
Positive (green) immunofluorescent staining was seen for ZO-1 (A), α-tubulin (B), 
MUC5B (C) and SPLUNC1 (D). Control was stained with Anti-rabbit secondary 
antibody only (E). Nuclei were stained blue with DAPI. (Images of cells from Donor 
3, but are representative of all differentiations). 
 122 
 
  
Figure 4.9: Comparison of SPLUNC1, LPLUNC1, MUC5AC and MUC5B in 
cells cultured in the presence and absence of IL-13 by qPCR. 
Cell cultured in the presence of IL-13 appear to show lower levels of expression of 
SPLUNC1 (A) and MUC5B (D). They show higher levels of LPLUNC1 (B) and 
much higher levels of MUC5AC (C). A ratio paired t test performed on the raw data 
values showed significant increases in MUC5AC (p<0.05) (n=3).Error bars show 
SEM. (Donor 3 cells). 
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 IFN-γ stimulation of ALI cells 4.3.3.
After establishing the ALI model it was important to test the responsiveness to 
additional stimulus that could be measured easily. IFN-γ was used as Britto, Liu et al. 
(2013) showed a reduction of SPLUNC1 expression in a murine airway epithelial model 
when stimulated with IFN-γ, a finding which was partially corroborated in humans 
using the NCI-H292 cell line. Due to their putative functions in immune responses and 
our previous use of PLUNCs as differentiation markers we sought to test these findings 
in human ALI cells. We treated 21 day differentiated ALI cells with IFN-γ for 18 hours 
based on the study by Britto, Liu et al. (2013). Apical surface washes were collected, 
cells lysed in TRI reagent and RNA extracted. Due to the limited number of cells 
available we only used a single dose of IFN-γ for a single time period.  
 
Apical secretions were separated using SDS-PAGE, Western blotted and probed with 
antibodies against LPLUNC1 (Figure 4.10A) and SPLUNC1 (Figure 4.10C). The 
results show bands at the expected sizes for both proteins. Densitometry analysis 
showed difference 4-fold increase in LPLUNC1 (Figure 4.10B) secretion and a 2-fold 
increase in SPLUNC1 (Figure 4.10D) secretion when stimulated with IFN-γ.  
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Figure 4.10: Western blot for LPLUNC1 and SPLUNC1 in ALI cells stimulated 
with IFN-γ. 
10µl of secretion was separated by SDS-PAGE and Western blotted for LPLUNC1 
(A) and SPLUNC1 (C). Bands appear at the appropriate sizes for both proteins in the 
samples and positive control (an apical secretion from ALI cells cultured by 
Synairgen and provided to us for a previous study). Densitometry analysis was 
performed to show induction of LPLUNC1 (B) and SPLUNC1 (D) after stimulation 
with IFN-γ. A ratio paired t test shows no significance (n=3). Error bars show SEM. 
(All IFN-γ stimulations performed on differentiations using Donor 3 cells). 
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qPCR generated quantitative data on the expression of SPLUNC1, LPLUNC1 and IP-10 
following IFN-γ treatment. No significant differences in SPLUNC1 (Figure 4.11A) and 
LPLUNC1 (Figure 4.11B) were noted but marked differences (average 1250-fold 
difference) were seen in the induction of IP-10 following IFN-γ stimulation (Figure 
4.11C), this was not significant upon statistical analysis with a paired t test. This change 
confirmed that the stimulation of the cells did exert an IFN-γ effect but that this 
stimulation had no effect on expression of SPLUNC1 or LPLUNC1. The fold change 
data from each replicate is shown in Appendix 4.  
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Figure 4.11: Comparison of SPLUNC1, LPLUNC1 and IP-10 in cells stimulated 
with IFN-γ by qPCR 
Quantitative data was generated using qPCR performed with primers against 
SPLUNC1 (A), LPLUNC1 (B) and IP-10 (C) in samples from cells stimulated with 
IFN-γ and unstimulated controls. A paired t test showed no significance (n=3). Error 
bars show SEM. 
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4.4. Discussion 
The aim of this chapter was to reproducibly establish ALI cell cultures in our 
laboratory. Previously, work from the lab with such cells was done on a collaborative 
basis with ALI cell RNA and secretions being provided by a number of different 
collaborators (Bingle, Cross et al. 2006; Bingle, Barnes et al. 2007; Bingle, Wilson et al. 
2010). We were able to successfully differentiate primary HBE cells using the ALI 
culture method numerous time using cells from five different donors and modulate this 
phenotype with the addition of IL-13 to generate a more goblet cell rich phenotype. 
 
 The ALI technique was established in 1990 (Wu, Martin et al. 1990) and has been 
replicated and utilised by many groups since, using a number of differing protocols that 
have become increasingly more complex, including modulation of cellular phenotype 
with growth factors and use of a variety of culture tools with transwell inserts resulting 
in effective differentiation of mucus-secreting cell types. The process of differentiation 
causes the cells to take on a pseudostratified appearance (Ross, Dailey et al. 2007) and 
has been shown to be a good representation of the in vivo airway epithelial 
transcriptome (Dvorak, Tilley et al. 2011). We considered that this differentiation 
process and the associated complex secretory products produced would not only closely 
mimic the airway in vivo but would also help to overcome the issues of cell death and 
the limited responses seen in cell lines and uHBE cells infected with RSV and NTHi 
and described in the previous chapter and be a useful tool for studying the responses of 
the airway epithelium to a variety of stimuli. 
 
In principle, airways cells, whether extracted from patients or purchased commercially, 
are cultured in transwells with a source of growth medium available below the transwell 
in the basolateral compartment, while the cells on the apical surface of the transwell are 
exposed to the air. The transwells can be coated with a number of extracellular matrix 
proteins, e.g. collagen, for cells to adhere to (Nlend, Bookman et al. 2002; Ross, Dailey 
et al. 2007; Parker, Sarlang et al. 2010). This is more commonly used in cases where 
cells are limited, for example when cells are obtained from bronchial brushings, as it 
aids in cellular adherence in order to aid growth of the cells. The commercial cells used 
in this project grew well in flasks that were not collagen coated so were also cultured on 
non-collagen coated transwells. There is some suggestion in the literature that collagen 
coating is critical for ciliated cell differentiation (Ross, Dailey et al. 2007), however this 
was not the case for our studies, and the cells differentiated into ciliated and goblet cells 
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with proportions visibly altered when cultured in the presence of IL-13 to increase 
goblet cell numbers (Laoukili, Perret et al. 2001; Turner, Roger et al. 2011). 
Modification of the phenotype through IL-13 provides a model for studies of airway 
diseases that are associated with mucous cell metaplasia and increased production of 
mucus, as in situ diseased airways, such as those from patients with COPD and asthma 
contain significantly increased numbers of goblet cells. Thus our aim was to establish 
these cultures for our own studies, including modulation of the phenotype by changing 
the culture conditions, and to validate these against those already established by other 
groups. 
 
Differentiation to a mucociliary phenotype, results in the induction of a significant 
number of genes which can then act as markers for different epithelial cell types within 
the cultures. These markers are easily accessible in the mucus-rich secretions of the 
mucociliary phenotype. Transcriptional analysis performed by Ross, Dailey et al. (2007) 
showed that two of the most induced genes during the process of mucociliary 
differentiation are SPLUNC1 and LPLUNC1. The proteins encoded by these genes are 
members of a larger family known as the PLUNC (BPIF) family (Bingle and Craven 
2002; Bingle, Bingle et al. 2011) and are found abundantly in the mucus of the upper 
airways and nasal passages (Bingle and Bingle 2000; Bingle, Wilson et al. 2010). The 
induction of PLUNC proteins as a direct result of differentiation of primary airway 
epithelial cells in vitro (Bingle, Barnes et al. 2007; Ross, Dailey et al. 2007; Bingle, 
Wilson et al. 2010), and the ease in which it is possible to obtain samples (by washing 
the apical surface of the cultures) make them ideal candidates to use as markers for 
tracking differentiation during the establishment of ALI culture. Neither of these genes 
is significantly expressed in undifferentiated primary airway cells (Ross, Dailey et al. 
2007). As our group works extensively with these proteins, they were chosen as markers 
of differentiation for use in this project. It was important to identify and validate 
antibodies against PLUNC family members in order to use them as markers.  
 
In the absence of readily available commercial antibodies at the start of our studies we 
generated antibodies against a number of family members using two epitopes per 
protein to increase the chances of successful antibody generation. The founding PLUNC 
family member, SPLUNC1 was identified by a number of groups (Weston, LeClair et 
al. 1999; Bingle and Bingle 2000; Iwao, Watanabe et al. 2001; Di, Harper et al. 2003) 
and has become one of the most characterised family members since then. During our 
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studies commercial antibodies did become available and we used one of these as a 
positive control for the antibodies we had generated. As the single discrete bands for 
each SPLUNC1 antibody, including the commercial antibody, appeared to be the same 
size on the gel we concluded that they were identifying SPLUNC1. In other studies in 
the laboratory we have also validated these same antibodies against recombinant 
SPLUNC1 protein (Bingle, Cross et al. 2005).  The LPLUNC1 gene was identified after 
conducting BLAST and PSI-BLAST searches to identify expressed sequence tags 
(Bingle and Craven 2002). Our recent publication (Bingle, Wilson et al. 2010) was the 
first to focus on LPLUNC1. Our in-house antibodies were validated using recombinant 
LPLUNC1 expressed in Chinese hamster ovary cells in the absence of a commercially 
available antibody. 
 
Western blotting performed using the LPLUNC1B antibody showed a discrete banding 
pattern with a double-band suggesting that LPLUNC1 is post-translationally modified 
by N-linked glycosylation, an observation supported by the identification of 
glycosylated LPLUNC1 isoforms in saliva (Ramachandran, Boontheung et al. 2008). 
Deglycosylation studies showed a reduction of the double band to a single band and 
further supported this conclusion. We were also able to show that BAL fluid samples 
contained bands with the same molecular mass as seen in the ALI secretion, suggesting 
that the ALI cells produce native LPLUNC1 essentially identical to that seen in lung 
secretions. In other studies the antibodies have been used to localise LPLUNC1 in a 
population of goblet cells in situ as well as in ALI cultures (Bingle, Wilson et al. 2010). 
 
Data produced from our cell cultures supports our suggestion that they were able to 
differentiate into a mucociliary phenotype. Cells were cultured for 21 days as 14 to 21 
days of culture has previously been shown to be sufficient for full differentiation to 
occur (Ross, Dailey et al. 2007; Turner, Roger et al. 2011). Western blotting for both 
SPLUNC1 and LPLUNC1 confirmed that both proteins were increasingly detected in 
the cell secretions during this period of differentiation. As expected, prior to 
differentiation, cell secretions were negative for both proteins. Undifferentiated cells 
have a more basal cell phenotype and do not express the differentiated cell markers. Our 
data did exhibit some variation in the time at which each protein was detected which is 
in agreement with previous results from our lab using cell samples prepared by the 
Campos lab in Miami. It does appear however that cells cultured for this study secrete 
the proteins at a later stage of culture than we have seen previously with LPLUNC1 
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being secreted by day 5 (Campos, Abreu et al. 2004; Bingle, Wilson et al. 2010) 
whereas we didn’t see it until day 14 in this study. This may reflect differences in the 
origin of the cells, their passage number and the exact culture conditions that are used. 
Our cells were from a commercial supplier whereas the Campos lab uses cells isolated 
from unused donor material, cells are cultured on collagen-coated transwells and the 
media used is slightly different (Campos, Abreu et al. 2004). LPLUNC1 was secreted as 
a double band on Western blot illustrating differential glycosylation, which was 
removed by treatment with deglycosylation reagents (Bingle, Wilson et al. 2010). This 
confirms that our cells were secreting a similar protein to that previously reported and 
that is seen in vivo. As gene transcription always precedes the production of secreted 
proteins perhaps unsurprisingly our PCR data showed activation of gene transcription 
for both LPLUNC1 and SPLUNC1 by day 2 of the differentiation period. This confirms 
that cells used in this study begin to undergo the process of differentiation soon after 
being moved to the ALI and that perhaps the lack of secreted protein may reflect a 
sensitivity issue in the blotting procedure. Importantly, we were able to show that both 
LPLUNC1 and SPLUNC1 were always detectable in secretions from cells after 21 days 
of ALI culture and in all of our subsequent studies we used cells that had been cultured 
for this period of time prior to use. Washes were collected throughout all successful 
differentiations with induction of both PLUNCs proteins being a consistent occurrence. 
 
Our data also showed that the ALI cultures expressed a number of additional marker 
proteins. Examining the cellular composition by immunofluorescence staining 
demonstrated an increase in the number of goblet cells following stimulation with IL-13 
during differentiation. The histological sections from similar samples clearly 
demonstrated the presence of ciliated and goblet cells, as well as the multi-level 
arrangement that gives the epithelium its pseudostratified appearance. These images are 
in keeping with those produced by Ross, Dailey et al. (2007), and confirmed that we 
had been able to establish successful differentiation in our cultures. On the basis of all 
of these observations we felt confident in using these cultures in subsequent infection 
studies. 
 
One of the major issues associated with the use of primary cells is that of donor 
variation. This may in part have been the cause of the temporal differences in secretion 
of the proteins discussed above. To attempt to overcome this variation we studied 
multiple samples from eighteen separate differentiation experiments using cells from 
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five distinct donors. We also generated quantitative data through use of qPCR, dot 
blotting and densitometry analysis to compare differences between cells cultured in the 
absence and presence of IL-13. Donors from all cells successfully differentiated into a 
pseudostratified layer with a mucociliary phenotype. All showed induction of 
SPLUNC1 and LPLUNC1 upon differentiation although this was consistent within 
individual donors it was clear that the level of induction was variable between donors.  
 
Immunofluorescence staining for β-tubulin, a marker of ciliated cells identified in the 
array studies of Ross, Dailey et al. (2007), and a classical ciliated cell marker confirmed 
the presence of cilia on the surface of cells, although surprisingly there appeared to be 
no clear difference between those cultured in the presence and absence of IL-13. This 
contrasts with changes seen previously where there was a marked decrease in the 
number of ciliated cells in IL-13 positive cultures (Laoukili, Perret et al. 2001), however 
they utilised an antibody against glutamylated tubulin (Wolff, de Nechaud et al. 1992), 
a post-translational modification found in cilial axonemes and essential for airway 
ciliary function (Ikegami, Sato et al. 2010), which identifies more than just one specific 
class of tubulins providing a higher level of detection/positive staining. We used the 
same antibody as Villenave, Touzelet et al. (2010) as they had shown it to detect cilia in 
cultures, staining with the more specific antibody may have identified a higher amount 
of staining as well as confirming that the cilia are functional, and should be considered 
for staining of cilia in the future. A later study showed a decrease in expression of 
FOXJ1, a transcription factor expressed in ciliated cells, resulting in loss of cilia in 
cultures treated with IL-13 as IL-13 was shown to regulate the foxj1 promoter 
(Gomperts, Kim et al. 2007). Although we have detected FOXJ1 in our cells (Varsha 
Ganesan, unpublished data) we have not studied differential expression with and 
without IL-13 treatment.  
 
Marked differences in MUC5AC expression, consistent with previous studies (Laoukili, 
Perret et al. 2001; Atherton, Jones et al. 2003; Turner, Roger et al. 2011) was 
demonstrated by immunostaining, qPCR and immunoblotting. These studies utilised 
immunostaining or fluorescent labelling to examine the morphology of the epithelium 
and was then used to approximate proportions of goblet cells in comparison to ciliated 
cells at varying times through the differentiation period. These were estimated to be 
around 50% secretory and 10% ciliated cells after 21 days of treatment with IL-13 in 
comparison to the 15% secretory and 25% ciliated cells in cultures that weren’t treated 
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(Laoukili, Perret et al. 2001). Array studies were performed by Ross, Dailey et al. 
(2007) at differing time points throughout a 28 day differentiation period which 
focussed on genes that showed up-regulation of more than 10-fold. These studies 
identified large induction of MUC5B, confirming the study of Bernacki, Nelson et al. 
(1999). However, initial array studies did not show MUC5AC as undergoing large 
induction however qPCR studies did show a large induction of both MUC5AC and 
MUC5B by day 12. Our qPCR studies showed expression of PLUNC proteins, 
MUC5AC and MUC5B in agreement with Ross, Dailey et al. (2007) and comparison of 
the cells cultured in the presence and absence of IL-13 showed a significant difference 
in MUC5AC expression at day 21, consistent with previous studies (Laoukili, Perret et 
al. 2001; Atherton, Jones et al. 2003). Our data showed a 15-fold increase in MUC5AC 
expression, which is supported by the study conducted by Turner, Roger et al. (2011) 
which utilised TaqMan qPCR to compare expression of MUC5AC between cells 
cultured in the absence and presence of IL-13. They showed large increases in mRNA 
expression in cells cultured in the presence of IL-13 by day 14. IL-13 has also been 
shown to induce MUC18, which appeared to aid adherence of NTHi, suggesting action 
as a receptor for NTHi (Simon, Martin et al. 2011). 
 
A study conducted using cells isolated from nasal polyps and cultured at an ALI in the 
presence of differing doses of IL-13 showed down-regulation of SPLUNC1 expression 
(Yeh, Lee et al. 2010). This is not consistent with our study using HBE cells. The down-
regulation seen in the nasal cells was dose responsive, using 0, 1, 10 and 100ng/ml and 
as we used 20ng/ml of IL-13 this may account for the small decrease in our study, or it 
could equally be a result of the differing cell types used for culture. 
 
Having successfully established the ALI technique the responsiveness of the model was 
tested by stimulating the cells with IFN-γ as it was reported by Britto, Liu et al. (2013) 
that IFN-γ stimulation of ALI differentiated mouse tracheal epithelial cells (mTECs) 
inhibits the transcription of SPLUNC1. This data was further confirmed by Britto, Liu 
et al. (2013) using the human NCI-H292 cell line. This data complements previous 
studies on the NCI-H647 cell line using northern blotting (Bingle and Bingle 2000). 
When we performed these studies in ALI-differentiated cells we anticipated that 
standard PCR for LPLUNC1 and SPLUNC1 would show a decrease in gene expression 
in accordance with the data from Britto, Liu et al. (2013). However my findings, of no 
significant change in SPLUNC1, do not match that of Britto, Liu et al. (2013) or Bingle 
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and Bingle (2000); both groups showed a reduction of SPLUNC1 upon IFN-γ 
stimulation. Interestingly, we have been unable to readily detect SPLUNC1 expression 
in the NCI-H292 cells in our lab (unpublished results). The differences in responses 
could be due to the differing cell types used or could be due to the length of time the 
cells were stimulated for. We stimulated for only 18 hours in comparison to the Britto, 
Liu et al. (2013) study which stimulated cells for 24-48 hours. It seems unlikely that our 
data was due to lack of activity of the IFN-γ treatment as the large induction of IP-10, 
the IFN-γ inducible protein, shows that the cells are eliciting a response to the IFN-γ. 
These results need to be strengthened using both a dose and time course study before 
any firm conclusions can be drawn relating to the role of IFN-γ in the regulation of 
SPLUNC1 and LPLUNC1 gene expression in human ALI cells. 
 
As suggested previously, a limitation in the use of primary airway cells is the difficulty 
in obtaining sufficient cell numbers for replicates of experimental exposures. This 
certainly limited the number of studies we were able to perform in this validation work. 
Development of methods that would allow increased cell numbers to be 
isolated/cultured would allow more studies to be performed from a single donor. 
Recently published data shows that treatment of ALI cells with a Rho-Kinase (ROCK) 
inhibitor enhances basal cell proliferation without any subsequent effects on 
differentiation at the ALI (Horani, Nath et al. 2013). This treatment may provide an 
effective solution to issues of low cell numbers, allowing seeding of cells at lower 
densities which would be beneficial in future work to obtain more wells of cells for 
differentiation. We performed a simple experiment to show that this treatment does 
indeed appear to increase cell proliferation (Appendix 5) but time limitations did not 
allow for a systematic analysis of the differentiation capacity of these cells. However, 
subsequent work performed in the laboratory with primary mouse TBE cells has 
confirmed increased cell numbers following ROCK inhibitor treatment (Dr Khondoker 
Akram, personal communication). 
 
In conclusion, ALI culture was successfully and reproducibly established through 
eighteen differentiations using cells from five different donors. Our data confirmed 
induction through use of several markers. Modification of the phenotype was also 
achieved, with culture in the presence of IL-13 resulting in increased goblet cell 
numbers. Stimulation with IFN-γ did not appear to inhibit SPLUNC1 expression, as had 
been shown previously;, This could be due either to the length of time that cells were 
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stimulated for or due to the dose chosen. However, having established a differentiated in 
vitro model of ‘normal’ and ‘diseased’ airways we were then able to undertake infection 
studies as outlined in the next chapter. 
  
 5. Establishment of infection models using ALI-differentiated primary 
cells 
 
5.1. Introduction 
The ALI differentiation process results in development of a mucociliary phenotype, that 
includes ciliated, serous and goblet cells as well as the secretion of products from these 
cells. ALI cells have been shown to provide a good in vitro model of the respiratory 
epithelium, and thus a more representative tool to study the interaction of pathogens 
(Dvorak, Tilley et al. 2011). Cells become tightly packed, developing tight junctions 
and a pseudostratified appearance. We considered that the increased cell densities seen 
in these cultures as well as the multiple innate defence proteins that they release into the 
apical secretions may prevent the cell death and destruction of the cell-mono layers seen 
in the studies undertaken in the established cell lines and described in Chapter 3. 
 
As previously mentioned RSV is a common pathogen causing recurring infection in the 
airway. It has previously been shown that RSV specifically infects ciliated cells in ALI 
cultures (Zhang, Peeples et al. 2002). This specificity of infection provides an 
alternative tool to check the integrity of the ALI differentiation model as well as 
characterise the responses elicited by an RSV infection.  NTHi is associated with airway 
colonisation and exacerbations of symptoms in airway diseases. No key feature has 
been identified that is necessary of NTHi to establish an infection. However, NTHi 
strains are known to possess protease activity, in the form of IgA1 protease (Plaut, Qiu 
et al. 1992), that is utilised to impair the immune response (Kilian, Mestecky et al. 
1979; Male 1979). IgA1 protease functions as an autotransporter in bacterial 
aggregation mediating the formation of micro colonies (Plaut, Qiu et al. 1992) and the 
protease is found near the top of the biofilm structure, leading to the suggestion that it 
has a protective function against antibody attack (Webster, Wu et al. 2006). 
Examination of proteolytic activity exhibited by NTHi during the infection process may 
also provide insight into early infection and biofilm formation processes.  
 
 Aims 5.1.1.
The aims of this study were to: 
(1) Establish and characterise RSV infections in ALI cells 
(2) Establish and characterise NTHi infections in ALI cells 
(3) Investigate the proteolytic activity of NTHi on epithelial host defence products 
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5.2. Methods 
 Infection of ALI cells with RSV 5.2.1.
ALI cells were infected with either 5x10
5
 or 1x10
6
 pfu/50µl of RSV; both doses were 
used in cell line infections. After initial infections, 1x10
6
 pfu/50µl was used for 
infections to ensure infection of the more complex pseudo-stratified ALI cultures. The 
surface of the cells was washed after 48 hours and the wash frozen. At 5 days post 
infection, the experiment was terminated by washing the surface of the cells with 180µl 
of PBS (as above) and fixing for 10 minutes with 10% phosphate-buffered formalin. 
Fixative was replaced with PBS for storage until they were immunofluorescently-
stained. 
 
 Infection of cells with NTHi 5.2.2.
Primary cells differentiated at the ALI were already on transwells, and were cultured in 
antibiotic free media for at least three days prior to infection. The surface of half of the 
ALI wells was washed with 180µl of PBS 24 hours prior to infection; the other half was 
washed immediately before infection. Cells were infected with approximate MOIs of 5, 
25 and 50 diluted to final volumes of 50µl in PBS for 1 hour, 3 days and 7 days. After 
which, a gentle wash was taken from the surface of the transwell and stored. Wells were 
washed in the basolateral compartment with PBS to remove excess media and fixed for 
10 minutes in 10% phosphate-buffered formalin (basolateral and apical compartments). 
After 10 minutes the formalin was removed and replaced with PBS for longer term 
storage. Before imaging, membranes were cut from the transwell using a scalpel and 
mounted with Vectashield containing DAPI, sealed with nail polish and imaged using 
the Olympus FV-1000 Confocal Microscope. 
 
 Co-infection of RSV and NTHi 5.2.3.
ALI cells that had been differentiated for 21 days were infected with previously 
established doses of both RSV and NTHi. Cells were initially infected with 
1x10
6
pfu/50µL of RSV for 3 days, after which the surface of the cells were washed and 
basolateral media (antibiotic free) changed prior to a secondary infection with NTHi at 
an MOI of 25 for 3 days and 7 days. Cells were infected with RSV first as it  took 
longer to establish an infection than with the NTHi. Single pathogen infections of RSV 
at 1x10
6
pfu/50µL and NTHi at an MOI of 25 were performed alongside for the 
durations stated in the co-infections so as to act as controls. At the end of the 
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experimental exposures nuclei were counter-stained with DAPI, mounted and imaged 
using confocal microscopy. 
 
5.3. Results 
 Infection of ALI cells with RSV 5.3.1.
Differentiated ALI cells were infected with recombinant red RSV at a dose of 1x10
6
 
pfu/50µl for 5 days. This dose had previously been validated in the laboratory in a 
related project (Ugonna, Bingle et al. 2014). Infections were performed on cells that had 
been cultured for 21 days in either the absence (Figure 5.1A and Figure 5.2A) or 
presence (Figure 5.1B and Figure 5.2B) of IL-13.  This allowed us to study the effects 
of the differing phenotypes as  IL-13 treated cells have an increased number of goblet 
cells. After fixing, membranes were immunofluorescently stained for β-tubulin (Figure 
5.1) and MUC5AC (Figure 5.2). Membranes were then counter-stained with DAPI and 
staining was visualised and Z-stack images captured using confocal microscopy. 
Control staining was performed using secondary antibody only, these were not routinely 
imaged after initial images showed no background staining. Imaging of secondary 
antibody only controls can be seen in figures 4.7E and F. 
 
Overlap of green positive β-tubulin with the red virus infected cells was demonstrated 
(Figure 5.1) (white arrows). Staining for MUC5AC did not overlap with virus infected 
cells; rather the green staining of MUC5AC was seen around infected cells (Figure 5.2) 
(white arrows). Z-stack imaging allowed for a composite to be made of z-axis views, 
with the same patterns as the z-axis views (Figure 5.1 and Figure 5.2) (red arrows). 
These observations suggest that RSV selectively infected ciliated cells. These results are 
representative of n=3 individual experimental infections. 
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To obtain a snapshot of the cytokine profile produced by infected cultures, apical 
washes from day 4 and 5 of the RSV infected and control wells were combined and 
cytokine levels were assessed (Figure 5.3). The arrays were all performed at the same 
time and densitometry was performed on a single exposure of the films to allow 
comparison of the infected cells with controls. Washes from cells cultured in the 
absence of IL-13 showed increases in G-CSF (8-fold), IL-1ra (6-fold), and IL-6 (4-fold) 
alongside induction of IP-10 (Figure 5.4A). Washes from the RSV infected cells 
cultured in the presence of IL-13 showed induction of RANTES as well as IP-10, 
alongside increases in G-CSF (2.75-fold), GM-CSF (1.5-fold), IL-6 (1.5-fold) and MIF 
(2-fold) (Figure 5.4B) although the magnitude of these increases was less than was seen 
in the IL-13 negative cultures.  
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Figure 5.3: Cytokine Array of RSV infections 
Cells cultured in the absence (A and B) and presence (C and D) of IL-13 were 
infected with RSV (A and C) for 5 days. Part E shows the data table for the cytokine 
array. (Secretions from infections of Donor 1 cells) (n=1). 
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Figure 5.4: Densitometry performed on Cytokine Array of RSV infections 
Cells cultured in the absence (A) and presence (B) of IL-13 were infected with RSV 
for 5 days and washes used to perform a cytokine array (Figure 5.3) and densitometry 
analysis performed to quantify and show the differences between cytokine responses  
(n=1). 
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 Infection of ALI cells with NTHi 5.3.2.
Infections of ALI cells with NTHi were performed to attempt to establish chronic 
infections on the surface of the cells with the ultimate aim of developing biofilms. To 
directly examine the effect of surface secretions on infection and biofilm formation 
experiments were performed with the apical surface of cell cultures being washed either 
24 hours or immediately prior to the infection of the cultures.  
 
Preliminary studies determined numbers of NTHi required to establish infections on the 
ALI cells. We used the same doses (MOI of 5, 25 and 50) and time points (1 hour, 3 
days and 7 days) as in the cell line infection studies outlined in Chapter 3. After 
infection with a GFP-tagged strain of NTHi confocal microscopy allowed visualisation 
of resulting infections. 
 
All doses of NTHi used to infect cells in the presence and absence of apical secretions 
were compared at 7 days (Figure 5.5). There were visible differences between the two 
conditions with an MOI of 5 (Figure 5.5A and B). The presence of apical secretions 
appeared to have had an effect on rates of infection, with many fewer green bacteria 
being present in the infections performed in the absence of secretions. This suggested 
the absence of mucus may have prevented the NTHi from establishing a successful 
infection at this lower dose. This difference was much less noticeable in the MOI of 25 
(Figure 5.5C and D) and 50 (Figure 5.5E and F) infections with images showing 
presence of higher numbers of individual bacteria. Thus the MOI of 25 was used as the 
representative dose for presenting imaging data throughout the remainder of this 
chapter.  
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Figure 5.5: NTHi infections of ALI cells cultured with and without surface 
secretions with three doses of NTHi for 7days 
ALI cells were infected with a GFP-tagged strain of NTHi at an MOI of 5 (A and 
D), 25 (C and D) and 50 (E and F) for 7 days. The apical surface of cells was 
washed either 24h (A, C and E) or immediately prior (B, D and F) to infection. 
Nuclei are stained blue with DAPI, and green fluorescence confirms the presence of 
bacteria in infected wells. (Images from Donor 3, representative of n=3 infections, 
including Donors 4 and 5). 
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Using representative images from infections at MOI of 25 we showed the progression of 
the infection through the selected time points of 1 hour (Figure 5.6A-C), 3 days (Figure 
5.6D-F) and 7 days (Figure 5.6G-I); we utilised the one hour time point to check for 
viable bacteria.  As we were interested in chronic infections and biofilm formation we 
also utilised longer time points for infections. Green fluorescence showed the presence 
of small amounts of bacteria at 1 hour, which increased by 3 days and further increased 
by 7 days. As expected uninfected control wells showed no green fluorescence. DAPI 
staining of the nuclei showed that the majority of cells remained in the cultures at day 7, 
suggesting that the confluent layer of cells was maintained throughout. There was no 
significant difference in the amount of bacteria between infection of the cells washed 
immediately prior to infection and those with apical secretions (mucus, washed 24 hours 
before infection), however analysis of the green fluorescence channel showed an 
increase in green fluorescence in cells infected with NTHi for 7 days in the presence of 
apical secretions (Figure 5.6J).  
 
Bacterial viability was assessed 7 days after infection using apical washes from all 3 
MOIs (Figure 5.7). There was no significant difference and the presence of apical 
secretions on the cultures prior to infection also had no influence on viable bacteria 
counts.  
 
Infection did not have a significant impact on cell viability or bacterial numbers, 
therefore additional experiments were performed in which the infection was extended to 
10 (Figure 5.8A-C) and 14 days (Figure 5.8D-F). Representative images with MOI 25 
are shown (Figure 5.8). Green fluorescence at the 10 and 14 day time points was clearly 
below that seen in the shorter infections. DAPI staining of nuclei showed that cell 
numbers were reduced, with spaces being visible in the 10 day image and this was more 
apparent in the 14 day image when compared to the mock infected control.  
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Figure 5.6: NTHi infections of ALI cells cultured with and without surface 
secretions for 1hour, 3days and 7days 
ALI cells infected with a GFP-tagged strain of NTHi for 1h (A-C), 3d (D-F) and 7d 
(G-I). The apical surface of cells was washed either 24h (A, D and G) or 
immediately prior (B, E and H) to infection. Nuclei are stained blue with DAPI, and 
green fluorescence confirms the presence of bacteria in infected wells. There was no 
green fluorescence in the controls (C, F and I). Images are from wells infected with 
an MOI of 25. Mean green fluorescence was measured using ImageJ to quantitate 
differences between the presence and absence of apical secretions (J). (Images from 
Donor 3, representative of n=3 infections, including Donors 4 and 5). 
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Figure 5.8: Viable Counts of 7 day NTHi infections of cells infected with and 
without removal of apical secretions 
Viable counts were taken for each of the three doses, MOI 5, MOI 25 and MOI 50 at 
7 days, from infections that were washed 24 hours and immediately prior to 
infection (n=3).  Errors bars show SEM. 
Figure 5.7: NTHi infections of ALI cells after 14 days 
ALI cells were infected with a GFP-tagged strain of NTHi for an additional 10 (A-
C) and 14 days (D-F). The apical surface of cells was washed either 24h (A and D) 
or immediately prior (B and E) to infection Nuclei are stained blue, and green 
fluorescence confirms the presence of bacteria in infected wells. There was no green 
fluorescence in the controls (C and F). Images are from wells infected with an MOI 
of 25. (Images from infection of Donor 5 cells for n=1). 
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Bacterial viability was also determined in the 10 and 14 day cultures for all 3 MOIs 
with and without apical secretions prior to infection (Figure 5.9). Bacteria remained 
viable until 14 days of infection; however there is some variance between the doses by 
this time point, especially in those with 24 hours of apical secretions prior to infection 
and bacterial numbers reduced in comparison to the 7 day cultures.  
 
 
 
 
To compare the responses elicited from the different airway models, washes from 7 day 
infections of ALI cells and the A549, NCI-H292 and uHBE cells with GFP-tagged 
NTHi were used to perform a cytokine array. Control samples were not analysed in this 
array as this was a comparison of the complexity of the responses elicited in response to 
NTHi. In the infection of A549 cells (Figure 5.10A) GM-CSF, GRO-α, IL-8, MIF and 
SerpinE1 were detected whereas infection of NCI-H292 (Figure 5.10B) shows the 
presence of GRO-α, IL-1ra, IL-8, MIF and SerpinE1. Infection of uHBE (Figure5.10C) 
cells results in increased GM-CSF, GRO-α, sICAM-1, IL-1ra, IL-6, IL-8, MIF and 
SerpinE1. Infection of ALI (Figure 5.10D) cells show presence of G-CSF, GM-CSF, 
GRO-α, sICAM-1, IL-1ra, IL-6, IL-8, IP-10, MIF and SerpinE1 showing the more 
complex responses elicited by differentiated cells.  
Figure 5.9: Viable bacterial counts of NTHi after infections for 14 days with 
and without secretions 
Viable counts were taken for each of the three doses, MOI 5, MOI 25 and MOI 50 at 
14 days, from infections that were washed 24 hours and immediately prior to 
infection (n=1). 
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Figure 5.10: Cytokine Array of washes from all 4 different cell types infected 
with NTHi for 7 days 
A549 (A), NCI-H292 (B) uHBE (C) and ALI (D) cells were infected for 7days with 
NTH and washes used to perform a cytokine array. (Donor 3 ALI and uHBE cells) 
(n=1). 
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The GFP strain used in these studies is a well-established experimental strain but in 
order to investigate inter-strain differences a clinical isolate was used to infect ALI 
cultures for 7 days following differentiation in the absence (Figure5.11B and C) and 
presence of IL-13 (Figure 5.11D and E) and cytokine array performed. The clinical 
isolate was provided by the Medical Microbiology department at the Royal Hallamshire 
Hospital, Sheffield. The isolate had been identified as part of a diagnostic work-up in a 
single patient and sub-cultured and a frozen stock prepared. We were provided with a 
plate cultured from this frozen stock. As in previous experiments the arrays were all 
performed at the same time and densitometry (Figure 5.12) was performed on a single 
exposure so as to compare the infected cells with the controls. The cytokine array 
performed using GFP-tagged NTHi (from Figure 5.10) is included in this figure for 
comparison. Cells cultured in the absence of IL-13 infected with a clinical isolate of 
NTHi (Figure 5.11B) shows the induction of GM-CSF, IL-1α, IL-1β and IP-10 as wells 
as all cytokines identified in the control (Figure 5.11C). Densitometry analysis 
confirmed this and showed a large increase in G-CSF and sICAM-1 and a small 
increase in IL-1ra (Figure 5.12A). Infected cells cultured in the presence of IL-13 
(Figure 5.11D) show the induction of G-CSF, sICAM-1, IL-1α and IL-1β alongside all 
cytokines identified in the control (Figure 5.11E).Densitometry analysis confirmed this 
and showed a large increase in MIF expression (Figure 5.12B). Comparing the 
responses elicited by the clinical isolate (Figure 5.11B) and the GFP-tagged strain 
(Figure 5.11A) of NTHi showed some similarities, with the presence of G-CSF, GM-
CSF, GROα, sICAM-1, IL-1ra, IL-8, IP-10 and MIF common to both strains; however 
comparisons with the controls for the clinical isolate show GM-CSF and IP-10 to be 
induced. When comparing differences, the GFP strain shows the presence of IL-6 as 
part of the response it stimulates; however there was no control for this as the cytokine 
array was conducted to compare the responses of the differing cell types so it may not 
be a response to the GFP strain, but IL-6 is not present in the –IL-13 control for the 
clinical isolate cytokine array either. The clinical isolate stimulated a very robust 
induction of IL-1α, IL-1β and IL-1ra. 
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Figure 5.11: Cytokine Array of washes from ALI cells infected with a clinical 
isolate of NTHi for 7days 
Cells cultured in the absence (B and C) and presence (D and E) of IL-13 were 
infected with a clinical isolate of NTHi (B and D) for 7 days. The cytokine array 
from ALI cell infected with GFP-tagged NTHi (Figure 5.10) is shown for 
comparison (A). The data table for the cytokine array is also shown (F). (Donor 2 
ALI cells) (n=1). 
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Figure 5.12: Densitometry performed on Cytokine Array of Clinical Isolate 
NTHi infections 
Cells cultured in the absence (A) and presence (B) of IL-13 were infected with a 
clinical isolate of NTHi for 7 days and washes used to perform a cytokine array 
(Figure 5.11) and densitometry analysis performed to quantify and show the 
differences between cytokine responses  (n=1). 
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 Base line cytokine profile comparison in ALI cells differentiated in the 5.3.3.
absence and presence of IL-13 
The control cytokine array data from RSV and clinical isolate infections of ALI cells 
differentiated in the absence and presence of IL-13 enabled comparison of the cytokine 
profiles exhibited by these two culture conditions. Additionally, the RSV infection was 
performed in cells from Donor 1 and the NTHi infection in cells from Donor 2 allowing 
comparisons between donors. Donor 2 (Figure 5.13B) showed a more complex baseline 
cytokine profile than donor 1 (Figure 5.13A), with donor 2 expressing GM-CSF and IL-
6 in addition to G-CSF, GRO-α, sICAM-1, IL-1ra, IL-8, MIF and SerpinE1. The graphs 
for both donors showed an increase in IL-1ra and decreases in GRO-α and MIF 
expression, although the decrease in MIF expression was higher in donor 1. In contrast 
to each other, IL-8 and SerpinE1 appear to decrease upon addition of IL-13 in donor 2, 
whereas it increases donor 1. Donor 2 showed a complete induction of GM-CSF in cells 
cultured with in the presence of IL-13. It also showed induction of G-SCF and sICAM-
1, however in donor 1, these two cytokines are only expressed in cells cultured in the 
absence of IL-13. The two data sets were grouped together (Figure 5.13C) to show the 
average relative expression of cytokines the two donors have in common. 
 
  
 154 
 
  
Figure 5.13: Comparison of Baseline Cytokine expression in ALI cells cultures 
in the absence and presence of IL-13 
Densitometry performed on control cytokine array data for ALI infection from 
Donor 1 (A) and Donor 2 (B) was compared to examine the differing cytokine 
profiles between cells culture in the absence and presence of IL-13. The values were 
averaged (C) for further comparison. (n=2 datasets). 
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 Investigating the proteolytic cleavage of PLUNC markers in secreted 5.3.4.
products 
Analysis of the NTHi viability following longer periods of infection showed that both 
bacterial numbers and cell viability were reduced suggesting the innate defences of the 
cells were likely impaired following prolonged periods of infections. NTHi possesses an 
IgA1 protease which may be utilised to evade host defence mechanisms by cleaving 
host defence proteins. We therefore utilised the readily accessible PLUNC proteins as 
markers to study proteolytic cleavage of immune molecules using apical secretions from 
cells following NTHi exposure. These samples came from our long-term infections and 
through direct interaction for shorter time periods. We initially began these experiments 
with and examination of exogenous proteases as we wanted to see how PLUNC proteins 
could be broken down by trypsin and neutrophil proteases. These would then act as 
controls for studying degradation by NTHi proteases. 
 
 Investigating the proteolytic activity of neutrophil products and trypsin 5.3.4.1.
In order to investigate the effect of neutrophil proteolytic activity on SPLUNC1, human 
peripheral blood neutrophils were lysed by multiple freeze-thaws in either PBS or in 
PBS containing a pan-protease inhibitor solution. An ALI apical secretion sample was 
incubated with the equivalent of approximately 2.5x10
5
 lysed neutrophils for 15 and 60 
minutes to examine the effect of the proteolytic activity of whole neutrophil lysate. 
These samples were then separated by SDS-PAGE and Western blotted for SPLUNC1 
using both antibodies we generated (to two different epitopes) SPLUNC1A (Figure 
5.14A) and SPLUNC1B (Figure 5.14B). Probing with SPLUNC1B showed a reduction 
in full-size protein as time progressed, however there was no indication of cleavage 
fragments to explain the reduction. This was not the case for the blots probed with 
SPLUNC1A antibody, where the reduction in full size protein coincided with an 
increase in the number of smaller bands which are likely to be fragments of degraded 
protein. Neutrophils lysed in the pan-protease inhibitor appeared to cleave the proteins 
much more slowly, with cleavage fragments appearing at T=60min (Figure 5.14A) 
alongside a reduction in full-size protein. This was most clearly seen in the blots probed 
with the SPLUNC1B antibody (Figure 5.14B). The different antibodies recognise 
different antigens in either the C- or N- terminus of the protein, which is reflected in the 
difference in the appearance of cleavage products.  
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Figure 5.14: Incubation of ALI secretion with Neutrophil Lysate to examine 
proteolytic degradation 
An ALI sample provided by Synairgen was incubated with 250000 neutrophils lysed 
by repeated freeze-thawing in PBS or pan-protease inhibitor solution for 0, 15 and 60 
minutes. These samples were then Western blotted alongside a 1:5 dilution of the 
ALI sample and probed with the antibodies generated by our lab against SPLUNC1. 
Replicate blots were probed with SPLUNC1A (A) and SPLUNC1B (B) (n=1).
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Trypsin is a naturally occurring protease found in the digestive system, produced by the 
pancreas, where it functions to break down proteins as part of protein absorption in the 
digestive system. It is routinely used as a proteolytic agent in experimental studies. 
Therefore, we decided to use this as an alternative proteolytic agent to investigate the 
cleavage of LPLUNC1 and SPLUNC1. ALI samples were incubated with trypsin for 
20, 40 and 60 minutes, and Western blotted with antibodies against SPLUNC1 and 
LPLUNC1 (Figure 5.15).  The LPLUNC1 blot (Figure 5.15A) showed a small reduction 
in size whilst still maintaining the double band representing glycosylated protein. 
Levels of the cleaved product appeared to remain stable for up to 60 minutes of 
treatment. The SPLUNC1 blot (Figure 5.15B) showed bands for full size protein in all 
samples, with band intensity decreasing as incubation was extended. This decrease in 
intensity was coupled with increased intensity of smaller bands of cleavage fragments. 
 
 
 
  
Figure 5.15: Incubation of ALI secretion with trypsin to examine proteolytic 
degradation 
An ALI sample provided by Synairgen was incubated with trypsin for 20, 40 and 60 
minutes. Samples were then Western blotted and probed with antibodies against 
LPLUNC1 (A) and SPLUNC1 (B) (n=1). 
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 Investigating the proteolytic activity of NTHi 5.3.4.2.
To directly study the proteolytic effects of NTHi products on airway secretions we 
incubated apical secretions from non-infected differentiated ALI cultures with 
approximately 200000 cfu NTHi for 1, 4 and 24 hours. These samples were then 
separated using SDS-PAGE and Western blotted for LPLUNC1 (Figure 5.16A) and 
SPLUNC1 (Figure 5.16B). The 0 hour time point was taken prior to addition of NTHi 
and contains bands at the appropriate size for both LPLUNC1 and SPLUNC1. These 
results (Figure 5.16) show significant bands at small sizes which appear to be 
degradation products. Only one dose and three time points were chosen to gain a quick 
insight into the effects of incubating NTHi with airway secretions. There are also faint 
larger bands present in the blots (approx. 55-60kDa), which appear to be non-specific; 
however these could be a result of PLUNC proteins binding to bacterial products as 
SPLUNC1 has been shown to bind LPS (Zhou, Li et al. 2008). SPLUNC1 has also been 
shown, through examination of its crystal structure (Garland, Walton et al. 2013), to 
exist as a dimer (PDB Structure ID: 4KGH/4KGO), and the large bands (approx.55kDa) 
appear to be at the appropriate size for this to be a potential explanation. 
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We had previously used ALI samples, provided by Synairgen, in other studies in our lab 
and found them to contain higher levels of total protein in a smaller volume than the 
samples we had generated during our own ALI cultures. We used one of these samples 
to generate more intense bands and increase the chance of seeing full-length protein 
alongside degradation products as there were more proteins to degrade. Also, in an 
attempt to combat the rapid loss of full-length protein, (Figure 5.16) and so that we 
could study the effects of the bacteria on protein degradation, we used different numbers 
of bacteria for a set time.  We incubated approximately 1000, 2000, 5000, 10000, 25000 
and 50000 cfu NTHi with secretion for 1 hour. As previously the 0 hour time point was 
taken prior to addition of NTHi. The samples were separated using SDS-PAGE and 
Western blotted for LPLUNC1 (Figure 5.17A) and SPLUNC1 (Figure 5.17B). The 
bands in the T=0h lanes show bands of the correct size for LPLUNC1 and SPLUNC1. 
As the number of bacteria used increases, a proteolytic band appears in both at 
approximately 10kDa increased in density as the bacterial numbers increase. Taken 
together, these blotting results show that both SPLUNC1 and LPLUNC1 are targets for 
Figure 5.16: Incubation of ALI secretion with NTHi to examine proteomic 
degradation 
Apical secretions incubated with NTHi for 1, 4 and 24h show bands at the 
appropriate size for LPLUNC1 (A) and SPLUNC1 (B) in the T=0h time point. 
Bands in the other samples are degradation products (n=1). 
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proteolytic degradation and that both are directly degraded by NTHi derived proteases. 
Furthermore, secretions from infected ALI cultures appear to contain predominantly 
degraded SPLUNC1 and LPLUNC1 indicating that unrestrained proteolytic activity is 
present within the cultures. 
 
  
Figure 5.17: Incubation of an ALI secretion with NTHi to examine proteomic 
degradation 
Apical secretion from Synairgen, incubated with varying numbers of NTHi for 1 
hour and Western blotted for LPLUNC1 (A) and SPLUNC1 (B) show bands at the 
appropriate size for both proteins (n=1). 
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 Establishing co-infection of ALI cells with RSV and NTHi 5.3.5.
RSV and NTHi can both be associated with co-infection or secondary infection, 
particularly in diseased airways, and this may result in severe exacerbations of 
symptoms. It has been suggested that RSV enhances NTHi attachment in the airway 
through the use of fimbria-binding receptors on the outer surface membrane of the 
NTHi (Jiang, Nagata et al. 1999). As we had successfully established individual 
infections, the next logical step was to use 21 day differentiated transwells cultured in 
the absence of IL-13 to attempt establishment of a co-infection.  
 
Single pathogen infections were performed alongside the co-infections to act as controls 
(Figure 5.18A and B). 21 day ALI cells were infected with RSV for 3 days, prior to a 
secondary infection with NTHi for 3 days (Figure 5.18C) and 7 days (Figure 5.18D). 
The presence of red fluorescence shows successful establishment of an RSV infection 
and green fluorescence shows that NTHi are present. Nuclei were counter-stained with 
DAPI when mounted. There was a large amount of destruction in the control RSV 
infection (Figure 15.18A) with the presence of RSV alongside what appear to be 
fragments of nuclei. The control NTHi infection (Figure 5.18B) showed clustering of 
bacteria, however there are spaces beginning to form in the cell layer. There was a large 
amount of destruction in co-infection wells, with very few cells remaining.  
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Figure 5.18: Co-infection of ALI cells with RSV and NTHi 
Single pathogen control infections were performed in ALI cells (Donor 5) with RSV 
(A) and NTHi (B) for the longest combined infection period, 10 days, alongside 
cells which were first infected with RSV for 3 days, followed by infection with 
NTHi for 3 days (C) and 7 days (D). Red fluorescence shows the presence of virus 
infected cells. Green fluorescence shows the presence of NTHi. The blue nuclei 
showed positive staining with DAPI. (n=1). 
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5.4. Discussion 
To more faithfully represent the airway epithelium in vivo and overcome the cell death 
issues experienced when using cell lines and uHBE cells outlined in Chapter 3, the aim 
of this chapter was to establish and characterise infection models using both RSV and 
NTHi in ALI-differentiated cells. Our ultimate aim was also to establish long-term 
infection of cultures and to attempt to establish dual infections. As described in detail in 
Chapter 4 the ALI cultured cells are more complex as a result of the differentiation 
process that results in the development of a mucociliary phenotype and the secretion of 
mucus. This is likely to allow the cells to mount a more complex response to foreign 
material. We postulated that this complexity would aid cell survival, post infection and 
provide a more accurate representation of the human airway.  
 
RSV is a common respiratory pathogen, predominantly affecting children and the 
elderly and is a frequent cause of COPD exacerbations. Previous research has shown 
that RSV preferentially infects the ciliated cells of the airway epithelium (Zhang, 
Peeples et al. 2002; Villenave, Thavagnanam et al. 2012; Smith, Kulkarni et al. 2013) 
although the virus has also been shown to infect other cell types and non-differentiated 
cells. We monitored infection of the ALI cells with a red fluorescent tagged strain of 
RSV, followed by immunofluorescence staining for MUC5AC (goblet cells) and β-
tubulin (ciliated cells) confirming that RSV targeted ciliated cells. Limited infection 
was seen in other cell types within the culture and so our data confirms that the airway 
model has differentiated successfully, generating ciliated and goblet cells which are 
secreting mucus.  
 
We reasoned that altering the phenotype of the epithelium through the use of IL-13 
treatment would result in the cells mounting a different response to viral infection. IL-
13 treated ALI cultures have increased goblet cells (and reduced ciliated cell). Our 
cytokine array data suggested that there were limited differences between the different 
culture conditions. In both conditions a gene shown to be induced by viral infections, 
IP-10 was induced as expected, (Becker, Reed et al. 1997; Oshansky, Barber et al. 
2010). A recent publication by Smith, Kulkarni et al. (2013) utilised ALI culture cells to 
study RSV infected cells, also showed a significant increase in IL-6 and IP-10 
expression. RANTES (regulated by IL-13) was only seen in infections performed in the 
presence of IL-13 (Tekkanat, Maassab et al. 2002) but has previously been associated 
with RSV infections; one study found increased RANTES expression during RSV 
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infections when performed during smoke-induced COPD exacerbations in mice 
(Foronjy, Dabo et al. 2014) and RSV induced RANTES expression has been linked to 
exacerbations of airway disease with RANTES being identified in samples from 
patients with bronchiolitis (Hull, Rowlands et al. 2003). Another study characterised 
responses to RSV infection in mice and used immunohistochemistry analysis to identify 
high numbers of eosinophils in the lungs of RSV infected mice (John, Berlin et al. 
2003). A study conducted by Bukreyev, Belyakov et al. (2001) showed that GM-CSF 
attenuated viral replication and increased the number of pulmonary antigen-presenting 
cells. Another study, using a BEAS2B cell line, showed accumulation of IL-6 and GM-
CSF in infections that took place for longer than 96 hours, with IL-8 being a 
predominant cytokine released in the first 24 hours (Noah and Becker 1993). As these 
cytokine arrays were performed on cells that had been infected for 5 days, we would 
possibly expect to see GM-CSF in the responses of cells from both culture conditions, 
although it is possible that levels may have dropped by 5 days post infection, and 
remained for longer in the cultures differentiated in the presence of IL-13 as they are 
more representative of ‘diseased’ cells. 
 
One of the objectives of this project was to establish long-term NTHi infections on the 
ALI cells with a view to using these for biofilm formation. Our work with the cell lines 
(presented in Chapter 3) had shown that it was not possible to establish such cultures in 
cell lines.  This was probably because they did not mount robust enough innate defence 
responses to counter the effect of the infections. We were, however, able to show that 
longer term infections could be established in the ALI cultures. The maximum length of 
time infections could be tolerated by the ALI cell was around 7 days as viable bacterial 
counts performed using 7 day washes show that the bacteria were still viable and IF 
microscopy showed abundant bacteria on the cultures. Viable bacterial counts were also 
performed at 14 days and show more variation in viable bacteria between starting doses 
and the presence of secretions on the surface prior to infection. Removal of surface 
secretions (containing mucus and host defence proteins secreted by the cells) prior to 
infection did not have a major impact on the development of infection. There also was 
no major impact on the cell layer at this time however extending the infection period to 
14 days resulted in the cell layer becoming disrupted, with gaps beginning to appear in 
the cell layer. Only one previous study has used differentiated airway epithelial cells for 
extended infection with NTHi (Ren, Nelson et al. 2012).  They infected cells with NTHi 
for periods of up to 10 days, collected internalized bacterial numbers, used trans-
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epithelial electrical resistance and performed ELISAs and electron microscopy to 
characterise their infections. Comparing out cytokine array data with their ELISA data 
we identified IL-1β, IL-6, IL-8 and GM-CSF but no TNF-α. Out of the 5 cytokines they 
performed ELISA for they showed high amounts of IL-8 and IL-6 with exposures on 
the cytokine array showing large amounts of both cytokines. The exposures for GM-
CSF and IL-1β appear to show more GM-CSF than IL-1β which was not the case in the 
ELISA data. These differences could be due to donor or culture technique variability. 
 
Our data suggests that infecting for 7 days is best for both the cell and the bacterial 
survival. By 7 days the bacteria appear to cluster around cells in small patches and 
comparing this to biofilm studies performed on NTHi and other bacterial species, this 
appears to be consistent with the initiation of a biofilm structure (Starner, Zhang et al. 
2006; Hall-Stoodley, Nistico et al. 2008; Ma, Conover et al. 2009; Juneau, Pang et al. 
2011). Examination of the side view image from Z-stack imaging indicates bacteria are 
located between and below nuclei, although this appears to be in close proximity to the 
nucleus suggesting that they could be inside the cells. A study conducted using cell lines 
showed that NTHi are able to use paracytosis to migrate through epithelial layers (van 
Schilfgaarde, van Alphen et al. 1995); which could allow invasive infections or evasion 
of the immune response; NTHi has also been shown to invade the airway epithelium 
(Ketterer, Shao et al. 1999; Murphy and Kirkham 2002). The extended infections, of up 
to 10 days, performed by Ren, Nelson et al. (2012) found that NTHi is located 
paracellularly. As we were only able to work with limited numbers of ALI cell cultures, 
we were unable to performing studies to establish the location of the bacteria in the 
cultures. Staining the tight junctions that form when these cells differentiate with an 
antibody against ZO-1 would provide an outline of the cells in order to locate the 
bacterial location as being inside or outside of the cell.   
 
The cytokine array data comparing infected primary and ALI cells to cells lines shows 
that primary and ALI cells elicit a much more complex response to NTHi infection. 
This might be expected as the ALI cells are more complex cultures, representing the 
multiple cell types seen in the airway epithelium as well as the products they secrete. 
Controls for these infections were not analysed by cytokine array we were unable to 
identify cytokines induction/up-regulation upon infection. 
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To investigate issues relating to the strain specific responses to infection we also used a 
clinical isolate of NTHi obtained from the Medical Microbiology department at the 
Royal Hallamshire Hospital, Sheffield. This could not be visualised in the same manner 
as the GFP-tagged strain so we limited our analysis to the cytokine array to study the 
differences in the immune response.  Use of a clinical isolate elicited a more complex 
response from the cells than the GFP-tagged strain. The most visible differences 
between the strains are the presence of IL-6 in the GFP-strain infections and IL-1α and 
IL-1β in the clinical isolate samples. This data clearly shows that cellular responses 
differ between individual strains and the different cytokines produced suggest 
differences in responses by the immune system to different strains. This showed that 
one model is not enough; and a model needs to be generated for each strain. Some 
strains of NTHi are more successful at colonising the airway, and different responses 
may contribute to this, particularly due the variable nature of virulence factors present 
between strains. Laboratory strains often become attenuated and so clear differences in 
the number/range of cytokines elicited by the two isolates were observed. NTHi has 
previously been shown to induce NF-κB dependent transcription of TNF-α, IL-1β and 
IL-8 in normal HBE cells (Watanabe, Jono et al. 2004) and IL-1α, IL-6 and IP-10 in 
human middle ear epithelial cells (Moon, Lee et al. 2006). A more recent study 
investigating the effects of extended culture of NTHi on ALI cells shows presence of 
IL-1β, IL-6, TNF-α, GM-CSF and IL-8 (Ren, Nelson et al. 2012). The differences that 
we have seen in the cytokine array data (particularly relating to IL-1) may be mediated 
by differences in the LOS molecules on the surface of the bacteria inducing innate 
defence pathways through TLRs (Clemans, Bauer et al. 2000), however this n=1 data 
set is the only data to show induction of IL-1α. IL-1β and IL-1ra and with limited 
literature on available requires further investigation. 
 
Cytokine array results from both strains we used do not show presence of TNF-α, which 
based on the studies mentioned above, was somewhat surprising. Studies have 
suggested that TNF-α expression is induced earlier than IL-6 and IL-8 (Foxwell, Kyd et 
al. 1998; Clemans, Bauer et al. 2000). This combined with the variation between strains, 
may have resulted in our time point of 7 days being too late to pick up the peak of TNF-
α expression that this strain elicits. The studies by Ren, Nelson et al. (2012) and 
Watanabe, Jono et al. (2004) used different strains to our study so may have elicited 
different responses at different times. TNF-α stimulates an acute response and regulates 
immune cells so should be detectable in response to a bacterial infection, and our 
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inability to detect this could mean immune cells are not activated and any response 
mounted is ineffective. 
 
The cytokine array data generated for the infections in this chapter enabled comparison 
of the baseline cytokine profiles between cells cultured in the absence and presence of 
IL-13. This showed the variability between donors, with one donor exhibiting a slightly 
more complex response than the other. Differentiations modulated with IL-13 generally 
showed similar cytokine profiles to those cultured in the absence of IL-13 but showed 
higher or lower expression of cytokines they had in common. This expression was not 
consistent between donors.  
 
Host-pathogen interactions both in vivo and in vitro result in the generation of a 
complex milieu which is often characterised by alterations in the protease/anti-protease 
balance. Dis-regulated proteases can impair host responses due to degradation of 
specific host defence molecules and cause tissue damage. Abnormalities of 
protease/anti-protease balance are associated with many pulmonary infection and 
inflammatory diseases. Such shifts in this balance can significantly affect epithelial host 
defence protein function with many being known to be inactivated by the action of 
unrestrained proteases (Greene and McElvaney 2009; Kukkonen, Tiili et al. 2013). 
Infection with NTHi in vivo leads to recruitment of immune cells to the site of infection, 
and their proteolytic activity could result in degradation of immune molecules. 
Neutrophil products, specifically neutrophil elastase, have been shown to degrade 
SPLUNC1 (Hobbs, Blanchard et al. 2013; Jiang, Wenzel et al. 2013). This degradation 
of SPLUNC1 resulted in an increase in bacterial load of NTHi, which was reduced upon 
addition of recombinant SPLUNC1. We examined degradation of proteins with 
neutrophil lysate, trypsin and NTHi. Neutrophil lysates were prepared in the presence 
and absence of a pan-protease inhibitor. Our data showed rapid degradation of 
SPLUNC1 into a number of fragments, with smaller bands appearing after 15 minutes 
and further loss of full-length protein after a 1 hour incubation period. This degradation 
was slowed by the addition of a pan-protease inhibitor as degradation did not begin until 
at least 1 hour incubation. This is only partially consistent with the data of Jiang, 
Wenzel et al. (2013) who showed cleavage of a 3kDa fragment. This could be due to 
their use of human neutrophil elastase, as opposed to the lysed whole neutrophils we 
used, which contains a variety of other proteases and also to the use of different 
antibodies designed against different epitopes of the proteins 
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Trypsin has been shown to activate the epithelial sodium channel ENaC, which is the 
rate limiting step in sodium adsorption in the regulation of airway surface liquid and 
mucociliary clearance (Donaldson, Hirsh et al. 2002; Haerteis, Krappitz et al. 2014). 
Our incubations with trypsin showed a similar degradation pattern for SPLUNC1 as that 
achieved when samples were incubated with neutrophil lysate, with a reduction of 
whole protein and the appearance of multiple smaller bands, however this degradation 
was slower in trypsin digestions. Truncation of SPLUNC1 has been reported in vivo, 
with samples from nasal lavage of patients with RSV (Fornander, Ghafouri et al. 2011) 
suggesting that proteolytic inactivation of the protein may be an important determinant 
of its function in airway disease. Currently there is no similar information on the 
degradation of LPLUNC1 but our data shows that this protein is also a target for 
protease digestion, again suggesting that its function may be impaired in diseases 
associated with protease imbalance. 
 
As SPLUNC1 and LPLUNC1 were degraded by exogenous proteases we then looked 
for evidence of protein degradation in apical secretions from cells infected with NTHi. 
The rationale for this being that impairment of host defence proteins might be 
associated with inadequate cellular responses to in vitro infections. Proteolytic activity 
of NTHi is due to the IgA1 protease (Plaut, Qiu et al. 1992) which is used to aid evasion 
of the host defences (Kilian, Mestecky et al. 1979; Male 1979). Recent work has shown 
that NTHi expresses two different types of iga gene that are adapted for infection and 
colonisation (Murphy, Lesse et al. 2011). Our data shows increasing amounts of 
degradation with increasing bacterial numbers, with bands appearing at the appropriate 
size for the whole protein and also smaller bands just below 10kDa. As both of these 
proteins have putative functions in host defence (Bingle and Craven 2002; Bingle and 
Craven 2004), degradation may result in negative effects on the immune response. This 
degradation can be seen in other defence proteins and with other bacterial species (as 
reviewed by Potempa and Pike (2009) and Koprivnjak and Peschel (2011)). As 
previously mentioned degradation of SPLUNC1 reportedly leads to an impaired 
epithelial defence against NTHi (Jiang, Wenzel et al. 2013). The direct degradation of 
these proteins by NTHi may also be a mechanism employed by NTHi to diminish the 
epithelial defences in order to establish a successful infection. 
 
 169 
 
As RSV and NTHi co-infect airways, particularly in COPD exacerbations (Bandi, 
Jakubowycz et al. 2003; Sethi, Mallia et al. 2009) we attempted to study co-infection in 
ALI cells. Previous studies have shown that a prior RSV infection, as this has been 
identified as the virus most commonly associated with paediatric otitis media 
development due to NTHi, can facilitate a potential NTHi infection by aiding 
attachment of the P5 fimbriae of NTHi to the cell (Jiang, Nagata et al. 1999) and 
causing dysregulation of a mucosal β-defensin in order to enhance colonisation by 
NTHi. In our studies ALI cells infected with RSV for 3 days, prior to a secondary NTHi 
infection for 3 and 7 days showed successful infection with both pathogens; however 
we saw large amounts of cell death, with very few cells remaining. This was the only 
attempt at establishing this type of infection as establishment of a successful co-
infection requires more extensive optimisation than the time allowed in this project.  
 
During the latter part of the project we encountered difficulties with maintaining the 
differentiation status of the ALI cultures which limited studies. Cultures would 
differentiate successfully (as judged by microscopy and Western blotting of SPLUNC1) 
but then lose confluence developing ‘holes’ in the differentiated cell layer between 14-
21 days after ALI conditions were imposed. This ‘failure to thrive’ was investigated 
ruling out degradation of retinoic acid and not collagen coating the transwells.  We were 
unable to identify a cause for this prior to the end of the study. 
 
The aims of this chapter were to establish and characterise RSV and NTHi infections in 
the ALI model. We were able to successfully establish infections with RSV and NTHi, 
however, while many infections were performed, further infections need to be 
performed to generate a reproducible infection model and completely characterise the 
responses. The infections need to be performed with cells obtained from many more 
donors and using a number of strains of the pathogens in order to generate a more 
robust data set that is representative of the airway epithelium and responses elicited 
upon exposure to pathogens. 
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 6. Discussion 
The main aim of this study was to establish an in vitro model of the airway epithelium, 
to use as a tool to understand pulmonary innate defence mechanisms following 
exposure to pathogens, particularly RSV and NTHi. The secondary aim was to establish 
NTHi cultures, in the form of biofilms, on the surface of the airway epithelium, as these 
are frequently identified in the airways of patients with pre-existing airway disease. 
 
6.1. Major Findings 
Initial work using immortalised cell lines A549 and NCI-H292 cells and primary uHBE 
cells showed that they are not a representative model for the airway epithelium and are 
not robust enough to withstand infection with RSV and NTHi. Long term infections did 
appear to show that biofilms were achievable. The cells exhibited poor survival rates 
and limited cytokine responses and comprise of a single cell type, unable to differentiate 
to recapitulate the features of the airway epithelium. We were able to successfully 
establish the ALI cell culture technique in our lab using primary HBE cells. These cells 
develop a pseudostratified epithelium complete with mucociliary phenotype providing a 
good representation of the airway epithelium. These cultures showed induction of 
SPLUNC1 and LPLUNC1, and positive staining for a number of markers including 
tubulin and mucins. Stimulations with IFN-γ showed induction of the IFN-inducible 
protein IP-10 showing the cells were able to mount a cytokine response. Infection of 
these cells with RSV and NTHi showed them to be much more robust and responsive 
when exposed to pathogens. Infections using two different strains of NTHi showed the 
difference in responses elicited by different strains of bacteria.  
 
6.2. Establishing an airway infection model 
The first step in this work was to establish a representative airway model. Initially 
cancer derived cell lines, A549 and NCI-H292, were investigated alongside primary 
uHBE cells, which were used to introduce donor variability. The limited responses from 
cancer derived cell lines and undifferentiated primary cells, and poor cell survival upon 
infection showed that they are not the most effective tool for conducting studies aimed 
at characterising the immune response due to the limited number of cytokine and 
chemokines produced and that cells do not produce the full range of molecules seen in 
the airway.  
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The ALI culture technique is becoming widely used for airway epithelial studies. We 
successfully established this differentiation of primary airway epithelial cells in our lab, 
with cytokine array showing that ALI cells elicited a much more complex response and 
proved to be much more resilient upon infection. This increased robustness allowed for 
longer term experiments to be performed in order to establish NTHi biofilms. 
Modulation of the phenotype with IL-13 increased the proportions of goblet cells, 
enabling study of the diseased airway epithelium. 
 
 NTHi infection 6.2.1.
An ALI model, called the EpiAirway™ model was utilised by Ren, Nelson et al. (2012) 
to study long-term NTHi infections. They saw clustering of bacteria at focal sites of the 
epithelium during an infection was also reported by. Our studies also showed clusters of 
bacteria towards the apical surface of cells with the bacteria remaining in our wells 
appearing to cluster around surviving cells. This observation coupled with our 
unsuccessful attempts to grow bacteria in cell media alone, suggests that NTHi may 
require cells to be able to grow (results not shown), contributing to the suggestion that 
clustering aids survival. Confocal imaging of a 3 day uHBE infection showed a mesh-
like structure around the clusters of bacteria, which could represent the glue-like matrix 
observed by Moxon, Sweetman et al. (2008). This could also be seen in small amounts 
in 7 day infections of cell lines and resembles the formation of biofilms seen in both 
NTHi and other bacterial species (Starner, Zhang et al. 2006; Hall-Stoodley, Nistico et 
al. 2008; Ma, Conover et al. 2009; Juneau, Pang et al. 2011). It has also suggested that 
MUC18 is a putative receptor for NTHi (Simon, Martin et al. 2011), aiding adherence to 
cells. This suggests that IL-13 modulated cultures may have higher levels of bacterial 
adherence, which was not the case in the study, however these infections were 
performed for long periods of time and this may have more of an impact during 
establishment of infection and when trying to infection. 
 
Preliminary studies were performed to investigate the role of neutrophils in the 
formation of biofilms (the role of which is outlined in section 1.4.2). We investigated 
the effect of the ALI cell media on neutrophils, as this is not the standard media for 
neutrophil culture work. We were able to establish that there is no significant effect on 
neutrophil survival when neutrophils are cultured in ALI medium as opposed to the 
standard RPMI based medium used in neutrophil culture (data is shown in Appendix 4). 
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 RSV infection 6.2.2.
We were able to successfully establish RSV infections in ALI cells, and showed that 
RSV was specifically targeting ciliated cells. The ALI model has previously been 
shown to be an effective tool for studying RSV infections (Villenave, O'Donoghue et al. 
2011; Villenave, Thavagnanam et al. 2012; Guo-Parke, Canning et al. 2013). The study 
by Guo-Parke et al 2013 also showed use of nasal epithelial cells instead of bronchial 
epithelial cells cultured at the ALI to be an effective tool. These three studies have used 
the ALI model extensively to begin to characterise RSV infection, including utilisation 
of multiple RSV strains and the responses the cells elicited, which includes induction of 
IP-10, RANTES, IL-6 and IL-8 (Villenave, Thavagnanam et al. 2012). We wanted to 
establish an RSV infection model for use in co-infections in order to study the effects of 
multiple pathogens. 
 
 Co-infection 6.2.3.
A number studies have begun to look at RSV and NTHi co-infections. A number of 
studies show that NTHi colonisation is aided by an initial RSV infection (Jiang, Nagata 
et al. 1999; Fukasawa, Ishiwada et al. 2009; McGillivary, Mason et al. 2009). A recent 
study showed that NTHi increases the airways susceptibility to RSV infections and 
amplifies the inflammatory response (Gulraiz, Bellinghausen et al. 2015).  
 
6.3. Signalling 
To confirm the airway model functioned like an airway, and ensure exposure to 
pathogens elicited responses from the cells and stimulated inflammatory mediator 
production, semi-quantitative arrays were performed. Within experiments, arrays were 
performed at the same time, and data generated using the same exposure time per 
experiment. Our initial aim for using the cytokine arrays was to not to identify novel 
expression patterns or quantify the responses elicited, but ensure that the cells were 
responding to stimulus, therefore all cytokine arrays were only performed once andwere 
not replicated to generate such data. However, a summary of the cytokine profiles pre- 
and post- infection in all cell types can be found in table 6.1 with an indication from the 
available data as to level of increased/decreased expression. In general, the results show 
that infection of ALI differentiated cells generated a more ‘significant’ response than 
that seen in cell lines. It also demonstrates that the clinical isolate stimulates a more pro-
inflammatory response than laboratory strains. 
 
 174 
 
The results from the cytokine arrays, alongside published data, were used to identify 
targets for qPCR on samples from cells infected with NTHi and RSV for 24 hours with 
primers against IP-10 and IL-6 (Clemans, Bauer et al. 2000; Gaschler, Skrtic et al. 
2009; Oshansky, Barber et al. 2010; Smith, Kulkarni et al. 2013). Additionally, based 
on published data (Wang, Lim et al. 2002; Jono, Xu et al. 2003; Chen, Lim et al. 2004; 
Shen, Yoshida et al. 2008; Jono, Lim et al. 2012), primers against MUC5AC were used 
with samples from NTHi infected cells.  
 
An obvious target to study, in both the ALI cells and cell lines would have been IL-8, 
however, the cytokine arrays performed on ALI cultures showed that readily detectable 
amounts of IL-8 were present in our control cultures, suggesting constitutive expression 
of IL-8 in normal cultures. This could either be due to the method of cell isolation, or 
the donors that they were isolated from (as cells are rarely taken in large numbers from 
healthy patients).  
 
 Cell type 
Cytokine 
A549  
NCI-
H292  
uHBE  ALI (-IL-13)  ALI (+IL-13)  
CD40 Ligand              
G-CSF      + +  + + + + +   + + 
GM-CSF      + + +  +    + 
GRO-α  0  +  - 0  - -  - - 
sICAM-1         + + + +  + - 
IFN-              
IL-1      + - -  + +   + +  
IL-1β         + +   + +  
IL-1ra         + + +   - 0 
IL-6      0 +   + +   + 
IL-8  + + +  + + +  0 -  0 0  0 - 
IL-23              
IP-10       + +  + + +   + + + 
MIF  -  0  0 0  0 0  + + + + + 
SerpinE1  -  +  + + 0  - -  - - 
RANTES             + 
Key: 
 Control  RSV infections 
 NTHi 86-028NP-GFP 
infections 
 NTHi Clinical Isolate 
infections 
- = decreased expression 0 = no change + = increased expression 
 
 
Table 6. 1: Summary of cytokine profiles pre- and post- infection in all cell types. 
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Our studies showed an induction in IP-10 and IL-6 in response to RSV infection in all 
cell types; and in IL-13 stimulated ALI cells RANTES was also induced. Studies 
performed on a variety of cell types show that RSV utilises TLR2 (Murawski, Bowen et 
al. 2009), TLR3 (Groskreutz, Monick et al. 2006; Huang, Wei et al. 2009), TLR4 
(Haeberle, Takizawa et al. 2002; Tulic, Hurrelbrink et al. 2007; Wheeler, Chase et al. 
2009; Zhou, Yang et al. 2014) and TLR7 (Huang, Wei et al. 2009) to activate and elicit 
an immune response. This results in activation of the MyD88 and RIG-I signalling 
pathways, leading to up-regulation of a variety of molecules, including IL-6, IL-8, IP-
10, RANTES, leukocyte inhibitory factor (LIF), MIF, ICAM-1, TNF-α and IFNs, 
predominantly type III IFNs (Tulic, Hurrelbrink et al. 2007; Okabayashi, Kojima et al. 
2011; Lotz and Peebles 2012; Smith, Kulkarni et al. 2013; Villenave, Shields et al. 
2013; Foronjy, Dabo et al. 2014). RSV has been show to activate these cytokines 
through a number of signalling pathways including NF-κB, MAPK and JAK/STAT 
signalling (Bitko, Velazquez et al. 1997; Chen, Monick et al. 2000; Kong, San Juan et 
al. 2003). RANTES was found to be induced in a time-dependent manner by Hirakawa, 
Kojima et al. (2013), who also identified upregulation of MMP-10 which was prevented 
by inhibitors of JAK/STAT, EGFRs and MAPK (Hirakawa, Kojima et al. 2013). RSV 
has been shown to activate EGFR by phosphorylation in lung epithelial cells, increasing 
ERK activity to stimulate the immune response and increase survival of RSV infected 
cells by delaying apoptosis (Monick, Cameron et al. 2005; Krzyzaniak, Zumstein et al. 
2013). The induction of RANTES and IL-6 and increased MIF expression in our RSV 
infected ALI cells shows activation of signalling pathways consistent with that observed 
in other studies. 
 
NTHi stimulates an immune response predominantly through the activation of TLR2 
(Shuto, Xu et al. 2001), and a study investigating the clearance of NTHi in mouse lungs 
has shown that signalling through TLR4 is also important (Wieland, Florquin et al. 
2005). Both receptors activate MyD88-dependent and independent signalling and both 
the canonical and non-canonical NF-κB signalling pathways, with NTHi particularly 
leading to activation of p38 MAPK and thus a plethora of pro-inflammatory cytokines 
and mucins (Wang, Lim et al. 2002; Jono, Xu et al. 2003; Chen, Lim et al. 2004; 
Mikami, Gu et al. 2005; Mikami, Lim et al. 2006; Lee, Takeshita et al. 2008; Shen, 
Yoshida et al. 2008; Xu, Xu et al. 2008; Jono, Lim et al. 2012; Kyo, Kato et al. 2012). 
Studies have shown increases in expression of IL-1α, IL-1β, TNF-α, IL-6, IL-8, MCP-1 
and GM-CSF (Clemans, Bauer et al. 2000; Ren, Nelson et al. 2012) which these studies 
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have also shown. NTHi has been shown to increase ICAM-1 expression (Frick, Joseph 
et al. 2000), but has also been shown to bind to ICAM-1 (Avadhanula, Rodriguez et al. 
2006) suggesting that this increased expression is a tool utilised by NTHi to increased 
numbers of adherent bacteria. ICAM-1 expression is regulated by the NF-κB, 
JAK/STAT and MAPK pathways which release of these cytokines is consistent with. 
We also observed increased expression if ICAM-1 consistent with these studies. More 
recently, NTHi has been shown to interact with the type II transmembrane receptor 
Dectin-1, which is expressed in lung tissues to induce the pro-inflammatory response, 
however the ligand for this activity is unidentified (Heyl, Klassert et al. 2014). 
 
6.4. Strengths and Weaknesses 
Establishment of the ALI model provides a good representation of the complex airway 
epithelium as all cell types are present and airway lining fluid can be studies. 
Modulation of the mucociliary phenotype with IL-13 models an airway that is more 
reflective of diseased airways seen in subjects with CF, COPD and asthma. The 
infection models we established used different culture conditions, for example we did 
not collagen coat the transwell prior to initiating ALI culture, differing time periods, 
cells were differentiated for a minimum of 21 days prior to removal of antibiotics and 
were exposed to pathogens for longer periods of time and we also used different strains 
of pathogen, specifically when working with the clinical isolate of NTHi. 
 
One of the limiting factors with the use of primary human ALI cells is the number of 
cells that can be generated from a single sample/donor. Novel strategies need to be 
developed to overcome this. A recent publication showed that culture of primary human 
airway cells with Rho Kinase (ROCK) inhibitors (specifically Y27632) enhanced basal 
cell survival and proliferation (Horani, Nath et al. 2013). ROCK proteins are involved 
in cell adhesion, migration, apoptosis, proliferation and differentiation. We have 
replicated this data using two different doses of ROCK inhibitor, which improved basal 
cell proliferation, regardless of dose, providing an effective solution to issues 
surrounding low cell numbers. They also showed that treatment with ROCK inhibitor 
did not have any effect on cells when they were differentiated at the ALI (Horani, Nath 
et al. 2013). Again this is an area that should be further addressed in the future. 
Currently our laboratory is using this technique to increase the yield of primary mouse 
airway cells for culturing at the ALI. 
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As it stands the model is not particularly robust as it needs to factor in the high levels of 
variability between replicates from the same donor, and the variability between donors. 
A high level of variability was also seen by Gohy, Hupin et al. (2015) during their work 
on COPD airway cells. This demonstrates an issue with the quality of the cells we are 
working with as each well of cells is different, i.e. differing cell population proportions, 
even from cells from the same donor. To increase robustness of the model, many more 
replicates need to be performed both within the same donor number and additional 
donor numbers.  
 
One of the limitations of the infection aspect of the model is that lab strains were used 
throughout, with only a small investigation performed using a clinical isolate. There is 
suggestion that lab strains are somewhat attenuated, reducing their 
virulence/pathogenicity. This is particularly important for the use of NTHi as no key 
virulence feature has been identified for NTHi infection. The small amount of work we 
performed with a clinical isolate shows that multiple strains of NTHi need to be 
investigated including lab strains and potentially more virulent clinical isolates. We also 
worked under the assumption that we started each infection with the same amount of 
each pathogen; this is yet another variable that contributes to the large amount of 
variability seen. The infections would also need to be performed with far more 
replicates than are performed in this project.  
 
Further work performed within out group using similar techniques has since shown that 
quantifying RNA through use of the Nanodrop is not very precise at quantifying RNA 
in low concentrations using A280/A260, therefore we may not have obtained accurate 
concentrations for use in proceeding work. We have also found that use of TaqMan 
probes as opposed to SYBR-green labelled probes to give more robust qPCR data sets. 
There is also an issue with potential contaminants remaining after RNA extraction using 
TRI reagent, which also has an impact upon downstream work. Use of TaqMan probes, 
an alternative to TRI reagent and a more reliable quantification method would increase 
the reliability of qPCR data sets. 
 
The high variability introduced by both the differences between donors, between each 
transwell of cells cultured and load if inoculate used to perform the infection is seen in 
the quantification data throughout this thesis, large differences can be seen between 
stimulated/infected cells and controls when data is combined, however individual 
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replicates (and the error bars) show the high level of variability between experiments. 
The only way to establish the significance of results reliably is to perform many more 
replicates, for example the study performed by Gohy, Hupin et al. (2015) used cells 
from 104 patients. In this project it would improve confidence in statistical analysis 
performed on quantitative data. 
 
One of the major difficulties we experienced with the nature of establishing this culture 
technique and establishing infections was the need to plan new experiments prior to 
being able to fully analyse and understand the results from the experiments already 
performed, resulting in performance of fewer replicates that we now consider necessary 
for interpreting data.  
 
6.5. Future Directions 
Upon increasing the robustness of the model, a study focussing on identification and 
quantification of immune responses using a variety of techniques, including ELISA, 
micro array/cytokine arrays, Western blotting and qPCR would help to understand the 
role of specific cytokines and also provide information about defence mechanisms and 
key virulence factors involved in these infections. These can then be studied either by 
knocking down or silencing expression of selected target genes, or over-expressing 
specific genes in either the epithelial cells or the pathogen.  
 
Preliminary studies showed that co-infection with multiple pathogens and introducing 
neutrophils to study their effects on biofilm formation would require more optimisation 
time than this project allowed; however introducing multiple pathogens into the 
infection model would increase understanding of multiple pathogen colonisation seen in 
the airways of CF and COPD patients and further study into biofilm composition would 
aid understanding of why they are so difficult to treat. 
 
These further characterisation studies could be used to aid our understanding of immune 
responses, pathogen interactions and biofilm formations and help to develop 
therapeutics.  The model provides an ideal platform to test the efficacy of treatments in 
eliminating the pathogen. This can also be said for the identification of potential 
vaccination targets for NTHi. A vaccine already exists for RSV, which is administered 
to high risk patients to prevent a severe RSV infection but does not completely prevent 
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infection as it is not very effective; therefore further study may identify a treatment that 
totally eradicates it from the host.  
 
6.6. Conclusions 
The main aim of this thesis was to develop a model of the airway epithelium in vitro in 
order to use it as a tool to understand pulmonary innate defence mechanisms. To 
establish the airway model we investigated the use of cell lines, primary cells and the 
ALI culture model to generate a differentiated airway epithelium. To begin to study 
defence mechanisms we chose two pathogens to focus on, RSV and NTHi which are 
both frequently identified as causing respiratory infections in healthy and ‘diseased’ 
airways. My initial objective was to establish the effectiveness of cell lines and uHBE 
cells for use as a model of the airway, and establish starting doses of both pathogens and 
begin to optimise them. The cell lines proved unable to cope with infections for 
extended periods of time, exhibiting significant cell death at longer time points. 
Infection of the uHBE cell line allowed biofilm formation. None of these cells elicited a 
response to stimulus with pathogens, showing that they were not an effective tool. 
 
The results of the cell line/undifferentiated primary cell work suggested the use of a 
more complex model that represented the multiple cell types within the airway 
epithelium; therefore we chose to establish ALI culture of uHBE cells. As this 
technique has been established by a number of other groups it was important to 
characterise the cultures we established to ensure that they were consistent with those of 
other groups; this was successfully done.  After establishing the ALI culture model, the 
third objective was to expose the more complex and representative cultures to RSV and 
NTHi, in order to establish infections and investigate the immune responses elicited. 
These two pathogens have also been implicated in co-infection; especially in ‘diseased’ 
airways. Therefore, key objectives were to establish RSV and NTHi infections, 
establish a biofilm-type infection/colonisation in the bacterial infection and establish co-
infection models. Although we were unable to conduct any short term infection studies 
due to development of issues with cell differentiation, long term infections show 
clustering of bacteria in cell cultures that is consistent with biofilm formation. Washes 
taken from these infections confirmed that the bacteria present were still viable and that 
the bacteria appeared to be having some effect on immune molecules. This resulted in 
direct interaction studies between live NTHi and ALI secretions, showing degradation 
of the putative immune molecules LPLUNC1 and SPLUNC1. We also attempted a co-
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infection using the same doses we had used for individual experiments, however large 
amounts of cell death showed that this would need lots more optimisation than time 
allowed, even without the issues we were experiencing with cell differentiation. As 
such, what we learnt from this thesis relates to the technical issues of working with 
primary cells and the requirements for generating robust data when working with these 
cells, rather than contributing any new data. 
 
In conclusion, we have successfully generated a representative model of the airway 
epithelium established infections on these cells with RSV and NTHi and established 
NTHi biofilms. Cytokine arrays showed that ALI cells elicited a more complex 
response, which differs between isolates. Unfortunately, we were unable to establish a 
model of co-infection; however this could be addressed in a future project. The 
successful establishment of an airway and infection model provides an effective tool to 
study pulmonary innate defence mechanisms, mechanisms of infection and identify 
therapeutic/vaccination targets. 
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APPENDICES 
Appendix 1 – Materials 
 
1. List of Materials 
0.5M Tris pH6.8 Bio-Rad Laboratories 
1.5M Tris pH8.8 Bio-Rad Laboratories 
10% Phosphate-buffered Formalin Fischer 
20% Sodium Dodecyl Sulphate Sigma 
24-well plate Costar 
40% Acrylamide Geneflow 
4-chloro-1naphthol Sigma 
96-well Plates for qPCR Starlabs 
96-well qPCR plate sealers Starlabs 
Agarose Sigma 
Airway Epithelial Cell Basal Medium Promocell 
AlexaFluor 488 (Anti-Mouse) Invitrogen 
AlexaFluor 488 (Anti-Rabbit) Invitrogen 
AlexaFluor 568 (Anti-Rabbit) Invitrogen 
Ammonium PerSulphate Fischer 
AMV-RT  Promega 
Anti-goat IgG peroxidase conjugate Sigma 
Anti-Rabbit HRP Dako 
Anti-V5 HRP Antibody Life Technologies (R96125) 
Applied Biosystems 7900HT Fast Real-Time 
PCR System 
Applied Biosystems 
Bio Rad (LU101 imaging system) Bio Rad 
Bio-Rad Mini-PROTEAN 3 Gel 
Electrophoresis System 
Bio-Rad Laboratories 
Bio-Rad Trans-Blot SD Semi-Dry 
Electrophoretic Transfer Cell 
Bio-Rad Laboratories 
Bovine Serum Albumin Sigma 
Brain Heart Infusion Broth Oxoid 
Bromophenol Blue Phi Bio 
ColorPlus Prestained Protein Ladder New England BioLabs 
Columbia Agar Base Oxoid 
Cryo-SFM Promocell 
Developer Ilford 
DMEM Sigma 
DMSO Sigma 
dNTPs Promega 
DPX Sigma 
DTT AGTC Bioproducts 
Eosin Fischer Scientific 
EZ-ECL Chemiluminescence Detection Kit 
for HRP 
Geneflow 
Foetal Bovine Serum (FBS) (heat inactivated) Fischer Scientific 
Fixer Ilford 
Formaldehyde Fischer Scientific 
FV10-ASW 2.0 Viewer http://www.olympus-global.com/en/ 
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Glycerol Fischer Scientific 
Glycine VWR 
Goat Serum Sigma 
GoTaq Flexi DNA Polymerase Promega 
Haematoxylin Fischer Scientific 
Hemin Sigma 
Human Bronchial Epithelial (HBE) Cells  Promocell 
Human Cytokine Array Panel A Array Kit R & D Systems 
Hydrogen Peroxide Sigma 
Hypercassette Amersham 
Hyperfilm Amersham 
HyperLadder I Bioline 
HyperLadder IV Bioline 
I-block Invitrogen 
IFN-γ R & D Systems 
IL-13 eBioscience 
Incubator Sanyo 02/CO2 incubator 
Kanamycin sulphate Invitrogen 
Laminar Flow Hood MDH Inter Med 
Leica DMIRB and Spot Advanced Imaging 
Software 
Leica 
L-Glutamine Sigma 
MBF ImageJ for Microscopy http://www.macbiophotonics.ca/imagej/  
MOPS (10x) Fischer Scientific 
Mr Frosty Nalgene 
Muc5AC Antibody AbD Serotec (1695-0128) 
Muc5B Antibody Santa Cruz (SC20119) 
Nanodrop-1200 Core facility-University of Sheffield 
Nitrocellulose Membrane Bio-Rad 
Oligo(dT) Promega 
Oligonucleotide Primers Sigma 
Olympus FV-1000 Confocal Microscope Light Microscopy Facility- University 
of Sheffield 
Oxalated Horse Blood Oxoid 
Penicillin/Streptomycin Sigma 
Phosphate Buffered Saline (PBS) Gibco 
PNGaseF New England Biolabs 
Protease Inhibitor Tablet (EDTA free) Roche 
PVDF Bio-Rad Laboratories 
Quick-diff Blue Reagena 
Quick-diff Red Reagena 
Retinoic Acid Sigma 
RNA Loading Buffer Sigma 
RNasin Promega 
RPMI 1640 Sigma 
RSV Antibody AbD Serotec (7950-0004) 
Scott’s tap Water Sigma 
SPLUNC1 Antibody R & D Systems (MAB1897) 
Sodium Chloride (NaCl) Sigma 
Sterile Water for injection Braun 
SYBR Green (find out proper name) Thermo Fischer 
T25 & T75 Tissue Culture Flasks Nunc 
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TEMED Fischer 
Transwell inserts (transparent PET membrane 
with 0.4µm pores) 
BD Falcon 
Tris (powder) VWR 
Tris-HCl pH8.0 Sigma 
Triton-X Sigma 
Trypsin-EDTA Sigma 
Tween-20 Sigma 
Vectashield Mounting Medium containing 
DAPI 
Vector Laboratories 
Vectastain Elite ABC kit Vector Laboratories 
Vector NovaRed Substrate kit Vector Laboratories 
Vivaspin tubes Sartorius Stedim UK Ltd 
Xylene VWR 
Y27632 (ROCK Inhibitor) Tocris 
Yeast Extract Oxoid 
ZO-1 antibody Invitrogen (40-2200) 
α-tubulin antibody Abcam (ab61226) 
β-NAD Sigma 
β-tubulin antibody Sigma (T5201) 
 
2. List of Primary Cell Donors (Lot Nos.) 
Donor 1 9102601.3 
Donor 2 9082701.12 
Donor 3 9022003.10 
Donor 4 1101701.12 
Donor 5 6031301.14 
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3. List of Primers 
Primer Sequence 
SP1 F AGGTCTTCTGGACAGCCTCA 
SP1 R TGTCCAAGCCTCTGAGAACC 
LP1 F TCCCAGTGTCATTGGTGAAG 
LP1 R AGGAGGCTGGAGTAAGCACA 
Actin F GATCATTGCTCCTCCTGAGC 
Actin R ACATCTGCTGGAAGGTGGAC 
IP-10 F1 CCAATTTTGTCCACGTGTTG 
IP-10 F2 CCACGTGTTGAGATCATTGC 
IP-10 R1 ATTTTGCTCCCCTCTGGTTT 
IP-10 R2 CCTCTGTGTGGTCCATCCTT 
IL-6 F1 CACACAGACAGCCACTCACC 
IL-6 F2 AAAGAGGCACTGGCAGAAAA 
IL-6 R1 TTTTCTGCCAGTGCCTCTTT 
IL-6 R2 TTTCACCAGGCAAGTCTCCT 
MCP-1 F1 CCCCAGTCACCTGCTGTTAT 
MCP-1 F2 AGCAAGTGTCCCAAAGAAGC 
MCP-1 R1 AGATCTCCTTGGCCACAATG 
MCP-1 R2 TGGAATCCTGAACCCACTTC 
Muc5AC F GTGTCACCAACACCAGCAAG 
Muc5AC R TCCTGGTGCTTCTCACACTG 
Muc5B F ATGAAACCTGGGTCAACAGC 
Muc5B R TCCTCACAGGAGTAGCAGCA 
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4. Antibody Details and Dilutions 
 
Western Blotting  
Antibody 
Species 
Raised In 
Primary 
Antibody 
Dilution 
Secondary 
Antibody 
Secondary 
Antibody 
Dilution 
Human LPLUNC1A 
(in-house) 
Rabbit 1:200 
Anti-Rabbit 
HRP 
1:2000 
Human LPLUNC1B 
(in-house) 
Rabbit 1:500 
Anti-Rabbit 
HRP 
1:2000 
Human SPLUNC1A 
(in-house) 
Rabbit 1:1000 
Anti-Rabbit 
HRP 
1:2000 
Human SPLUNC1B 
(in-house) 
Rabbit 1:200 
Anti-Rabbit 
HRP 
1:2000 
SPLUNC1 (Mono) 
(R&D, MAB1897) 
Mouse 1:200 
Anti-Mouse 
HRP 
1:2000 
MUC5AC (AbD 
Serotec, 1695-0128) 
Mouse 1:500 
Anti-Mouse 
HRP 
1:2000 
MUC5B (Santa Cruz, 
SC20119) 
Rabbit 1:500 
Anti-Rabbit 
HRP 
1:2000 
Anti-V5 HRP (Life 
Technologies, 
R96125) 
Mouse 1:2000 N/A- Already HRP conjugated 
 
 
Immunohistochemistry 
Antibody 
Species 
Raised In 
Primary 
Antibody 
Dilution 
Blocking 
Serum 
Antigen 
Retrieval 
Human 
LPLUNC1B (in-
house) 
Rabbit 1:600 
Normal 
Goat 
Yes 
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Immunofluorescence 
Antibody 
Species 
Raised In 
Primary 
Antibody 
Dilution 
Secondary 
Antibody 
Secondary 
Antibody 
Dilution 
Human 
SPLUNC1B 
(in-house) 
Rabbit 1:500 
Anti-Rabbit 
AlexaFluor 488 
1:250 
MUC5AC 
(AbD Serotec, 
1695-0128) 
Mouse 1:200 
Anti-Mouse 
AlexaFluor 488 
1:250 
MUC5B 
(Santa Cruz, 
SC20119) 
Rabbit 1:500 
Anti-Rabbit 
AlexaFluor 488 
1:250 
α-tubulin 
(Abcam, 
ab61226) 
Rabbit 1:1000 
Anti-Rabbit 
AlexaFluor 488 
1:250 
β-tubulin 
(Sigma, T5201) 
Mouse 1:500 
Anti-Mouse 
AlexaFluor 488 
1:250 
ZO-1 
(Invitrogen, 40-
2200) 
Rabbit 1:250 
Anti-Rabbit 
AlexaFluor 488 
1:250 
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5. Cytokine Array Data Reference Table 
Co-ordinate Target/Control Co-ordinate Target/Control 
A1, A2 Positive C11, C12 IL-17 
A3, A4 C5a C13, C14 IL-17E 
A5, A6 CD40 Ligand, CD154 C15, C16 IL-23 
A7, A8 G-CSF, CSFβ, CSF-3 C17, C18 IL-27 
A9, A10 GM-CSF, CSFα, CSF-2 C19, C20 - 
A11, A12 GRO-α, CXCL1 D1, D2 - 
A13, A14 I-109, CCL1 D3, D4 IL-32α 
A15, A16 sICAM-1, CD54 D5, D6 IP-10, CXCL10 
A17, A18 IFN-γ, Type II IFN D7, D8 I-TAC, CXCL11 
A19, A20 Positive D9, D10 MCP-1, CCL2 
B1, B2 - D11, D12 MIF, GIF, DER6 
B3, B4 IL-1α D13, D14 MIP-1α, CCL3 
B5, B6 IL-1β D15, D16 MIP-1β, CCL4 
B7, B8 IL-1ra D17, D18 SerpinE1, PAI-1 
B9, B10 IL-2 D19, D20 - 
B11, B12 IL-4 E1, E2 Positive 
B13, B14 IL-5 E3, E4 RANTES, CCL5 
B15, B16 IL-6 E5, E6 SDF-1, CXCL12 
B17, B18 IL-8, CXCL8 E7, E8 TNF-α, TNFSF2 
B19, B20 - E9, E10 sTREM-1 
C1, C2 - E11, E12 - 
C3, C4 IL-10 E13, E14 - 
C5, C6 IL-12, p70 E15, E16 - 
C7, C8 IL-13 E17, E18 - 
C9, C10 IL-16, LCF E19, E20 Negative 
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Appendix 2 – Solutions 
 
1. Cell culture 
 
Complete culture Medium Concentration Volume 
RPMI  500ml 
Heat-inactivated FBS 10% 50ml 
Penicillin/Streptomycin  1% 5ml 
Penicillin/Streptomycin not added when making up antibiotic-free medium. 
 
5% Serum HeLa Medium Concentration Volume 
DMEM  500ml 
Heat-inactivated FBS 5% 25ml 
Penicillin/Streptomycin 1% 5ml 
L-Glutamine 2mM 5ml 
 
2% Serum HeLa Medium Concentration Volume 
DMEM  500ml 
Heat-inactivated FBS 2% 10ml 
Penicillin/Streptomycin 1% 5ml 
L-Glutamine 2mM 5ml 
 
Freezing Medium Concentration Volume 
RPMI  35ml 
Heat-inactivated FBS 20% 10ml 
DMSO 10% 5ml 
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BEGM Concentration Volume 
Airway Epithelial Cell Basal 
Medium 
 500ml 
Penicillin/streptomycin 1% 5ml 
Bovine Pituitary Extract 0.004ml/ml  
Epidermal growth factor 
(recombinant human) 
10ng/ml  
Insulin (recombinant human) 5µg/ml  
Hydrocortisone 0.5µg/ml  
Epinephrine 0.5µg/ml  
Triiodo-L-thyronine 6.7ng/ml  
Transferrin (human) 10µg/ml  
Penicillin/Streptomycin not added when making up antibiotic-free medium. 
 
ALI Media Concentration Volume 
DMEM  250ml 
Airway Epithelial Cell Basal 
Medium 
 250ml 
Penicillin/Streptomycin 1% 5ml 
Bovine Pituitary Extract 0.004ml/ml  
Epidermal growth factor 
(recombinant human) 
10ng/ml  
Insulin (recombinant human) 5µg/ml  
Hydrocortisone 0.5µg/ml  
Epinephrine 0.5µg/ml  
Triiodo-L-thyronine 6.7ng/ml  
Transferrin (human) 10µg/ml  
Retinoic Acid 50nmol  
Penicillin/Streptomycin not added when making up antibiotic-free medium. 
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2. Western Blotting 
 
SDS-PAGE Gels 
Makes 2 gels. 
Resolving Gel 12% 15% 
Water 9.9ml 8.1ml 
40% Polyacrylamide 6.8ml 8.4ml 
1.5M Tris pH8.8 5.7ml 
112.5µl 
225µl 
9µl 
20% SDS solution 
20% APS 
TEMED 
 
Stacking Gel (5%)  
Water 6.0ml 
40% Polyacrylamide 1240µl 
0.5M Tris pH6.8 2520µl 
20% SDS solution 50µl 
20% APS 100µl 
TEMED 10µl 
 
2x SDS Lysis Buffer 
Reagent Concentration Mass/Volume 
1M DTT 0.1M 1ml 
Glycerol 20% 2ml 
0.5M Tris pH 6.8 0.06M 1ml 
0.2% Bromophenol Blue 
(dissolved in ethanol) 
0.02% 200µl 
20% SDS Solution 4%  
Protease Inhibitor 2% 1 tablet 
Water  Up to 10 ml 
Stored in 1ml aliquots at -20
o
C 
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10x SDS-PAGE Running Buffer 
Reagent Concentration Mass/Volume 
Tris 25mM 30.3g 
Glycine 4mM 2.9g 
20% SDS solution 0.1% 50ml 
Water  Up to 1 litre 
To make 1 litre of 1x solution 100ml of 10x added to 900ml water. Stored at room 
temperature. 
 
1x Transfer Buffer 
Reagent Concentration Mass/Volume 
Tris 48mM 2.9g 
Glycine 38.6mM 1.45g 
20% SDS solution 0.037% 925µl 
Methanol 20% 100ml 
Water  Up to 1 litre 
Stored at room temperature. 
 
10x TBS-Tween 
Reagent Concentration Mass/Volume 
1M Tris-HCl pH8.0 0.01M 100ml 
NaCl 0.17M 97.3g 
Tween-20 0.05% 5ml 
Water  Up to 1 litre 
To make 1 litre of 1x solution 100ml of 10x added to 900ml water. Stored at room 
temperature. 
 
10x TBS 
Reagent Concentration Mass/Volume 
1M Tris-HCl pH8.0 0.01M 100ml 
NaCl 0.17M 97.3g 
Water  Up to 1 litre 
To make 1 litre of 1x solution 100ml of 10x added to 900ml water. Stored at room 
temperature. 
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Blocking Buffer/ Antibody Buffer 
Reagent Concentration Mass/Volume 
Powdered Milk 5% 5g 
TBS-Tween  100ml 
Stored at +4
o
C for 24 hours 
 
3. Gel Electrophoresis 
 
RNA Gel 
Reagent Mass/Volume 
Agarose 0.5g 
Water 38.5ml 
10x MOPS 5ml 
Formaldehyde 8.5ml 
Makes 50mls.  
 
DNA Gel 
Reagent 1% Gel 2% Gel 
Agarose 1g 2g 
1x TAE 100ml 
Makes 100mls. 
 
4. Immunofluorescent Staining 
 
Permeabilisation buffer 
Reagent Concentration Mass/Volume 
Goat Serum 10% 1ml 
PBS 90% 15ml 
Triton-x 0.5% 50µl 
Makes 10mls. Stored at 4
o
C. 
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5. Bacterial culture 
 
Chocolate agar plates / + kanamycin 
Reagent Concentration Mass/Volume 
Columbia Agar Base 3.9% 7.8g 
Oxalated Horse Blood 7.5% 15ml 
De-ionised Water  200ml 
Kanamycin (20mg/ml) 20µg/ml 215 µl 
Columbia agar base and water are mixed and autoclaved. Agar is cooled to 70
o
C in a 
water bath for 15 minutes. Horse blood was added and put back in the water bath for 5 
minutes to lyse the blood until the mixture has turned a chocolate colour. If agar is 
being supplemented with kanamycin (for 86-028NP GFP strain) it is then cooled to a 
maximum of 55
o
C whilst mixing gently before addition of kanamycin.  Plates are then 
poured, allowed to cool and stored at +4
o
C and dried and warmed before use. 
 
BHI broth 
Reagent Concentration Mass/Volume 
BHI 3.7% 18.5g 
Yeast Extract 0.5% 2.5g 
De-ionised Water  500ml 
BHI, yeast extract and water mixed and placed in universal bottles in 20ml aliquots. 
These are then autoclaved and stored at room temperature. 
 
Supplement Concentration Mass/Volume 
Kanamycin (20mg/ml) 20µg/ml 20 µl  
Hemin (1mg/ml) 10µg/ml 200µl 
β-NAD (200µg/ml) 2µg/ml 200µl 
Kanamycin is stored long term at -20
o
C and at +4
o
C for up to 1 month. Hemin and β-
NAD are stored at +4
o
C. All are added to 20mls of BHI broth as and when needed. 
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Appendix 3 - Validation and Characterisation of Antibodies 
  
Appendix Figure 1: Characterisation of the LPLUNC1 antibody by Western 
blotting 
V5-epitope tagged LPLUNC1 proteins were generated by coupled in vitro 
transcription and translations (IvT-LPLUNC1) or from conditioned medium from 
stable CHO expressing cell lines (CHO-LPLUNC1) or control medium (CHO) as 
outlined in the materials and methods section. 2µl of the IVT reaction or 5µl of 
concentrated conditioned media was resolved on replicate 12% SDS-PAGE gels and 
Western blotted using the LPLUNC1B polyclonal antibody or an antibody to the 
V% epitope as described (A). V5-epitope tagged PLUNC proteins were generated 
from conditioned medium from stable CHO expressing cell lines, expressing wt- and 
cys-mutant SPLUNC1, SPLUNC2 or LPLUNC1 (CHO-LPLUNC1) or control 
medium (CHO) as outlined in the materials and methods section. 5µl of 
concentrated conditioned media was resolved on replicate 12% SDS-PAGE gels and 
Western blotted using the LPLUNC1B polyclonal antibody or an antibody to the 
V% epitope as described (B). All blots show presence of bands at the appropriate 
size for all samples. Data was generated by Dr Frances Barnes and taken from 
Bingle et al (2010). 
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Appendix Figure 2: Location of Epitopes used for SPLUNC1 and LPLUNC1 
antibody generation 
The location of peptides used for antibody generation are shown in yellow on 
alignments of the human and mouse SPLUNC1 and LPLUNC1 proteins.   
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Appendix 4 – qPCR Data 
 
1. Confirmation of Amplification Product of Primer Pairs 
After the qPCR was complete, dissociation curves were performed to ensure that the 
desired amplicon was detected.  SYBR green detects any dsDNA, including primer 
dimers and contaminating DNA resulting in a curve with multiple peaks, whereas a pure 
sample has one peak therefore eliminating the need to run a DNA gel. Dissociation 
curves were generated for SPLUNC1 (Appendix Figure 3A), LPLUNC1 (Appendix 
Figure 3B), Actin serving as the endogenous control for the PLUNC qPCR samples 
(Appendix Figure 3C), MUC5AC (Appendix Figure 3D), MUC5B (Appendix Figure 
3E) and Actin serving as the endogenous control for the Mucin qPCR samples 
(Appendix Figure 3F). All curves, except MUC5AC, show a single peak, indicating 
amplification of a single product. However, the MUC5AC plot appears to show one 
sample that does not conform to the others so a selection of samples from this plate was 
run on a 2% agarose gel, including the ‘abnormal’ sample (Appendix Figure 3G). This 
shows bands for actin, MUC5B and MUC5AC at the expected sizes, confirming 
amplification of the right product. The sample loaded on the far right, next to the 
markers, is the ‘abnormal’ sample seen in the dissociations curve, which does appear to 
be any different to the other samples. 
 
A 1.5% DNA gel was poured and two replicate samples of IFN-γ stimulated and control 
from the qPCR were resolved to confirm correct product size. The gel showed bands at 
the expected size for all three primer pairs, SPLUNC1, LPLUNC1 and actin, in all 
samples (Appendix Figure 4).  
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Appendix Figure 3: Dissociation Curve and Agarose Gel of qPCR products 
Dissociation curves were performed for SPLUNC1 (A), LPLUNC1 (B), Actin 
serving as the endogenous control for the PLUNC qPCR samples (C), MUC5AC 
(D), MUC5B (E) and Actin serving as the endogenous control for the Mucin qPCR 
samples (F). All curves, except MUC5AC, show a single peak, indicating 
amplification of a single product. However, the MUC5AC plot appears to show one 
sample that does not conform to the others so a selection of samples from this plate 
was run out on a 2% agarose gel, including the abnormal sample (G). This shows 
bands for actin, MUC5B and MUC5AC at the expected sizes, confirming 
amplification of the right product. The sample loaded on the far right, next to the 
markers, is the ‘abnormal’ sample seen in the dissociations curve, which does appear 
to be any different to the other samples. 
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Appendix Figure 4: DNA gel of samples from qPCR to confirm correct 
amplification product 
Samples from two repeats of the IFN-γ stimulated and control wells for SPLUNC1, 
LPLUNC1 and actin were run on a 1.5% agarose gel. The bands were of expected 
size in each sample.  
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2. Individual replicates of qPCR data 
 
  
Appendix Figure 5: Fold change qPCR data for each individual replicate in 24h 
NTHi infection of A549, NCI-H292 and uHBE cells 
Data for the individual replicates of qPCRs performed for IP-10, IL-6 and MUC5AC 
in A549 (A), NCI-H292 (B) and uHBE (C) cells to show the variation between 
replicates. 
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Appendix Figure 6: Fold change qPCR data for each individual replicate in 24h 
RSV infection of A549, NCI-H292 and uHBE cells 
Data for the individual replicates of qPCRs performed for IP-10 and IL-6 in A549 
(A), NCI-H292 (B) and uHBE (C) cells to show the variation between replicates. 
 233 
 
  
Appendix Figure 7: Fold change qPCR data for each individual replicate in 
ALI cells cultured in the absence and presence of IL-13 
Data for the individual replicates of qPCRs performed for SPLUNC1 (A), 
LPLUNC1 (B), MUC5AC (C) and MUC5B (D) in cells cultured in the absence and 
presence of IL-13 to show the variation between replicates. 
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Appendix Figure 8: Fold change qPCR data for each individual replicate in 
ALI cells stimulated with IFN-γ 
Data for the individual replicates of qPCRs for SPLUNC1 (A), LPLUNC1 (B) and 
IP-10 (C) in ALI cells treated with IFN-γ and controls to show the variation between 
replicates. 
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Appendix 5 – Preliminary Studies 
1. Effect of ROCK Inhibitor on Cell Numbers 
Primary human bronchial epithelial cells were seeded into 24 well plates at a density of 
10,000 cells per well. Wells were cultured in the presence of 5µM or 10µM of the Rho 
Kinase inhibitor, Y27632, alongside control wells that were cultured in standard media. 
These were cultured for 3 days, after which they were fixed with methanol and stained 
using quick-diff stains; quick-diff red for 2 minutes, then quick-diff blue for 1 min and 
washed with tap water. These were then imaged using a Leica IMDRB microscope. 
Images of the monolayer primary cell cultures show increased cell numbers in wells 
treated with the Rho Kinase inhibitor  in comparison to the control wells  There appears 
to be no difference between the 5µM and 10µM doses of Y27632. 
 
 
 
 
  
Appendix Figure 9: Culture of primary human bronchial epithelial cells with 
the Rho Kinase Inhibitor Y27632 increases cell proliferation 
10,000 cells per well were cultured in the presence of 5µM (A) or 10µM (C) of 
Y27632 for 3 days alongside untreated controls (B and D). Quick-diff staining of 
cells showed increased cell numbers in treated wells than controls. 
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2. Neutrophil Studies 
Neutrophils were cultured in RPMI medium and ALI medium for 4 and 20 hours. The 
samples were then cytospun and stained using Quick-diff staining. The number of live 
and apoptotic neutrophils were counted and percentage apoptosis calculated. At 4 hours 
there appeared to be no difference between the two conditions; however at 20 hours the 
differences are much more visible. This difference was not found to be significant using 
a paired t-test for each time point. 
 
 
Appendix Figure 10: Effect of ALI medium on neutrophil apoptosis 
Neutrophils cultured in the RPMI medium they prefer and ALI medium for 4 and 20 
hours showed no difference in levels of apoptosis after 4 hours. There was a more 
marked difference at 20 hours; however this was not significant when using a paired 
t-test for each time point. 
